https://www.newslocker.com/en-au/profession/biotechnology/en-auCopyright (C) 2026 newslocker.comWed, 27 May 2026 21:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/labors-cgt-challenge-deepens-as-biotech-sector-raises-alarm/Wed, 27 May 2026 21:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/labors-cgt-challenge-deepens-as-biotech-sector-raises-alarm/https://www.newslocker.com/en-au/profession/biotechnology/ambitious-plan-to-convert-forestry-waste-into-fuel-for-ships-and-planes/Thu, 25 Sep 2025 06:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ambitious-plan-to-convert-forestry-waste-into-fuel-for-ships-and-planes/https://www.newslocker.com/en-au/profession/biotechnology/sydney-man-becomes-cryonics-facilitys-first-client-with-hopes-he-will-eventually-be-brought-back-to-life/Thu, 23 May 2024 06:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sydney-man-becomes-cryonics-facilitys-first-client-with-hopes-he-will-eventually-be-brought-back-to-life/https://www.newslocker.com/en-au/profession/biotechnology/seedless-mangoes-could-be-around-the-corner-but-are-shoppers-willing-to-pay-for-them/Sun, 28 Apr 2024 21:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/seedless-mangoes-could-be-around-the-corner-but-are-shoppers-willing-to-pay-for-them/https://www.newslocker.com/en-au/profession/biotechnology/how-a-croc-bite-and-quick-thinking-could-make-for-a-world-beating-pain-relief-remedy/Thu, 02 Nov 2023 11:07:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/how-a-croc-bite-and-quick-thinking-could-make-for-a-world-beating-pain-relief-remedy/https://www.newslocker.com/en-au/profession/biotechnology/elon-musks-neuralink-gets-approval-to-start-clinical-trials-implanting-chips-in-human-brains/Fri, 26 May 2023 04:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/elon-musks-neuralink-gets-approval-to-start-clinical-trials-implanting-chips-in-human-brains/https://www.newslocker.com/en-au/profession/biotechnology/these-robots-are-built-using-biology-from-insects-mdash-the-creators-say-its-a-game-changer/Sun, 12 Mar 2023 20:17:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/these-robots-are-built-using-biology-from-insects-mdash-the-creators-say-its-a-game-changer/https://www.newslocker.com/en-au/profession/biotechnology/halfway-between-brisbane-and-the-gold-coast-this-city-wants-to-be-the-next-silicon-valley-heres-how/Sun, 05 Feb 2023 20:32:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/halfway-between-brisbane-and-the-gold-coast-this-city-wants-to-be-the-next-silicon-valley-heres-how/https://www.newslocker.com/en-au/profession/biotechnology/pearl-to-bone-project-hopes-to-inspire-northern-australia-tech-boom/Mon, 25 Apr 2022 02:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pearl-to-bone-project-hopes-to-inspire-northern-australia-tech-boom/https://www.newslocker.com/en-au/profession/biotechnology/app-screening-coughs-for-covid-receives-promising-early-trial-results/Tue, 22 Mar 2022 08:10:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/app-screening-coughs-for-covid-receives-promising-early-trial-results/https://www.newslocker.com/en-au/profession/biotechnology/its-a-disaster-australian-rat-producers-slam-governments-for-dragging-their-feet-on-at-home-testing/Thu, 13 Jan 2022 18:44:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/its-a-disaster-australian-rat-producers-slam-governments-for-dragging-their-feet-on-at-home-testing/https://www.newslocker.com/en-au/profession/biotechnology/australian-made-rats-await-tga-approval-amid-supply-shortage/Thu, 13 Jan 2022 18:44:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/australian-made-rats-await-tga-approval-amid-supply-shortage/https://www.newslocker.com/en-au/profession/biotechnology/australian-made-rats-await-tga-approval-amid-rapid-antigen-test-shortage/Thu, 13 Jan 2022 18:44:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/australian-made-rats-await-tga-approval-amid-rapid-antigen-test-shortage/https://www.newslocker.com/en-au/profession/biotechnology/sleep-apnoea-going-undiagnosed-as-current-tests-miss-the-full-story-study-finds/Mon, 20 Dec 2021 05:03:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/sleep-apnoea-going-undiagnosed-as-current-tests-miss-the-full-story-study-finds/https://www.newslocker.com/en-au/profession/biotechnology/how-a-cracker-program-teaching-girls-to-weld-is-widening-career-options/Tue, 28 Sep 2021 00:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-a-cracker-program-teaching-girls-to-weld-is-widening-career-options/https://www.newslocker.com/en-au/profession/biotechnology/elizabeth-holmes-goes-on-trial-for-theranos-scandal/Sat, 11 Sep 2021 22:10:26 +0200https://www.newslocker.com/en-au/profession/biotechnology/elizabeth-holmes-goes-on-trial-for-theranos-scandal/https://www.newslocker.com/en-au/profession/biotechnology/how-should-we-treat-insects/Thu, 19 Aug 2021 08:45:17 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-should-we-treat-insects/https://www.newslocker.com/en-au/profession/biotechnology/pfizer-az-and-moderna-have-dominated-the-globe-but-australias-next-generation-covid-19-vaccines-offer-something-different/Sat, 10 Jul 2021 21:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pfizer-az-and-moderna-have-dominated-the-globe-but-australias-next-generation-covid-19-vaccines-offer-something-different/https://www.newslocker.com/en-au/profession/biotechnology/chasing-the-mutants-the-australian-researchers-searching-for-next-generation-covid-19-vaccines/Sat, 10 Jul 2021 21:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/chasing-the-mutants-the-australian-researchers-searching-for-next-generation-covid-19-vaccines/https://www.newslocker.com/en-au/profession/biotechnology/bill-and-melinda-gates-agree-to-divide-their-assets-but-exactly-who-gets-what-is-uncertain/Tue, 04 May 2021 04:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bill-and-melinda-gates-agree-to-divide-their-assets-but-exactly-who-gets-what-is-uncertain/https://www.newslocker.com/en-au/profession/biotechnology/australian-astrazeneca-manufacturer-still-committed-to-make-50-million-vaccine-doses/Fri, 09 Apr 2021 04:42:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/australian-astrazeneca-manufacturer-still-committed-to-make-50-million-vaccine-doses/https://www.newslocker.com/en-au/profession/biotechnology/why-big-tech-literally-wants-to-read-your-mind/Wed, 10 Mar 2021 21:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/why-big-tech-literally-wants-to-read-your-mind/https://www.newslocker.com/en-au/profession/biotechnology/the-thought-controlled-technology-that-has-big-tech-excited/Wed, 10 Mar 2021 21:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-thought-controlled-technology-that-has-big-tech-excited/https://www.newslocker.com/en-au/profession/biotechnology/the-thought-controlled-tech-that-has-facebook-and-elon-musk-excited-and-ethicists-worried/Wed, 10 Mar 2021 21:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-thought-controlled-tech-that-has-facebook-and-elon-musk-excited-and-ethicists-worried/https://www.newslocker.com/en-au/profession/biotechnology/scientist-extracts-dried-coronavirus-samples-from-bank-notes/Sun, 11 Oct 2020 21:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/scientist-extracts-dried-coronavirus-samples-from-bank-notes/https://www.newslocker.com/en-au/profession/biotechnology/you-may-never-have-heard-of-him-but-andrew-barkla-was-australias-highest-paid-ceo-in-2019/Thu, 06 Aug 2020 20:53:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/you-may-never-have-heard-of-him-but-andrew-barkla-was-australias-highest-paid-ceo-in-2019/https://www.newslocker.com/en-au/profession/biotechnology/first-australian-made-covid-swabs-a-promising-sign-for-local-manufacturers/Sat, 01 Aug 2020 22:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/first-australian-made-covid-swabs-a-promising-sign-for-local-manufacturers/https://www.newslocker.com/en-au/profession/biotechnology/first-aussie-made-covid-swabs-reveals-manufacturing-pivot/Sat, 01 Aug 2020 22:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/first-aussie-made-covid-swabs-reveals-manufacturing-pivot/https://www.newslocker.com/en-au/profession/biotechnology/a-promising-coronavirus-vaccine-and-a-200-million-profit-now-for-the-bad-news/Mon, 27 Jul 2020 21:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-promising-coronavirus-vaccine-and-a-200-million-profit-now-for-the-bad-news/https://www.newslocker.com/en-au/profession/biotechnology/tech-stocks-soar-as-the-world-stays-indoors-but-will-it-all-come-crashing-down/Tue, 14 Jul 2020 19:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tech-stocks-soar-as-the-world-stays-indoors-but-will-it-all-come-crashing-down/https://www.newslocker.com/en-au/profession/biotechnology/tech-stock-bubble-warnings-rise-amid-coronavirus-rally/Tue, 14 Jul 2020 19:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tech-stock-bubble-warnings-rise-amid-coronavirus-rally/https://www.newslocker.com/en-au/profession/biotechnology/renewed-australian-motor-industry-to-be-fuelled-by-low-emission-hydrogen-cars/Mon, 29 Jun 2020 02:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/renewed-australian-motor-industry-to-be-fuelled-by-low-emission-hydrogen-cars/https://www.newslocker.com/en-au/profession/biotechnology/could-sugarcane-regions-pioneer-a-bioplastics-industry/Sun, 21 Jun 2020 23:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/could-sugarcane-regions-pioneer-a-bioplastics-industry/https://www.newslocker.com/en-au/profession/biotechnology/could-farmers-fuel-the-next-stage-of-renewables/Wed, 13 May 2020 02:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/could-farmers-fuel-the-next-stage-of-renewables/ Emergency workers are scrambling together contingency plans, fearing hospitals could soon be overwhelmed.
Scientists are racing to invent a faster, cheaper Covid-19 test kit available for us all.
Restaurants are reinventing themselves as delivery services, artists are turning to live-streaming to make a living.
This week, the entire Background Briefing team investigates how each of us are finding new ways to get by.]]>https://www.newslocker.com/en-au/profession/biotechnology/how-were-getting-through-this/Sat, 28 Mar 2020 22:05:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/how-were-getting-through-this/https://www.newslocker.com/en-au/profession/biotechnology/cbas-falling-profit-and-csls-gains-highlight-differing-fortunes-of-banks-and-biotech/Wed, 12 Feb 2020 00:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/cbas-falling-profit-and-csls-gains-highlight-differing-fortunes-of-banks-and-biotech/https://www.newslocker.com/en-au/profession/biotechnology/biotech-giant-csl-close-to-overtaking-cba-as-profit-reports-confirm-diverging-fortunes/Wed, 12 Feb 2020 00:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/biotech-giant-csl-close-to-overtaking-cba-as-profit-reports-confirm-diverging-fortunes/https://www.newslocker.com/en-au/profession/biotechnology/australian-biotech-industry-struggling-to-keep-innovations-out-of-foreign-hands/Tue, 11 Feb 2020 20:07:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/australian-biotech-industry-struggling-to-keep-innovations-out-of-foreign-hands/https://www.newslocker.com/en-au/profession/biotechnology/a-biotech-firm-is-about-to-pass-the-commonwealth-bank-as-australias-second-biggest-company/Tue, 11 Feb 2020 20:07:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/a-biotech-firm-is-about-to-pass-the-commonwealth-bank-as-australias-second-biggest-company/https://www.newslocker.com/en-au/profession/biotechnology/the-radical-experimenters-a-rapper-a-poet-and-a-biological-artist/Sun, 09 Feb 2020 07:05:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-radical-experimenters-a-rapper-a-poet-and-a-biological-artist/ While the value of data is not disputed, the art of patient storytelling is seldom discussed.  I believe this is partly due to the desire that patients’ experiences be respected, not questioned, or confronted in the same manner policies are debated.  There’s also a desire not to cherry-pick the patie]]>https://www.newslocker.com/en-au/profession/biotechnology/patient-storytelling-theres-an-art-to-it/Mon, 18 Nov 2019 17:21:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/patient-storytelling-theres-an-art-to-it/ Sadly, after two decades, there remain technologies in the]]>https://www.newslocker.com/en-au/profession/biotechnology/could-the-lifesaving-promises-of-golden-rice-finally-be-realized/Thu, 14 Nov 2019 21:32:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/could-the-lifesaving-promises-of-golden-rice-finally-be-realized/ “The agency [Centers for Medicare & Medicaid Services] on Friday announced a $9 monthly premium increase and $13 annual deductible hike, but argued that the White House is working to bring down cost drivers for seniors.
“The increase in the Part B premiums and deductible is largely due to rising spending on physician-administered drugs,” CMS said in its announ]]>https://www.newslocker.com/en-au/profession/biotechnology/cmss-own-data-do-not-support-claims-on-part-b-drug-spending/Tue, 12 Nov 2019 11:30:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/cmss-own-data-do-not-support-claims-on-part-b-drug-spending/ Problem #1: H.R. 3 does NOT reinvest savings back into the NI]]>https://www.newslocker.com/en-au/profession/biotechnology/in-speaker-pelosis-extreme-drug-pricing-bill-funding-for-nih-is-mia/Thu, 07 Nov 2019 22:44:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/in-speaker-pelosis-extreme-drug-pricing-bill-funding-for-nih-is-mia/ Synthetic biology can be used to develop renewable chemicals to create products like synthetic rubber for tires or bioplastics]]>https://www.newslocker.com/en-au/profession/biotechnology/synthetic-biology-to-sustain-agriculture-and-transform-the-food-system/Thu, 07 Nov 2019 21:11:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/synthetic-biology-to-sustain-agriculture-and-transform-the-food-system/https://www.newslocker.com/en-au/profession/biotechnology/gmos-and-animal-feed-getting-the-facts/Wed, 06 Nov 2019 22:23:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/gmos-and-animal-feed-getting-the-facts/ Biotech Primer and BIO are joining forces to offer online training/education to the BIO Membership community and bi]]>https://www.newslocker.com/en-au/profession/biotechnology/expanding-benefits-to-members-bio-now-offering-education-and-training-courses/Wed, 06 Nov 2019 18:15:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/expanding-benefits-to-members-bio-now-offering-education-and-training-courses/https://www.newslocker.com/en-au/profession/biotechnology/the-pelosi-plan-and-me-too-drugs/Tue, 05 Nov 2019 15:59:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-pelosi-plan-and-me-too-drugs/ “We’re poised on the precipice of scientific possibility, there’s enormous potential for sci]]>https://www.newslocker.com/en-au/profession/biotechnology/biosummit19-concludes-with-message-of-hope-offered-by-innovation/Mon, 04 Nov 2019 21:14:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/biosummit19-concludes-with-message-of-hope-offered-by-innovation/https://www.newslocker.com/en-au/profession/biotechnology/australia-is-rich-but-unsophisticated-says-harvard-but-is-it-true/Fri, 01 Nov 2019 20:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/australia-is-rich-but-unsophisticated-says-harvard-but-is-it-true/ This was the key question addressed by the “Practices and Principles: Navigating the FDA” panel on day one of BIO’s Patient and Health Advocacy Summit. 
 
“It’s really been heartening to see the ways that not just the FDA but industry is inco]]>https://www.newslocker.com/en-au/profession/biotechnology/fda-discusses-effective-patient-engagement-at-biosummit19/Fri, 01 Nov 2019 19:02:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/fda-discusses-effective-patient-engagement-at-biosummit19/ “I didn’t understand the language of the scientists,” Dant recalled. “The key for every advocate is education. Once I was able to understand the basic terminology, I was able to ask the right questions. It’s not someone else’s responsibility to teach]]>https://www.newslocker.com/en-au/profession/biotechnology/biosummit19-education-and-partnerships-raise-awareness/Fri, 01 Nov 2019 18:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/biosummit19-education-and-partnerships-raise-awareness/ Farmers can be part of the climate change solution by cutting greenhouse gas emissions, increasing carbon sequestration and making farms more resilient, according to a Capitol Hill hearing this week.
“Anyone who eats should care about the climate]]>https://www.newslocker.com/en-au/profession/biotechnology/our-farms-our-food-and-our-future-depend-on-climate-change-solutions/Thu, 31 Oct 2019 19:20:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/our-farms-our-food-and-our-future-depend-on-climate-change-solutions/https://www.newslocker.com/en-au/profession/biotechnology/how-diverse-is-our-export-economy/Thu, 31 Oct 2019 07:30:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/how-diverse-is-our-export-economy/ “The reason why so few antibiotics are being developed is simple – the market is broken. Estimates show that it takes more than a decade to develop a new antibiotic or vaccine and can cost more than $1 billion. But even when a product does make it to the market, it mi]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-solving-the-looming-superbug-crisis-will-require-bold-action-from-congress/Mon, 28 Oct 2019 14:26:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/greenwood-solving-the-looming-superbug-crisis-will-require-bold-action-from-congress/ The National Business Aviation Association’s (NBAA) week-long Convention & Exhibition event is showcasing sustainability. As part of the event’s aircraft display, all t]]>https://www.newslocker.com/en-au/profession/biotechnology/ready-for-takeoff-sustainable-fuels-are-decarbonizing-our-skies/Thu, 24 Oct 2019 21:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ready-for-takeoff-sustainable-fuels-are-decarbonizing-our-skies/ Attendance set a n]]>https://www.newslocker.com/en-au/profession/biotechnology/fundraising-companies-find-strategic-partners-that-best-fit-their-stage-of-development-at-bio-investor-forum/Thu, 24 Oct 2019 02:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fundraising-companies-find-strategic-partners-that-best-fit-their-stage-of-development-at-bio-investor-forum/ That was the unanimous consensus of a panel of experts who explored the topic at the BIO Investor Forum on Tuesday in San Francisco. The topic is especially timely for biotech companies headquartered in California, which las]]>https://www.newslocker.com/en-au/profession/biotechnology/ipos-are-a-gateway-to-more-diverse-biotech-boards/Wed, 23 Oct 2019 21:27:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ipos-are-a-gateway-to-more-diverse-biotech-boards/ That was the message of James Huang, a managing partner in Kleiner Perkins’s China office who specializes in facilitating cross-border deal financing. He told attendees at the BIO Investment Forum that the Trump administration’s new rules scrutinizing foreign investment]]>https://www.newslocker.com/en-au/profession/biotechnology/investment-crackdown-prompts-chinese-investors-to-leave-us-biotech-market-and-focus-on-europe/Wed, 23 Oct 2019 02:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/investment-crackdown-prompts-chinese-investors-to-leave-us-biotech-market-and-focus-on-europe/ Gene therapies have the potential to increase the healthspan of patients and offer new approaches to treating diseases, with a sizable pipeline in development. Early leaders in the field have focused on rare diseases which continues to open the path]]>https://www.newslocker.com/en-au/profession/biotechnology/gene-therapies-the-pipeline-towards-a-new-era-for-patients/Wed, 23 Oct 2019 02:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gene-therapies-the-pipeline-towards-a-new-era-for-patients/ The new app, available for free in the App Store and Google Play Store, has a streamlined interface that is designed to put key information a]]>https://www.newslocker.com/en-au/profession/biotechnology/new-bio-one-on-one-partnering-mobile-app/Wed, 16 Oct 2019 22:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-bio-one-on-one-partnering-mobile-app/ Nothing was off the table this week as BIO engaged in two pivotal discussions focused on the future of agriculture and food.
On Monday, Dana O’Brien, vice president for BIO’s food and agriculture section, attended the Wall Street Journal’s Global Food Forum in New York City.
At the event, leaders from USDA and several food companies, including McDonald’s, Cargill and Mondelez, were on hand to discuss the next breakthrou]]>https://www.newslocker.com/en-au/profession/biotechnology/bios-week-with-food-and-ag-leaders/Thu, 10 Oct 2019 22:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bios-week-with-food-and-ag-leaders/ Dr. Holaday’s career was nothing short of inspiring. After earning his Ph.D. from the University of California, San Francisco School of Medicine, he served at the Walter Reed Army Institute of Research as an Army captain, and later as head of the Neuropharmacology Department. Holaday was also a professor at both Johns Hopkins University and the Uniformed Services Univ]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-mourns-passing-of-dr-john-holaday/Thu, 10 Oct 2019 18:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-mourns-passing-of-dr-john-holaday/ Read the full letter below.
When I was a college student during the tumultuous years of 1969 to 1973, I dedica]]>https://www.newslocker.com/en-au/profession/biotechnology/bios-leadership-transition-the-fight-continues/Wed, 09 Oct 2019 23:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bios-leadership-transition-the-fight-continues/https://www.newslocker.com/en-au/profession/biotechnology/bringing-modern-agriculture-to-the-people/Tue, 08 Oct 2019 15:56:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bringing-modern-agriculture-to-the-people/ The Swedish teenager arrived in the Big Apple after a two-week boat trip from Europe across the Atlantic Ocean. The young climate activist refused to travel by plane because of aviation’s significant carbon footprint.]]>https://www.newslocker.com/en-au/profession/biotechnology/climate-week-biofuels-to-decarbonize-air-travel/Thu, 03 Oct 2019 18:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/climate-week-biofuels-to-decarbonize-air-travel/https://www.newslocker.com/en-au/profession/biotechnology/doing-agritourism-right/Wed, 02 Oct 2019 21:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/doing-agritourism-right/https://www.newslocker.com/en-au/profession/biotechnology/making-alzheimers-treatments-a-priority/Wed, 25 Sep 2019 21:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/making-alzheimers-treatments-a-priority/  WINNER: Early Stage Entrepreneur
 
SciBac creates live biotherapeutics that treat antibiotic resistant disease while fortifying the microbiome. The company improves beneficial microorganisms by using its MERGE (Microbial Enhanced Recombinants Generated by Evolution) platform that can quickly, naturally and safely transfer useful geneti]]>https://www.newslocker.com/en-au/profession/biotechnology/buzz-of-bio-winners-for-the-2019-bio-investor-forum/Mon, 23 Sep 2019 19:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/buzz-of-bio-winners-for-the-2019-bio-investor-forum/ And while IFIC has long hosted the annual event, the addition of EatingWell provided a new perspective on the intersection of technology and diet trends.
As part of that discussion, the summit highlighted the role that gene editing can play in protecting the future of foods.
Mark Guiltinan, professor of plant molecula]]>https://www.newslocker.com/en-au/profession/biotechnology/imagine-a-world-without-chocolate-futureoffood-summit-highlights-gene-editings-potential/Fri, 20 Sep 2019 17:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/imagine-a-world-without-chocolate-futureoffood-summit-highlights-gene-editings-potential/ This theme represents the collective efforts and perseverance to develop solutions that go beyond our wildest dreams. We don’t just ove]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-international-convention-aims-to-go-beyond/Thu, 19 Sep 2019 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-international-convention-aims-to-go-beyond/ **
I-MAK’s Distorted View of the U.S. Patent System
July 5, 2018
In an opinion piece published at&]]>https://www.newslocker.com/en-au/profession/biotechnology/tbt-debunking-some-common-myths-on-patent-protections/Thu, 19 Sep 2019 15:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tbt-debunking-some-common-myths-on-patent-protections/https://www.newslocker.com/en-au/profession/biotechnology/bio-hosts-2019-bio-latin-america-conference-in-brazil/Thu, 19 Sep 2019 15:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-hosts-2019-bio-latin-america-conference-in-brazil/ The biofuels industry is still feeling the sting from President Trump’s decision to grant refinery waivers to oil companies under the Renewable Fuel Standard. Since then, the Administration has been trying]]>https://www.newslocker.com/en-au/profession/biotechnology/will-the-rfs-deal-protect-innovation-and-our-planet/Wed, 18 Sep 2019 21:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/will-the-rfs-deal-protect-innovation-and-our-planet/https://www.newslocker.com/en-au/profession/biotechnology/tackling-hepatitis-c-hand-in-hand-with-communities/Wed, 18 Sep 2019 17:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tackling-hepatitis-c-hand-in-hand-with-communities/ Here’s how the current system works. Under Medicare Part B, the government reimburses payers for medicines that are administered directly by providers]]>https://www.newslocker.com/en-au/profession/biotechnology/the-challenges-and-risks-of-adopting-foreign-price-controls/Tue, 17 Sep 2019 21:41:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-challenges-and-risks-of-adopting-foreign-price-controls/ That’s why yesterday’s Environmental Protection Agency (EPA) Fed]]>https://www.newslocker.com/en-au/profession/biotechnology/as-mosquito-fears-rise-epa-considers-oxitec-2nd-generation-trial/Thu, 12 Sep 2019 19:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/as-mosquito-fears-rise-epa-considers-oxitec-2nd-generation-trial/ And given that it is Fashion Month, it’s a good time to learn about the benefits of one of the lesser talked about GMOs: cotton. Cotton provides more than just apparel and home furnishings, however. Every part of the cotton plant can be used. The long cotton fibers are used to make cloth, the]]>https://www.newslocker.com/en-au/profession/biotechnology/this-fashion-month-learn-about-the-benefits-of-gmo-cotton/Tue, 10 Sep 2019 20:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/this-fashion-month-learn-about-the-benefits-of-gmo-cotton/ Policymakers in Washington have long preferred to believe that scientists and researchers funded by federal taxpayer dollars discover medicines on their own, and that innovative biotech’s simply take advantage of this work and profit as result. But “nothing co]]>https://www.newslocker.com/en-au/profession/biotechnology/icymi-biopharmaceutical-companies-arent-free-riding-on-government-research/Thu, 05 Sep 2019 16:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/icymi-biopharmaceutical-companies-arent-free-riding-on-government-research/ That’s the good news.
Yet managing a disease is not the same as curing it. HIV patients must endure the onerous daily routine of ingesting a combination of therapies that typically]]>https://www.newslocker.com/en-au/profession/biotechnology/from-treatments-to-cures-bio-partnering-sets-the-stage/Wed, 04 Sep 2019 18:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/from-treatments-to-cures-bio-partnering-sets-the-stage/ Triple Crown PartnersKendyle Woodard, Co-found]]>https://www.newslocker.com/en-au/profession/biotechnology/more-meetings-more-results-with-bio-one-on-one-partnering/Tue, 03 Sep 2019 23:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/more-meetings-more-results-with-bio-one-on-one-partnering/ Ten biotechs will be selected in each of the three categories, “Early Stage Entrepreneurs”, “Late Stage Leaders” and “Diagnostics and Beyond”. Please note that this contest is restricted to companies headquartered in the U.S.
Buzz]]>https://www.newslocker.com/en-au/profession/biotechnology/nominate-your-company-to-be-the-buzz-of-bio/Thu, 29 Aug 2019 20:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nominate-your-company-to-be-the-buzz-of-bio/https://www.newslocker.com/en-au/profession/biotechnology/pitch-perfect-storytelling-is-key-for-bio-one-on-one-partnering/Thu, 29 Aug 2019 20:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pitch-perfect-storytelling-is-key-for-bio-one-on-one-partnering/ As you consider your holiday menu and shopping list for the Labor Day weekend, drink a toast to science and innovation for enhancing many of our staple foods – and beverages!It’s no secret that biotechnology helps repel insect pests so – whether white or yellow, that ear of corn is tasty and wormless. Biotechnology also makes non-browning apples for your fruit salad, and brings healthy, sustainably grown Atlantic salmon to]]>https://www.newslocker.com/en-au/profession/biotechnology/wine-without-the-whine/Thu, 29 Aug 2019 16:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/wine-without-the-whine/ Insurance Discrimination Is A Growing Problem
Since May, when a breakthrough gene therapy to treat spinal muscular atrophy (SMA) was appro]]>https://www.newslocker.com/en-au/profession/biotechnology/discrimination-against-vulnerable-patients-is-nothing-new/Thu, 29 Aug 2019 15:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/discrimination-against-vulnerable-patients-is-nothing-new/ “As an international public health community, we have eradicated the scourge of smallpox thanks to Edward Jenner’s research and the development of the world’s first vaccine. We are nearing the eradication of polio thanks to the commitment and research of Jonas Salk and Albert Sabin. Most recently,]]>https://www.newslocker.com/en-au/profession/biotechnology/national-immunization-awareness-month-is-a-reminder-about-the-value-of-vaccines/Tue, 27 Aug 2019 20:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/national-immunization-awareness-month-is-a-reminder-about-the-value-of-vaccines/ The enduring strength of the Northern California life science cluster attracts small biotech startups, which are subsequently finding massive success as venture capitalists turn their gaze from social networking and tech – industries that are inextricably associated with San Francisco and the greater Bay A]]>https://www.newslocker.com/en-au/profession/biotechnology/the-strong-keep-getting-stronger-why-the-bay-area-remains-1-biotech-hub-for-vc-investing/Thu, 22 Aug 2019 18:53:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-strong-keep-getting-stronger-why-the-bay-area-remains-1-biotech-hub-for-vc-investing/https://www.newslocker.com/en-au/profession/biotechnology/the-bio-investor-forum-links-promising-early-stage-technologies-with-an-active-investor-network/Thu, 22 Aug 2019 15:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-bio-investor-forum-links-promising-early-stage-technologies-with-an-active-investor-network/ This write-up, however, is not critical of Prince Harry and Meghan Markle. I don’t expect the British royal family to fly commercial airlines for obvious reasons and concerns. Let&rsqu]]>https://www.newslocker.com/en-au/profession/biotechnology/prince-harry-meghan-markle-and-biofuels/Wed, 21 Aug 2019 21:24:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/prince-harry-meghan-markle-and-biofuels/ Each year, it is estimated antimicrobial resistance (AMR) claims nearly 25,000 lives nationwide and nearly 700,000 across the globe, according to]]>https://www.newslocker.com/en-au/profession/biotechnology/new-coalition-to-raise-awareness-of-antimicrobial-resistance-threat-call-for-urgent-solutions/Wed, 21 Aug 2019 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-coalition-to-raise-awareness-of-antimicrobial-resistance-threat-call-for-urgent-solutions/ Watch the full segment below.]]>https://www.newslocker.com/en-au/profession/biotechnology/bios-jim-greenwood-talks-pricing-policy-and-science-on-cspan/Tue, 20 Aug 2019 22:13:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bios-jim-greenwood-talks-pricing-policy-and-science-on-cspan/ But how much do people know about them?  Yes, certainly we have been modifying our food for thousands of years, and many of the crops we eat today, through various breeding methods, look much different than they did 50, 100, and 500 years ago. But]]>https://www.newslocker.com/en-au/profession/biotechnology/some-gmo-basics/Tue, 20 Aug 2019 18:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/some-gmo-basics/https://www.newslocker.com/en-au/profession/biotechnology/country-breakfast-features/Fri, 16 Aug 2019 22:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/country-breakfast-features/ As Matt Reynolds writes in a piece for Wired UK, banana farmers are currently experiencing a bad case o]]>https://www.newslocker.com/en-au/profession/biotechnology/bananas-are-on-the-brink-of-extinction-gene-editing-can-reverse-that/Thu, 15 Aug 2019 17:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bananas-are-on-the-brink-of-extinction-gene-editing-can-reverse-that/ This week, the UN’s International Panel on Climate Change released their latest report, this time focusing on agriculture’s impact on the environment and the need to make the most use out of our current farmlands to prevent further damage.
Today, around 75 percent of the earth’s usable land is dedicated to feeding the world’s population. And as the population increases (expected to be 9.7 billion in 2050),]]>https://www.newslocker.com/en-au/profession/biotechnology/gene-editing-can-help-agriculture-be-climate-friendly-heres-how/Fri, 09 Aug 2019 20:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gene-editing-can-help-agriculture-be-climate-friendly-heres-how/https://www.newslocker.com/en-au/profession/biotechnology/biotech-leaders-warn-shortsighted-policies-threaten-miracle-breakthroughs/Tue, 06 Aug 2019 19:54:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biotech-leaders-warn-shortsighted-policies-threaten-miracle-breakthroughs/ See how rebates and discounts within the drug cost ecosystem are often not used by insurers to lower patients’ out-of-pocket drug costs. Learn about how changes to the way insurance is designed has left some vulnerable patients paying more out of pocket for the medicines they need. And understand why a holistic approach to add]]>https://www.newslocker.com/en-au/profession/biotechnology/why-are-patients-facing-higher-costs-when-they-go-to-the-pharmacy/Mon, 05 Aug 2019 17:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/why-are-patients-facing-higher-costs-when-they-go-to-the-pharmacy/https://www.newslocker.com/en-au/profession/biotechnology/questions-questions/Fri, 02 Aug 2019 17:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/questions-questions/ But controlling diseases is not a long-term or sustainable solution. Instead, how can we eliminate and eventually eradicate these deadly diseases? Today, scientists are working to develop techniques and technology, such as gene ed]]>https://www.newslocker.com/en-au/profession/biotechnology/technology-to-fight-malaria-zika-and-other-mosquito-related-diseases-is-being-blocked-why/Wed, 31 Jul 2019 21:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/technology-to-fight-malaria-zika-and-other-mosquito-related-diseases-is-being-blocked-why/ Over the past year, members of the World Trade Organization (WTO), such as the United States and Argentina have been leading an important effort to educate delegates on the value of innovative agricultural technology and the need for global, science-bas]]>https://www.newslocker.com/en-au/profession/biotechnology/biotech-innovation-is-key-to-ending-global-hunger/Tue, 30 Jul 2019 21:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biotech-innovation-is-key-to-ending-global-hunger/ Many of the innovations showcased as part of Start-Up Stadium could be the green solutions to address challenges like climate change and prote]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc19-start-up-stadium-winners-announced/Fri, 26 Jul 2019 17:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biowc19-start-up-stadium-winners-announced/https://www.newslocker.com/en-au/profession/biotechnology/experts-weigh-in-on-the-dangers-of-importing-foreign-price-controls/Wed, 24 Jul 2019 17:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/experts-weigh-in-on-the-dangers-of-importing-foreign-price-controls/ Why this matters: Biofuels are playing a significant role in reducing harmful pollution, particularly in the sector that emits the most greenhouse]]>https://www.newslocker.com/en-au/profession/biotechnology/biofuels-are-saving-aviation-and-attracting-environmentally-conscious-travelers/Tue, 23 Jul 2019 14:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biofuels-are-saving-aviation-and-attracting-environmentally-conscious-travelers/ The group warns that we need to accept and adopt new technologies if we are going to produce enough food for this growing population and that GMOs are one technology that will have to be part of the solution.  The report, co-issued by the World Bank, the U]]>https://www.newslocker.com/en-au/profession/biotechnology/how-gmos-can-help-us-to-feed-our-growing-population/Mon, 22 Jul 2019 17:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-gmos-can-help-us-to-feed-our-growing-population/ The group warns that we need to accept and adopt new technologies if we are going to produce enough food for this growing population and that GMOs are one technology that will have to be part of the solution.  The report, co-issued by the World Bank, the UN]]>https://www.newslocker.com/en-au/profession/biotechnology/how-gmo-can-help-us-to-feed-our-growing-population/Mon, 22 Jul 2019 17:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-gmo-can-help-us-to-feed-our-growing-population/ Unfortunately, these devastating i]]>https://www.newslocker.com/en-au/profession/biotechnology/new-videos-show-how-fail-first-policies-can-fail-patients/Fri, 19 Jul 2019 16:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-videos-show-how-fail-first-policies-can-fail-patients/ One of the first announced fireside chat speakers for the October (22-23) event is a seasoned investor who has spent much of her career championing innovation in med]]>https://www.newslocker.com/en-au/profession/biotechnology/influential-investor-wende-hutton-to-speak-at-bif19/Wed, 17 Jul 2019 16:07:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/influential-investor-wende-hutton-to-speak-at-bif19/ Biotech breakthroughs—such as biofuels that reduce carbon emissions, biodegradable plastics made from plants, or gene-edited plants that reduce agriculture’s impact on the environment—were center stage]]>https://www.newslocker.com/en-au/profession/biotechnology/2019-bio-world-congress-showcases-green-solutions-to-address-global-challenges/Tue, 16 Jul 2019 21:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/2019-bio-world-congress-showcases-green-solutions-to-address-global-challenges/ Yet while innovative biopharmaceutical companies have increased R&D investment in rare disease drug development in recent years, challenges remain. For example, the report indicates that:
Clinical through approval pha]]>https://www.newslocker.com/en-au/profession/biotechnology/rare-disease-drug-development-increases-but-challenges-remain/Tue, 16 Jul 2019 18:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rare-disease-drug-development-increases-but-challenges-remain/ Here are some highlights from the third day at the 2019 BIO World Congress…
Recognizing Leaders and Innovators: Advances in industrial and agric]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc19-day-3-wrap-up-bringing-people-ideas-and-technology-together/Thu, 11 Jul 2019 01:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biowc19-day-3-wrap-up-bringing-people-ideas-and-technology-together/ Here are a few highlights from the second day at #BIOWC19…
The New Food Revolution: #BIOWC19’s first plenary session was a full house and featured an opening spe]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc19-day-2-wrap-up-innovating-for-a-sustainable-future/Wed, 10 Jul 2019 01:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biowc19-day-2-wrap-up-innovating-for-a-sustainable-future/ Here is what you can expect this week and what’s already happening at the 2019 BIO World Congress…
New Programming, Engaging Sessions and Workshops, Company Presen]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc19-kicks-off-biotech-breakthroughs-take-center-stage-in-des-moines/Mon, 08 Jul 2019 22:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biowc19-kicks-off-biotech-breakthroughs-take-center-stage-in-des-moines/ Many Americans don’t know, however, that biotechnology will play a significant role in ensuring we can continue to celebrate the country’s independence for decades to come.
From the ethanol in your gas tank that will fuel your trek to the beach, to the renewable chemicals that can one day be used to make bioplastic solo cup]]>https://www.newslocker.com/en-au/profession/biotechnology/biotech-to-celebrate-america-and-save-the-planet/Wed, 03 Jul 2019 20:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biotech-to-celebrate-america-and-save-the-planet/ Sesquile Ramon, BIO’s Director, Science and Regulatory Affairs discussed advances in human genome editing
Matt O’Mara, BIO’s Vice President of International Affa]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-briefs-geneva-audience-on-science-of-human-genome-editing/Mon, 01 Jul 2019 22:49:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-briefs-geneva-audience-on-science-of-human-genome-editing/ The world’s largest conference on industrial biotechnology has a legacy of connecting investors, companies and researchers to partner and innovate on the ne]]>https://www.newslocker.com/en-au/profession/biotechnology/agtech-bio-world-congress/Thu, 27 Jun 2019 19:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/agtech-bio-world-congress/ “While CAR-T therapies represent a significant benefit and value for patient health outcomes and overall delivery of care, major reimbursement hurdles could prevent individuals from obtaining treatment. Personalized therapie]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-a-critical-medicare-policy-has-been-delayed-lets-use-this-opportunity-to-get-it-right/Thu, 27 Jun 2019 16:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/greenwood-a-critical-medicare-policy-has-been-delayed-lets-use-this-opportunity-to-get-it-right/ The bill establishes a tax credit for creating renewable products from forest, farm, sea, or solid waste biomass and brings back another]]>https://www.newslocker.com/en-au/profession/biotechnology/maine-takes-big-step-towards-reducing-carbon-footprint-and-creating-green-jobs/Wed, 26 Jun 2019 21:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/maine-takes-big-step-towards-reducing-carbon-footprint-and-creating-green-jobs/ Solutions driven by Africa, for Africa]]>https://www.newslocker.com/en-au/profession/biotechnology/a-sustainable-movement-to-curb-cancer-in-africa/Wed, 26 Jun 2019 21:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-sustainable-movement-to-curb-cancer-in-africa/https://www.newslocker.com/en-au/profession/biotechnology/new-bio-white-paper-incorporating-real-world-evidence-within-the-label-of-an-fda-approved-drug/Tue, 25 Jun 2019 18:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-bio-white-paper-incorporating-real-world-evidence-within-the-label-of-an-fda-approved-drug/ As an Ebola outbreak rages on in the Democratic Republic of Congo and the U.S. heads into the 2019 hurricane season, this new law – the Pandemic and All-Hazards Preparedness and Advancing Innovation Act – will help the U.S. Department of Health and Human Se]]>https://www.newslocker.com/en-au/profession/biotechnology/health-security-threats-are-real-what-is-congress-doing/Tue, 25 Jun 2019 14:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/health-security-threats-are-real-what-is-congress-doing/ While there is consensus across Capitol Hill that patent reform legislation is badly needed, the path to achieving a broadly supported bill remains elusive. This is clearly no easy task, as legislators must curb abusive patent practices, while strengthening the ability of patent owners to defend their inventions and businesses against infringement.
Last week, the American Enterprise Institute (AEI) illuminated the many complexities fac]]>https://www.newslocker.com/en-au/profession/biotechnology/congressman-stiver-continues-call-for-sensible-patent-reform/Mon, 24 Jun 2019 22:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/congressman-stiver-continues-call-for-sensible-patent-reform/ A blight-tolerant American chestnut tree is the latest example of what the science community has begun to call a GRO—a genetically rescued organism. In the past century approximately four billion chestnut trees have been lost in the U.S. due to blight that spread when the Cryphonectria parasitica fungus arrived with chestnut trees imported from Asia. A once-dominant hardwood species is now rare.]]>https://www.newslocker.com/en-au/profession/biotechnology/usa-science-saves-chestnuts/Mon, 24 Jun 2019 06:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/usa-science-saves-chestnuts/ There’s growing concern New Zealand will fall behind other countries unless the Government updates genetic modification laws. The Hazardous Substances and New Organisms Act hasn’t been changed since 1998. Plant and Food Research chief scientist Richard Newcomb is the latest to join the call for a public information campaign and discussion on gene editing, a technology that is more precise than previous genetic modification and doesn&]]>https://www.newslocker.com/en-au/profession/biotechnology/nz-gene-laws-need-update/Mon, 24 Jun 2019 06:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nz-gene-laws-need-update/https://www.newslocker.com/en-au/profession/biotechnology/eu-most-europeans-hardly-care-about-gmos/Mon, 24 Jun 2019 06:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/eu-most-europeans-hardly-care-about-gmos/ Scientists are exploring taking crops out of the field and growing them in warehouses to develop new varieties capable of feeding 10 billion people by 2050.This research from The University of Queensland was featured in the journal Nature Biotechnology on 17 June 2019.]]>https://www.newslocker.com/en-au/profession/biotechnology/aus-plant-factories-for-the-future/Mon, 24 Jun 2019 06:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aus-plant-factories-for-the-future/ The hearings are looking at Section 101 of the Patent Act (35 USC 101) which governs what sort of inventions are eligible for patent protection.  Over the last 9 years, the Supreme Court has crafted common law exceptio]]>https://www.newslocker.com/en-au/profession/biotechnology/bios-hans-sauer-calls-for-less-confusing-patent-eligibility-standards/Fri, 21 Jun 2019 18:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bios-hans-sauer-calls-for-less-confusing-patent-eligibility-standards/ “The business model, the way we reimburse and pay for antibiotics, has just fundamentally crashed,” said Kevin Outterson, a Boston University law professor who has studied market fa]]>https://www.newslocker.com/en-au/profession/biotechnology/the-disarm-act-can-help-fix-the-broken-antibiotics-market/Thu, 20 Jun 2019 18:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-disarm-act-can-help-fix-the-broken-antibiotics-market/ These critical issues will also be on spotlighted at the upcoming BIO Latin America Conference, but through the lens o]]>https://www.newslocker.com/en-au/profession/biotechnology/the-future-of-biotech-innovation-in-brazil-improving-patient-outcomes/Thu, 20 Jun 2019 17:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-future-of-biotech-innovation-in-brazil-improving-patient-outcomes/https://www.newslocker.com/en-au/profession/biotechnology/bio-sponsoring-cultivating-change-summit-as-part-of-right-mix-matters-initiative/Wed, 19 Jun 2019 19:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-sponsoring-cultivating-change-summit-as-part-of-right-mix-matters-initiative/https://www.newslocker.com/en-au/profession/biotechnology/4-things-you-probably-dont-know-about-gmos-but-definitely-should/Mon, 17 Jun 2019 18:58:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/4-things-you-probably-dont-know-about-gmos-but-definitely-should/ “The historic Flight for the]]>https://www.newslocker.com/en-au/profession/biotechnology/united-airlines-utilizes-biotechnology-for-most-eco-friendly-commercial-flight-of-its-kind/Fri, 14 Jun 2019 19:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/united-airlines-utilizes-biotechnology-for-most-eco-friendly-commercial-flight-of-its-kind/ These disorders present tremendous public health challenges that are estimated to cost around $800 billion]]>https://www.newslocker.com/en-au/profession/biotechnology/ai-helps-unravel-mystery-of-neurological-disorders/Thu, 13 Jun 2019 15:56:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ai-helps-unravel-mystery-of-neurological-disorders/ The executive order, titled “Modernizing the Regulatory Framework for Agricultural Biotechnology” was signed by the President “to speed up reviews of biotechnology so th]]>https://www.newslocker.com/en-au/profession/biotechnology/executive-order-on-agricultural-biotechnology-is-an-important-step-forward/Wed, 12 Jun 2019 22:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/executive-order-on-agricultural-biotechnology-is-an-important-step-forward/ No, he’s not really naked. He’s actually a medical doctor, who became so fascinated with science beyond his area of practice that he decided to put down the scalpel and pick up the mic.
What started as a weekend hobby for Dr. Chris Smith in his home in England,]]>https://www.newslocker.com/en-au/profession/biotechnology/the-naked-scientist-at-bio2019/Tue, 11 Jun 2019 15:49:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-naked-scientist-at-bio2019/ The report, “The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2017,” documents the significant return that US taxpayers receive on their investment in feder]]>https://www.newslocker.com/en-au/profession/biotechnology/licensing-of-research-has-had-huge-impact-on-economy-amp-jobs/Mon, 10 Jun 2019 21:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/licensing-of-research-has-had-huge-impact-on-economy-amp-jobs/https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-regulations-to-be-reviewed/Mon, 10 Jun 2019 10:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-regulations-to-be-reviewed/https://www.newslocker.com/en-au/profession/biotechnology/nigeria-gm-crops-can-boost-yields-by-20/Mon, 10 Jun 2019 10:42:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nigeria-gm-crops-can-boost-yields-by-20/https://www.newslocker.com/en-au/profession/biotechnology/int-gm-crops-soil-health-and-climate-change/Mon, 10 Jun 2019 10:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/int-gm-crops-soil-health-and-climate-change/https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-chestnut-trees/Mon, 10 Jun 2019 10:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-chestnut-trees/https://www.newslocker.com/en-au/profession/biotechnology/aus-gene-tech-regulations-to-be-updated/Mon, 10 Jun 2019 10:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aus-gene-tech-regulations-to-be-updated/ https://www.abc.net.au/radionational/progra]]>https://www.newslocker.com/en-au/profession/biotechnology/aus-do-we-need-gm-crops/Mon, 10 Jun 2019 10:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aus-do-we-need-gm-crops/ Convention doors are shut, and exhibits are breaking down, but the 17,300 BIO 2019 attendees who rallied under the theme “It Starts With One” will take with]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-wraps-up-in-philadelphia/Thu, 06 Jun 2019 22:24:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-wraps-up-in-philadelphia/ Basing the title and theme of the session on a publication out of MIT Media Lab entitled, “Whip]]>https://www.newslocker.com/en-au/profession/biotechnology/nature-biotechnology-and-scientific-american-super-session-highlights-the-future-of-the-biotech-sector/Thu, 06 Jun 2019 21:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nature-biotechnology-and-scientific-american-super-session-highlights-the-future-of-the-biotech-sector/ But over the past five years, gro]]>https://www.newslocker.com/en-au/profession/biotechnology/bio2019-the-state-of-the-vaccine-industry-stimulating-sustainable-growth/Thu, 06 Jun 2019 20:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio2019-the-state-of-the-vaccine-industry-stimulating-sustainable-growth/ A distinguished panel of deal-makers gat]]>https://www.newslocker.com/en-au/profession/biotechnology/bio2019-taking-the-pulse-of-dealmakers-2019-outlook/Wed, 05 Jun 2019 23:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio2019-taking-the-pulse-of-dealmakers-2019-outlook/ “The U.S. has led the way in drug approvals and dru]]>https://www.newslocker.com/en-au/profession/biotechnology/us-as-a-global-leader-for-patient-access/Wed, 05 Jun 2019 23:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/us-as-a-global-leader-for-patient-access/ We sat down with Hawkins to discuss his views on how Termeers’ optimism, patience and personality fueled his success and defined his legacy.
Listen to the full podcast here:http://www.biotech-now.org/wp-content/uploads/2019/06/johnauthor.m4a]]>https://www.newslocker.com/en-au/profession/biotechnology/buzz-at-bio-john-hawkins-author-of-conscience-and-courage/Wed, 05 Jun 2019 21:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/buzz-at-bio-john-hawkins-author-of-conscience-and-courage/ Biotech company CRIPSR Therapeutics is developing gene-editing therapy in treatin]]>https://www.newslocker.com/en-au/profession/biotechnology/the-future-is-bright-for-somatic-cell-genome-editing/Wed, 05 Jun 2019 21:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-future-is-bright-for-somatic-cell-genome-editing/ “The root of you comes from your parents and the values you have,]]>https://www.newslocker.com/en-au/profession/biotechnology/jamie-dimon-tackles-rising-health-care-costs-diversity-challenges-and-more/Wed, 05 Jun 2019 20:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/jamie-dimon-tackles-rising-health-care-costs-diversity-challenges-and-more/ We all have a part to play in helping to protect and preserve the environment, and agriculture has a huge role in that. Contrary to popular perception, GMOs can have a positive impact on the environment thro]]>https://www.newslocker.com/en-au/profession/biotechnology/celebrating-world-environment-day/Wed, 05 Jun 2019 20:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/celebrating-world-environment-day/ In 1996, her mother, Karen, died of breast cancer. It was a tragic time for her and her two sisters. But tragedy would strike again as Christi’s sister, Sherry, was later diagnosed with multiple myeloma. Christi and her other sibling, Shelley, put their lives on hold to help care for their sister and provide the additional support necessary for her sister to enroll in a clin]]>https://www.newslocker.com/en-au/profession/biotechnology/discussing-a-patient-centered-approach-at-bio-2019/Wed, 05 Jun 2019 17:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/discussing-a-patient-centered-approach-at-bio-2019/ The panel – Realizing the Promise of Gene Therapies for Patients Around the World- di]]>https://www.newslocker.com/en-au/profession/biotechnology/realizing-the-promise-of-gene-therapies-for-patients-around-the-world/Wed, 05 Jun 2019 13:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/realizing-the-promise-of-gene-therapies-for-patients-around-the-world/ Tang’s impact on the Science Center’s gro]]>https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-stephen-tang-and-the-future-of-biotechnology-in-philadelphia/Wed, 05 Jun 2019 13:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-stephen-tang-and-the-future-of-biotechnology-in-philadelphia/ To discuss this important issue, we sat down with Merck Chief Patient Officer Dr. Julie Gerberding to discuss how we can better understand the voices of patients, meeting the challenge of antimicrobial resistance (AMR), and Merck’s commitment to scientific excellence on behalf of patients.
Listen to the full podcast here:]]>https://www.newslocker.com/en-au/profession/biotechnology/buzz-at-bio-dr-julie-gerberding-merck/Wed, 05 Jun 2019 02:54:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/buzz-at-bio-dr-julie-gerberding-merck/ Philadelphia was the very first capital of the United States after the Revolutionary War, and landmarks here like the Liberty Bell and Independence Hall mark some of America’s earliest colonial history. But now there is a new revolution be]]>https://www.newslocker.com/en-au/profession/biotechnology/welcome-to-bio2019/Mon, 03 Jun 2019 13:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/welcome-to-bio2019/https://www.newslocker.com/en-au/profession/biotechnology/why-concerns-about-a-break-down-in-drug-pricing-are-misplaced/Sat, 01 Jun 2019 16:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/why-concerns-about-a-break-down-in-drug-pricing-are-misplaced/https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onenewborn-screening/Fri, 31 May 2019 14:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onenewborn-screening/ To honor Franklin’s monumental contribution to the field, BIO recognizes a leader in the fie]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-announces-2019-rosalind-franklin-award-winner-reshma-shetty-gingko-bioworks/Thu, 30 May 2019 21:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-announces-2019-rosalind-franklin-award-winner-reshma-shetty-gingko-bioworks/ The Innovation Zone is]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-innovation-zone-company-snapshot-litron-laboratories/Thu, 30 May 2019 18:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-innovation-zone-company-snapshot-litron-laboratories/ “Today, we have esteemed institutions like Children’s Hospital of Philadelphia (CHOP) and UPenn making investments of bot]]>https://www.newslocker.com/en-au/profession/biotechnology/spark-ceo-marrazzo-philadelphia-will-shine-at-bio2019/Thu, 30 May 2019 17:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/spark-ceo-marrazzo-philadelphia-will-shine-at-bio2019/ Reforms within China affecting the biomedical industry, such as the accelerated review and approval of drugs, and the expansion of the reimbursement scheme have provided a catalyst for transformation and innovation throughout Asia.
One year ago, the Hong Kong Exchange (HKEX) began to allow pre-revenue biotechnology companies to list &nd]]>https://www.newslocker.com/en-au/profession/biotechnology/the-growing-wave-of-biotech-ipos-in-china/Tue, 28 May 2019 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-growing-wave-of-biotech-ipos-in-china/ It is companies like OcuMedic that inspired the theme for BIO 2019: “It Star]]>https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-drop/Fri, 24 May 2019 16:39:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-drop/ The Innovation Zone is]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-innovation-zone-company-snapshot-healthrhythms-inc/Thu, 23 May 2019 16:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-innovation-zone-company-snapshot-healthrhythms-inc/ Take gene therapy, for example. Gene therapies that are expected over the next fe]]>https://www.newslocker.com/en-au/profession/biotechnology/important-perspectives-on-innovation-and-costs/Thu, 23 May 2019 14:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/important-perspectives-on-innovation-and-costs/ GMO Answers has put together a new video explaining just how GMO crops can help with global biodiversity issues, from helping to preserve land, to using less water, and to helping fight climate change.
Check out our new video, and then visit the GMO Answers web]]>https://www.newslocker.com/en-au/profession/biotechnology/gmos-and-biodiversity/Wed, 22 May 2019 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gmos-and-biodiversity/ The annual award is sponsored by the Iowa Biotechnology Association.
George Washington Carver was an alumnus of Iowa State University and had a profound impact on agricultural and industrial production in the state. At his industrial research laboratory, h]]>https://www.newslocker.com/en-au/profession/biotechnology/george-washington-carver-award-iowa-paves-the-way-for-biotech-innovation/Mon, 20 May 2019 18:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/george-washington-carver-award-iowa-paves-the-way-for-biotech-innovation/ The Innovation Zone is]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-innovation-zone-company-snapshot-trellis-biosciences/Thu, 16 May 2019 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-innovation-zone-company-snapshot-trellis-biosciences/https://www.newslocker.com/en-au/profession/biotechnology/sec-proposes-targeted-regulatory-relief-for-certain-small-public-companies-from-sarbanes-oxley-404b/Wed, 15 May 2019 18:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sec-proposes-targeted-regulatory-relief-for-certain-small-public-companies-from-sarbanes-oxley-404b/https://www.newslocker.com/en-au/profession/biotechnology/learning-from-game-theory-to-improve-negotiations-skills/Wed, 15 May 2019 14:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/learning-from-game-theory-to-improve-negotiations-skills/ This report, the fourth in a series on the innovation landscape of highly prevalent, chronic diseases, takes an in-depth look at the state of innovation for therapeutics in Alzheimer’s disease, which is expected to affect more than 13.8 million people in the United States by 2050 and cost well over $1 trillion annually.
“The good news is th]]>https://www.newslocker.com/en-au/profession/biotechnology/new-bio-report-on-state-of-innovation-for-alzheimers-disease-therapeutics/Tue, 14 May 2019 16:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-bio-report-on-state-of-innovation-for-alzheimers-disease-therapeutics/ Plant biologist Pamela Ronald recently told Knowledgeable Magazine that the future of food is dependent on using sustainable agriculture tools, such as crop rotation, and a combination of scientific-based farming practices and genet]]>https://www.newslocker.com/en-au/profession/biotechnology/plant-biologist-genetics-crucial-for-food-security-and-sustainable-agriculture/Tue, 14 May 2019 15:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/plant-biologist-genetics-crucial-for-food-security-and-sustainable-agriculture/https://www.newslocker.com/en-au/profession/biotechnology/health-cares-big-spending-mismatch/Fri, 10 May 2019 17:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/health-cares-big-spending-mismatch/ The uptake of these tests is remarkable—more than five million consumers in less than ten years’ time. And according to a report by Credence Research, the global DTC genetic testing market was value]]>https://www.newslocker.com/en-au/profession/biotechnology/new-guide-to-help-consumers-navigate-genetic-health-testing/Thu, 09 May 2019 15:42:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-guide-to-help-consumers-navigate-genetic-health-testing/https://www.newslocker.com/en-au/profession/biotechnology/starting-from-one-idea-to-building-a-winning-company-how-to-communicate-value-to-investors-and-partners/Wed, 08 May 2019 16:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/starting-from-one-idea-to-building-a-winning-company-how-to-communicate-value-to-investors-and-partners/https://www.newslocker.com/en-au/profession/biotechnology/what-health-and-wellness-dietitians-want-to-know-about-gmos-and-biotechnology/Tue, 07 May 2019 20:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/what-health-and-wellness-dietitians-want-to-know-about-gmos-and-biotechnology/ Understanding this challenge, researchers are innovating solutions that can help reduce carbon pollution, and thus climate change, faster. As noted in a piece for Wired Ma]]>https://www.newslocker.com/en-au/profession/biotechnology/a-secret-weapon-to-addressing-climate-change/Fri, 03 May 2019 17:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-secret-weapon-to-addressing-climate-change/ This “silent killer” and looming public health threat has severe social and economic consequences that could have a lasting impact on families, individuals, and]]>https://www.newslocker.com/en-au/profession/biotechnology/promising-results-offer-hope-in-fight-against-candida-auris/Mon, 29 Apr 2019 17:49:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/promising-results-offer-hope-in-fight-against-candida-auris/ As Joseph Allen – a former staff member for the U.S. Senate Judiciary Committee who was instrumental in helping craft and pass this historic legislation nearly 40 years]]>https://www.newslocker.com/en-au/profession/biotechnology/setting-the-record-straight-on-march-in-rights/Mon, 29 Apr 2019 15:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/setting-the-record-straight-on-march-in-rights/ Sometimes it’s a new disease, and other times, a plant that was once resistant to a particular disease is no longer capable of defending itself. Today, the banana is a victim of the latter and facing extinction if nothing is done.
The culprit: Panama disease. It’s a fungus &n]]>https://www.newslocker.com/en-au/profession/biotechnology/disease-putting-bananas-on-brink-of-extinction-gene-editing-could-save-them/Thu, 25 Apr 2019 17:58:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/disease-putting-bananas-on-brink-of-extinction-gene-editing-could-save-them/ Although researchers may not have known it at the time, their breakthrough would lead to significant biotech advancements, new legislation aimed at caring for our most vulnerable populations, and a global public health campaign dedi]]>https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-sequence-the-fight-against-hiv/Wed, 24 Apr 2019 22:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-sequence-the-fight-against-hiv/ Getting published in your hometown paper is always a feather in your cap, and having grown up on a farm about 30 miles outside of Buffalo, NY, having a guest column in the Buffalo News is definitely a highlight.
In a new op ed I wrote for the Buffalo News, I note that GMOs, or genetically modifie]]>https://www.newslocker.com/en-au/profession/biotechnology/gmos-have-benefits-for-the-environment/Mon, 22 Apr 2019 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gmos-have-benefits-for-the-environment/ I was invited to speak on the panel “What’s Behind the Label: How Do We Unde]]>https://www.newslocker.com/en-au/profession/biotechnology/top-five-takeaways-plus-four-myths-that-just-wont-die-from-a-community-dialogue-on-food-and-farming/Fri, 19 Apr 2019 15:54:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/top-five-takeaways-plus-four-myths-that-just-wont-die-from-a-community-dialogue-on-food-and-farming/ “When federal importation was floated in the early 2000s, an FDA analysis found that five of seven of America’s best-selling generic drugs for chronic conditions were cheaper than Can]]>https://www.newslocker.com/en-au/profession/biotechnology/wsj-drug-importation-is-impractical-unsafe-and-unlikely-to-lower-prices/Thu, 18 Apr 2019 16:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/wsj-drug-importation-is-impractical-unsafe-and-unlikely-to-lower-prices/ Lately, our members have been asking for our help to innovate in other ways. A modern industry calls for modern leadership, and BIO members value the kind of diverse and inclusive l]]>https://www.newslocker.com/en-au/profession/biotechnology/propelling-innovation-with-the-right-mix/Tue, 16 Apr 2019 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/propelling-innovation-with-the-right-mix/ Today, there are hundreds of patient advocacy groups, more than 770 ne]]>https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-rare-patient/Mon, 15 Apr 2019 20:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one-rare-patient/ And although it may seem like we could never run out of pasta, crop disease and turbulent weather are a real threat. Fortunately, thanks to biotechnology, steps are being taken to ensure durum wheat – also known as “pasta wheat” – will]]>https://www.newslocker.com/en-au/profession/biotechnology/whats-being-done-to-ensure-pasta-is-here-for-posterity/Fri, 12 Apr 2019 20:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/whats-being-done-to-ensure-pasta-is-here-for-posterity/ As Dolin states, current legislative proposals would allow excessive regulatory authority into the free market:
“…the government would be given the power not to “negotiate,” but to force drug manufacturers to accept a price that bud]]>https://www.newslocker.com/en-au/profession/biotechnology/when-intervention-stifles-innovation/Thu, 11 Apr 2019 22:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/when-intervention-stifles-innovation/ This resource will be distributed to Convention attendees to help them navigate all of the fabulous networking opportunities taking place in Philly, June]]>https://www.newslocker.com/en-au/profession/biotechnology/feature-your-bio-2019-networking-event-in-bio-compass/Wed, 10 Apr 2019 17:11:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/feature-your-bio-2019-networking-event-in-bio-compass/ “PBMs were originally conceived to help employers and insurers negotiate the best prices on prescription drugs, a fine idea in a market-based health care system like ours. But massive industry consolidation has funda]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-in-pharma-value-chain-pbms-manage-to-benefit/Wed, 10 Apr 2019 16:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/greenwood-in-pharma-value-chain-pbms-manage-to-benefit/ “We firmly believe that the rebates drugmakers provide insurers and other m]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-calls-rebate-rule-a-significant-step-forward-for-patients/Tue, 09 Apr 2019 21:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-calls-rebate-rule-a-significant-step-forward-for-patients/ More than in any other industry, the interplay between biotechnology innovation and regulation has important social and economic development implications. As developing nations seek to grow this in]]>https://www.newslocker.com/en-au/profession/biotechnology/unlocking-indias-biotech-potential/Tue, 09 Apr 2019 17:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/unlocking-indias-biotech-potential/ This, of course, includes a multitude of factors – livestock, field burning of crop residues, fuel use on farms, rice cultivation – but Mr. Gates focuses on an interesting component to ag emissi]]>https://www.newslocker.com/en-au/profession/biotechnology/how-biotech-can-reduce-emissions-through-soil-microbes/Tue, 09 Apr 2019 08:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-biotech-can-reduce-emissions-through-soil-microbes/ Question #]]>https://www.newslocker.com/en-au/profession/biotechnology/a-few-questions-as-pbms-have-their-day-on-capitol-hill/Mon, 08 Apr 2019 22:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-few-questions-as-pbms-have-their-day-on-capitol-hill/ For starters, drug prices are not “extreme.” Data show that the growth in net prices for brand-name medicines—the price drugmakers receive after paying rebates and discounts to insurers and others within the s]]>https://www.newslocker.com/en-au/profession/biotechnology/dr-emanuel-misses-the-mark-with-latest-industry-attack/Mon, 08 Apr 2019 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dr-emanuel-misses-the-mark-with-latest-industry-attack/ As a leader on both the Senate Committee on Health, Education, Labor, and Pensions and the Senate Committee on Finance, Senator Roberts has been at the cross-section of every major healthcare debate throughout his distinguishe]]>https://www.newslocker.com/en-au/profession/biotechnology/senator-roberts-is-a-champion-of-biotechnology-innovation/Fri, 05 Apr 2019 01:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/senator-roberts-is-a-champion-of-biotechnology-innovation/ Thanks to a system in the United Stat]]>https://www.newslocker.com/en-au/profession/biotechnology/icymi-dr-ted-love-explains-why-drug-pricing-controls-could-impede-innovation/Thu, 04 Apr 2019 15:13:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/icymi-dr-ted-love-explains-why-drug-pricing-controls-could-impede-innovation/https://www.newslocker.com/en-au/profession/biotechnology/bio-urges-ustr-to-take-action-on-growing-ip-barriers-in-overseas-markets/Thu, 28 Mar 2019 14:43:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio-urges-ustr-to-take-action-on-growing-ip-barriers-in-overseas-markets/ A collection of 17 goals and 169 targets set by the UN General Assembly in 2015, the UN SDGs were created as a blueprint to achieve a better and more sustainable future for all. Addressing the global challenges we face, including those related to poverty, climate, environmental degradati]]>https://www.newslocker.com/en-au/profession/biotechnology/biotechnology-a-critical-tool-in-achieving-the-un-sustainable-development-goals/Wed, 27 Mar 2019 19:34:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/biotechnology-a-critical-tool-in-achieving-the-un-sustainable-development-goals/ “[T]he administration announced its intention to lower the reimbursement rates of certain physician-administered drugs by basing rei]]>https://www.newslocker.com/en-au/profession/biotechnology/oncologist-warns-of-ipis-potentially-dangerous-implications/Tue, 26 Mar 2019 15:04:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/oncologist-warns-of-ipis-potentially-dangerous-implications/ Access to clean, safe water is obviously important to human health, but water also plays a critical role in ensuring billions of people have food on their table. Without water, the crops to produce food can’t grow.
And climate change only compounds the problem.
However, thanks to innovations in agriculture like genet]]>https://www.newslocker.com/en-au/profession/biotechnology/worldwaterday-ag-innovations-ensure-no-one-is-left-behind/Fri, 22 Mar 2019 19:43:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/worldwaterday-ag-innovations-ensure-no-one-is-left-behind/ Like the Cinderella stories that come out of the NCAA tournament, BIO’s World Congress in Des Moines will provide smaller, emerging, ind]]>https://www.newslocker.com/en-au/profession/biotechnology/march-madness-start-up-stadium-biowc19/Thu, 21 Mar 2019 21:22:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/march-madness-start-up-stadium-biowc19/https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onewinning-presentation-at-the-start-up-stadium/Thu, 21 Mar 2019 18:35:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onewinning-presentation-at-the-start-up-stadium/ From soda bottles to ethanol, researchers are testing multiple varieties of sugarcane that could be used in new applications that would help reduce society’s environmental footprint, and such biology-driven solutions could have a significant impact on our planet’s wellbeing.
Every year, 300 million tons of plastic is m]]>https://www.newslocker.com/en-au/profession/biotechnology/how-gene-edited-sugarcane-could-reduce-societys-environmental-footprint/Tue, 19 Mar 2019 20:43:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/how-gene-edited-sugarcane-could-reduce-societys-environmental-footprint/ It was the first GE animal deemed safe to eat by FDA after a 2015 agency review found that AquAdvantage salmon is not materially different from other Atlantic salm]]>https://www.newslocker.com/en-au/profession/biotechnology/fda-approval-of-ge-salmon-paves-way-for-sustainable-food-innovations/Fri, 15 Mar 2019 21:03:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/fda-approval-of-ge-salmon-paves-way-for-sustainable-food-innovations/ “In the United States, nearly $15 of every $100 spent on brand-name drugs goes to PBMs, which claim they lower drug costs. However, the share of annual drug price increases that PBMs pocket – as opposed]]>https://www.newslocker.com/en-au/profession/biotechnology/peter-pitts-examines-the-role-of-pbms-and-their-deceptive-tactics/Fri, 15 Mar 2019 16:10:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/peter-pitts-examines-the-role-of-pbms-and-their-deceptive-tactics/ Without farmers, many of the breakthroughs that BIO’s members are innovating, both as part of the Food & Agriculture and Industrial & Environmental sections, would not be possible.
In celebration of National Ag Day (#AgDay19), let’s explore how BIO has made agri]]>https://www.newslocker.com/en-au/profession/biotechnology/agday19-how-bio-is-advancing-agriculture/Thu, 14 Mar 2019 21:10:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/agday19-how-bio-is-advancing-agriculture/ That’s why BIO is excited to announce that four bioeconomy tours will be offered at #BIOWC19, starting the first day]]>https://www.newslocker.com/en-au/profession/biotechnology/iowa-bioeconomy-site-tours-bio-world-congress/Wed, 13 Mar 2019 17:42:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/iowa-bioeconomy-site-tours-bio-world-congress/ A European court has ruled that the UK can halt the process and stay in the EU at any time up to the deadline. Alternatively, the Brexit process can be extended if all 28 EU members agree. However, neither of these scenarios seems likely.
If the UK government is forced to leave the EU]]>https://www.newslocker.com/en-au/profession/biotechnology/how-will-brexit-impact-patients-and-biotech-innovation/Wed, 13 Mar 2019 16:45:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/how-will-brexit-impact-patients-and-biotech-innovation/ Lila Feisee BIO’s Vice President International Affairs addresses this issue and the International Council on Harmonization’s&]]>https://www.newslocker.com/en-au/profession/biotechnology/making-innovative-drugs-available-globally/Wed, 13 Mar 2019 14:34:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/making-innovative-drugs-available-globally/https://www.newslocker.com/en-au/profession/biotechnology/how-cracking-sugars-dna-could-help-save-the-planet/Tue, 12 Mar 2019 04:45:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/how-cracking-sugars-dna-could-help-save-the-planet/ This year’s event in Philadelphia of]]>https://www.newslocker.com/en-au/profession/biotechnology/bio2019-education-programming-taking-shape/Mon, 11 Mar 2019 18:10:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio2019-education-programming-taking-shape/ While asking questions about science and data is a good, legitimate part of the scientific method, our digital world provides vocal critics, even politicians, a platform to spread spurious myth]]>https://www.newslocker.com/en-au/profession/biotechnology/vaccines-work-the-proof-is-in-the-data/Mon, 11 Mar 2019 15:17:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/vaccines-work-the-proof-is-in-the-data/ The theme of this year’s IWD, #BalanceforBetter, is refl]]>https://www.newslocker.com/en-au/profession/biotechnology/women-who-are-changing-the-game-in-biotech/Fri, 08 Mar 2019 15:37:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/women-who-are-changing-the-game-in-biotech/ A group composed of biotech investors, entrepreneurs, and executives will climb to the top of Mt. Kilimanjaro]]>https://www.newslocker.com/en-au/profession/biotechnology/in-2019-women-are-not-waiting-to-climb-to-the-top/Fri, 08 Mar 2019 15:06:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/in-2019-women-are-not-waiting-to-climb-to-the-top/ Now, a new report by the U.S. Department of Agriculture confirmed China has added even more bar]]>https://www.newslocker.com/en-au/profession/biotechnology/usda-report-chinas-biotech-crop-approval-process-becoming-more-unpredictable-and-burdensome/Thu, 07 Mar 2019 21:20:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/usda-report-chinas-biotech-crop-approval-process-becoming-more-unpredictable-and-burdensome/ Hosted in the Midwest for the first time, #BIOWC19 will be getting back to the roots of industrial biotechnology and agriculture, where so many biotechnology innovations begin or are developed. From biotech crops, to feedstocks, to biofuel and ethanol production, Iowa and the Midwest is where many biotechnology innovations get their start.
Don’t miss out on w]]>https://www.newslocker.com/en-au/profession/biotechnology/early-bird-registration-for-the-2019-bio-world-congress-is-now-open/Thu, 07 Mar 2019 16:51:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/early-bird-registration-for-the-2019-bio-world-congress-is-now-open/ At issue is a little-known tactic called “spre]]>https://www.newslocker.com/en-au/profession/biotechnology/kentucky-officials-expose-pbms-for-gaming-the-system/Wed, 06 Mar 2019 18:47:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/kentucky-officials-expose-pbms-for-gaming-the-system/ Some public officials are promising voters that a way to lower the cos]]>https://www.newslocker.com/en-au/profession/biotechnology/the-empty-promise-of-safe-drug-importation/Mon, 04 Mar 2019 21:24:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-empty-promise-of-safe-drug-importation/ Through improved methodology, with an emphasis on regulatory science as an industry framework over the last ten years, the PDMA has been able to accelerate Japan’s drug approval process, making it amongst the world’s fastest. In fact, Dr. Kondo’s model of regulatory science has been popularized a]]>https://www.newslocker.com/en-au/profession/biotechnology/head-of-japans-drug-regulatory-authority-will-keynote-bio-asia/Mon, 04 Mar 2019 20:19:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/head-of-japans-drug-regulatory-authority-will-keynote-bio-asia/ “The truth is, incentives provided by the ODA have dramatically changed the number and types of therapies that are available to patients with rare diseases like these. Since the law’s passage in 1983, more than 400 new therapies have b]]>https://www.newslocker.com/en-au/profession/biotechnology/two-new-infographics-illustrate-the-success-of-the-orphan-drug-act/Thu, 28 Feb 2019 17:27:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/two-new-infographics-illustrate-the-success-of-the-orphan-drug-act/ Applications to participate in Start-up Stadium]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-start-up-stadium-changing-the-world-from-the-ground-up/Wed, 27 Feb 2019 17:04:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio-2019-start-up-stadium-changing-the-world-from-the-ground-up/ Innovations such as gene editing are helping us address many of the global challenges facing society today – climate change, a looming food crisis, malnourished populations, increased drought and disease and the availability of productive land, just to name]]>https://www.newslocker.com/en-au/profession/biotechnology/national-pork-producers-council-president-dont-strangle-promising-technology-with-red-tape/Mon, 25 Feb 2019 21:46:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/national-pork-producers-council-president-dont-strangle-promising-technology-with-red-tape/ What is the Buzz of BIO?
Buzz of BIO is a contest that recognizes U.S. based companies with groundbreaking, early stage technologies with the potential for improving our lives. Companies can submit in one of two cat]]>https://www.newslocker.com/en-au/profession/biotechnology/win-a-complimentary-company-presentation-amp-registration-at-bio2019/Mon, 25 Feb 2019 18:16:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/win-a-complimentary-company-presentation-amp-registration-at-bio2019/https://www.newslocker.com/en-au/profession/biotechnology/the-state-of-australian-innovation-in-2019/Fri, 22 Feb 2019 07:02:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-state-of-australian-innovation-in-2019/ With gene editing and the latest in plant breeding innovation, scientists can make stronger and more resilient crop varieties in years rather than decades. A world without orange trees or coffee plants has signifi]]>https://www.newslocker.com/en-au/profession/biotechnology/why-we-need-innovation-in-food-and-agriculture/Wed, 20 Feb 2019 15:42:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/why-we-need-innovation-in-food-and-agriculture/https://www.newslocker.com/en-au/profession/biotechnology/int-nutrient-boosted-cassava/Tue, 19 Feb 2019 04:14:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/int-nutrient-boosted-cassava/ proteins from Bacillus thuringiensis (Bt)
(mainly Cry proteins) have become a major control tactic for a number of key
lepidopteran and coleopteran pests, mainly in maize, cotton, and soybean.…Over the
past 20+ years, extensive experience and insight have been gained through
laboratory and field-based studies of the non-target effects of crops producing
Cry proteins. Overall, the vast majori]]>https://www.newslocker.com/en-au/profession/biotechnology/int-20-years-of-data-for-powerful-tool/Tue, 19 Feb 2019 04:11:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/int-20-years-of-data-for-powerful-tool/https://www.newslocker.com/en-au/profession/biotechnology/aus-fake-news-thwarts-gene-tech/Tue, 19 Feb 2019 04:07:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/aus-fake-news-thwarts-gene-tech/https://www.newslocker.com/en-au/profession/biotechnology/aus-wa-inquiry-supports-status-quo/Tue, 19 Feb 2019 04:04:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/aus-wa-inquiry-supports-status-quo/ So much so that in 2016, the United States Con]]>https://www.newslocker.com/en-au/profession/biotechnology/gmo-labels-what-you-need-to-know/Fri, 15 Feb 2019 17:30:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/gmo-labels-what-you-need-to-know/ Megan Molteni of Wired recently summarized what gene-editing technology means for industrial biotechnology: “Today, with the arrival of precise gene-editing technologie]]>https://www.newslocker.com/en-au/profession/biotechnology/from-anti-venoms-to-fertilizers-the-immense-potential-for-microbes-and-gene-editing/Thu, 14 Feb 2019 22:53:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/from-anti-venoms-to-fertilizers-the-immense-potential-for-microbes-and-gene-editing/ Even more worrying, challenges in the commercial market for antibiotics and other products to addres]]>https://www.newslocker.com/en-au/profession/biotechnology/bioceo19-were-out-of-time-to-address-the-dire-market-failures-in-antimicrobial-resistance/Wed, 13 Feb 2019 00:01:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bioceo19-were-out-of-time-to-address-the-dire-market-failures-in-antimicrobial-resistance/ A rec]]>https://www.newslocker.com/en-au/profession/biotechnology/with-an-air-of-optimism-bioceo19-concludes/Wed, 13 Feb 2019 00:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/with-an-air-of-optimism-bioceo19-concludes/ But the biotech IPO market is coming off of a hot 2018 with more than 50 biotech companies going public on the back of more than $5.4 billion in funding, marking the second-best year for biotech IPOs in a decade. But what challenges will need to be overcome]]>https://www.newslocker.com/en-au/profession/biotechnology/venture-creation-is-in-vogue/Tue, 12 Feb 2019 20:39:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/venture-creation-is-in-vogue/ Already, the U.S. Department of Health and Human Services (HHS) has proposed piloting an International Pricing Index payment model, tying costs for drugs under Medicare Part B to the lower rates paid in European benchmark countries with socialized medicine. They have moved to lower government costs for drug spending by empowering PBMs and middlemen to dramatica]]>https://www.newslocker.com/en-au/profession/biotechnology/policy-outlookhow-could-the-trump-administrations-drug-reimbursement-proposals-affect-medical-innovation/Tue, 12 Feb 2019 19:29:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/policy-outlookhow-could-the-trump-administrations-drug-reimbursement-proposals-affect-medical-innovation/https://www.newslocker.com/en-au/profession/biotechnology/bioceo19-navigating-payers-expectations-for-value-based-agreements/Tue, 12 Feb 2019 00:22:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bioceo19-navigating-payers-expectations-for-value-based-agreements/ As interest rate worries, international trade disputes, and regulato]]>https://www.newslocker.com/en-au/profession/biotechnology/market-outlookmdashleveraging-market-corrections-for-mampa-or-ipos/Tue, 12 Feb 2019 00:19:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/market-outlookmdashleveraging-market-corrections-for-mampa-or-ipos/ In the report, Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Emerging Growth Companies in the Biotech Industry?, renowned economists Craig Lewis and Joshua T. White of Vanderbilt University point]]>https://www.newslocker.com/en-au/profession/biotechnology/new-bio-report-on-impact-of-sarbanes-oxley-404b-on-emerging-biotech-innovators/Mon, 11 Feb 2019 17:21:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/new-bio-report-on-impact-of-sarbanes-oxley-404b-on-emerging-biotech-innovators/ These data points are not lost on the more than 600 active investors arriving today for the BIO CEO & Investor Conference (#BIOCEO19) in NYC. The most unique medical breakthroughs often come from small companies working]]>https://www.newslocker.com/en-au/profession/biotechnology/bioceo19-kicks-off-in-nyc/Mon, 11 Feb 2019 12:30:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bioceo19-kicks-off-in-nyc/https://www.newslocker.com/en-au/profession/biotechnology/missing-an-arm-this-university-student-made-one-from-lego/Thu, 07 Feb 2019 22:38:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/missing-an-arm-this-university-student-made-one-from-lego/ For example, the cacao tree produces the cocoa to make chocolate that so many of us enjoy, but climate change, warmer temperatures, lack of water, pests,]]>https://www.newslocker.com/en-au/profession/biotechnology/pro-gmo-chocolate-brand-shares-how-gmos-are-saving-some-of-worlds-most-cherished-foods/Thu, 07 Feb 2019 19:50:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/pro-gmo-chocolate-brand-shares-how-gmos-are-saving-some-of-worlds-most-cherished-foods/ “[Our] industry is eager to help deliver responsible solutions that ensure prescription drugs ar]]>https://www.newslocker.com/en-au/profession/biotechnology/health-care-in-focus-as-president-trump-addresses-the-nation/Thu, 07 Feb 2019 19:20:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/health-care-in-focus-as-president-trump-addresses-the-nation/ Through the institute’s Ideal Plant initiative, researchers hope to develop plants that can store more carbon dioxide in their roots. And if this is done on a very, very large scale across the world with major agriculture crops – such as corn, soybeans, wheat and cotton – it]]>https://www.newslocker.com/en-au/profession/biotechnology/could-this-biotechnology-innovation-help-combat-climate-change/Wed, 06 Feb 2019 22:25:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/could-this-biotechnology-innovation-help-combat-climate-change/https://www.newslocker.com/en-au/profession/biotechnology/meet-kallyopes-nancy-thornberry-fireside-chat-speaker-at-bioceo19/Mon, 04 Feb 2019 19:46:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/meet-kallyopes-nancy-thornberry-fireside-chat-speaker-at-bioceo19/ Even though GMO crops have been on the market for nearly 30 years, mistrust regarding these products escalated with the rise of the internet and social media platforms. In a new post for GMO Answers on our Medium page, Registered Dietitian N]]>https://www.newslocker.com/en-au/profession/biotechnology/gmos-are-not-as-seen-on-social-media/Mon, 04 Feb 2019 15:47:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/gmos-are-not-as-seen-on-social-media/ Fast forward seventeen years later to Sunday when the New England Patriots battle the Rams, this time the Los Angeles Rams, in t]]>https://www.newslocker.com/en-au/profession/biotechnology/flashfriday-super-bowl-edition/Fri, 01 Feb 2019 21:37:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/flashfriday-super-bowl-edition/ Brennan will be a headliner at the upcoming BIO CEO & Investor Conference, leading a fireside chat at 3:00PM on Tuesday February 12.
Dr. Brennan’s Personal Story
In her early years as a physician, Brennan ha]]>https://www.newslocker.com/en-au/profession/biotechnology/meet-synlogics-aoife-brennan-fireside-chat-speaker-at-bioceo19/Fri, 01 Feb 2019 17:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/meet-synlogics-aoife-brennan-fireside-chat-speaker-at-bioceo19/https://www.newslocker.com/en-au/profession/biotechnology/using-decision-science-for-negotiations-getting-to-win-win/Thu, 31 Jan 2019 22:46:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/using-decision-science-for-negotiations-getting-to-win-win/ In addition to bringing the world’s largest conference and partnering event on industrial biotechnology to a new region and city, #BIOWC19 will feature exciting new agricultural programming and opportunities for companies of any size to showcase their latest breakthroughs and explore what the region has to offer:
New Midwest Destination
Join us in Iowa ne]]>https://www.newslocker.com/en-au/profession/biotechnology/whats-new-at-biowc19/Thu, 31 Jan 2019 21:13:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/whats-new-at-biowc19/ In case the daunting weather forecast has sent you into hibernation (which is completely feasible given the historically cold temperatures impacting a large portion of America), here’s a sample of what]]>https://www.newslocker.com/en-au/profession/biotechnology/latest-measles-outbreak-is-a-crash-course-on-the-importance-of-immunization/Thu, 31 Jan 2019 16:36:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/latest-measles-outbreak-is-a-crash-course-on-the-importance-of-immunization/ One major component the Trump administration has pushed for in such trade talks is structural reforms of China’s market. China’s systemic impediments to trade and non-tariff barriers, such as the country’s regulatory framework for agricultural biotechnology, has hindered the timely]]>https://www.newslocker.com/en-au/profession/biotechnology/trump-administration-should-remain-steadfast-in-pushing-china-towards-structural-reforms/Wed, 30 Jan 2019 18:59:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/trump-administration-should-remain-steadfast-in-pushing-china-towards-structural-reforms/ Fact #1: Drug prices are headed in the right direction. The proof is in the data. The White House Council of Economic Advisers recently announced that drug prices decreased in 2018:This data re]]>https://www.newslocker.com/en-au/profession/biotechnology/heres-what-you-need-to-know-as-capitol-hill-talks-prescription-drug-costs/Mon, 28 Jan 2019 21:57:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/heres-what-you-need-to-know-as-capitol-hill-talks-prescription-drug-costs/ “President Trump on Wednesday spoke out against surprise medical bills that patients often cannot afford, highlighting an issue that has received bipartisan concern in Congress.
“‘The health care system too often harms people with some unfair surprises … medical bills and the like,’ Trump said at a]]>https://www.newslocker.com/en-au/profession/biotechnology/a-helpful-spotlight-on-the-need-for-more-health-care-transparency/Fri, 25 Jan 2019 20:49:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/a-helpful-spotlight-on-the-need-for-more-health-care-transparency/https://www.newslocker.com/en-au/profession/biotechnology/investors-lining-up-for-bio-ceo-amp-investor-conference/Thu, 24 Jan 2019 16:52:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/investors-lining-up-for-bio-ceo-amp-investor-conference/ The company that developed NARCAN® Nasal Spray is Opiant Pharmaceuticals, based in Santa Monica, CA. CEO Dr. Roger Crystal will be a headliner at the upcoming BIO CEO & Investor Conference, leading a fireside chat at noon on Tuesday, February 12.]]>https://www.newslocker.com/en-au/profession/biotechnology/meet-opiants-roger-crystal-fireside-chat-speaker-at-bioceo19/Wed, 23 Jan 2019 16:41:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/meet-opiants-roger-crystal-fireside-chat-speaker-at-bioceo19/ Through Senator Birch Bayh’s long career of public service, he led a number of social and economic achievements that did just that.
As a champion of America’s intellectual property system, Senator Bayh partnered with another luminary Senator at the opposite end]]>https://www.newslocker.com/en-au/profession/biotechnology/happy-91st-birthday-senator-bayh/Tue, 22 Jan 2019 21:41:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/happy-91st-birthday-senator-bayh/ Improve nutritional quality of crops and increase vitamin content;
Conserve water; Improve air quality; Enhance soil quality;
Reduce the use of pesticides and other chemical inputs; and much more.But unfortunately, there are still a lot of myths and misinformation surrounding G]]>https://www.newslocker.com/en-au/profession/biotechnology/new-study-suggests-those-extremely-opposed-to-gmos-know-the-least-about-gmos/Fri, 18 Jan 2019 15:39:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/new-study-suggests-those-extremely-opposed-to-gmos-know-the-least-about-gmos/ To cultivate a conversation around the potential of these innovations, BIO has teamed up with the American Seed Trade Association (ASTA) to launch Innovature.com.
Through Innovature’s website, social properties and other activities, the initiative aims to engage key influencers in a conversation around shared values t]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-and-asta-launch-innovature-a-new-platform-to-cultivate-conversations-about-innovation-in-food-and-agriculture/Thu, 17 Jan 2019 16:58:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio-and-asta-launch-innovature-a-new-platform-to-cultivate-conversations-about-innovation-in-food-and-agriculture/ “Under peculiar language of the statute, insurers are paid by Medicare for drugs in advance of their purchase, based on their own estimated outlays. However, they only have to repay a portion ]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-shines-spotlight-on-insurance-industry-rip-off/Thu, 17 Jan 2019 16:27:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/greenwood-shines-spotlight-on-insurance-industry-rip-off/https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onepartnering-meeting-leads-to-unique-public-private-partnership/Fri, 11 Jan 2019 21:12:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onepartnering-meeting-leads-to-unique-public-private-partnership/ Fortunately, scientists are working to develop techniques that could help address mosquito-related diseases like malaria, West Nile, and Zika.
Just this week, researchers at the University of Arizona (UA) discovered an approach that could act as a “mosquito birth control” and reduce mosquito populations where disease transmission]]>https://www.newslocker.com/en-au/profession/biotechnology/using-biotechnology-to-tackle-deadly-mosquito-borne-illnesses/Fri, 11 Jan 2019 18:09:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/using-biotechnology-to-tackle-deadly-mosquito-borne-illnesses/ As CBS profiled on 60 Minutes, Marshall Medoff, an 81-year-old inventor in Massachusetts, has uncovered the secret to accessing plant cellulose and transforming the inedible plant life into environment]]>https://www.newslocker.com/en-au/profession/biotechnology/inventor-unlocks-method-to-turn-plant-sugars-into-environmentally-friendly-fuel/Wed, 09 Jan 2019 21:30:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/inventor-unlocks-method-to-turn-plant-sugars-into-environmentally-friendly-fuel/ On Thursday, researchers at the University of Illinois announced they were successful in producing tobacco plants that were 40 percent larger.
Now, the goal of this endeavor is not to produce more tobacco. Instead, they are aiming to apply the]]>https://www.newslocker.com/en-au/profession/biotechnology/this-major-breakthrough-could-help-improve-global-food-supply/Tue, 08 Jan 2019 18:27:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/this-major-breakthrough-could-help-improve-global-food-supply/ In a recent blog for Vital Transformation, author Duane Schulthess examines a claim made by Secretary Azar at a Brookings Institute briefing where he touts the plan – k]]>https://www.newslocker.com/en-au/profession/biotechnology/despite-administrations-sky-high-rhetoric-importing-foreign-price-controls-will-harm-innovation-and-patient-access/Mon, 07 Jan 2019 17:11:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/despite-administrations-sky-high-rhetoric-importing-foreign-price-controls-will-harm-innovation-and-patient-access/ New disclosure requirements finalized by USDA for biotech foods will mandate the use of the term “bioengineered” while providing a key exemption for ingredients such as vegetable oils, sugar and other foods where the genetically altered DNA of the GMO crop can’t be detected. The requirements, which will be enforced starting in 2022, also will exempt foods that contain as much as 5 percent of a bioengineered ingredient that th]]>https://www.newslocker.com/en-au/profession/biotechnology/usa-gov-releases-gm-labeling-rules/Mon, 07 Jan 2019 08:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/usa-gov-releases-gm-labeling-rules/ Scientists in the US have engineered tobacco plants that can grow up to 40% larger than normal in field trials. The researchers say they have found a way of overcoming natural restrictions in the process of photosynthesis that limit crop productivity. They believe the method could be used to significantly boost yields from important crops. The study has been published in the journal Science. The team is now hoping to use these findings to boost the yields of soybean, rice,]]>https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-plants-with-growth-boosted-by-40/Mon, 07 Jan 2019 07:56:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-plants-with-growth-boosted-by-40/ While some individuals love the look and smell of a real Christmas tree, others prefer the low upkeep and longevity of an artificial tree.
But what if we could use genetics to improve the Christmas tree? Would you trade in the fake tree for a fir that loses less needles and requires less upkeep?
Here are four facts about using genetics in pursuit of a more perfect Christmas tree:
1) Very li]]>https://www.newslocker.com/en-au/profession/biotechnology/4-facts-about-using-genetics-in-pursuit-of-a-more-perfect-christmas-tree/Thu, 20 Dec 2018 21:57:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/4-facts-about-using-genetics-in-pursuit-of-a-more-perfect-christmas-tree/ “As policy professionals from different sides of the aisle, we believe there is a right way to address these issues and a wrong way. The right way will reduce out-of-pocket costs for patients, improve access to new medicines, and allow the United States to remain the global]]>https://www.newslocker.com/en-au/profession/biotechnology/the-right-way-to-address-prescription-drug-costs/Thu, 20 Dec 2018 15:27:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-right-way-to-address-prescription-drug-costs/ In a series of new infographics, BIO illustrates how far]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-illustrates-the-success-of-the-orphan-drug-act/Wed, 19 Dec 2018 17:49:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio-illustrates-the-success-of-the-orphan-drug-act/ As we move closer to celebrating the end of 2018, Congress has given those working in America’s bio-based and agricultural sectors a reason to celebrate early. The 2018 Farm Bill has passed both chambers of Congress, with overwhelming bipartisan support, and is now set to be delivered to 1600 Pennsylvania Avenue, so it can be signed into law.]]>https://www.newslocker.com/en-au/profession/biotechnology/road-to-2018-farm-bill-was-years-in-the-making/Tue, 18 Dec 2018 15:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/road-to-2018-farm-bill-was-years-in-the-making/ However, scientists are now exploring how gene editing technology, like CRISPR, could modify the protein of wheat so that those with celiac disease could enjoy foods that typically contain gluten.
Kansas Wheat, which is the cooperative agreement between the Kansas Wheat Commission and the Kansas Association of Wheat Growers, is currently supporting gene editing research to help]]>https://www.newslocker.com/en-au/profession/biotechnology/from-disease-to-looming-food-crisis-gene-editing-could-unlock-solutions-to-our-greatest-problems/Mon, 17 Dec 2018 15:54:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/from-disease-to-looming-food-crisis-gene-editing-could-unlock-solutions-to-our-greatest-problems/ R]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-comments-on-objectives-for-us-japan-trade-agreement/Fri, 14 Dec 2018 14:36:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio-comments-on-objectives-for-us-japan-trade-agreement/ According to The Guardian, the comments were made at a press conference ahead of the 2018 Nobel Peace Prize Award Ceremony.
“We’v]]>https://www.newslocker.com/en-au/profession/biotechnology/nobel-prize-winning-chemists-misguided-gmo-fears-could-hinder-technologys-societal-benefits/Thu, 13 Dec 2018 15:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/nobel-prize-winning-chemists-misguided-gmo-fears-could-hinder-technologys-societal-benefits/ This strong performance is due to the vital and wide-ranging collaborations between industry partners, universi]]>https://www.newslocker.com/en-au/profession/biotechnology/interactive-map-displays-strength-of-industrys-national-footprint/Wed, 12 Dec 2018 15:27:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/interactive-map-displays-strength-of-industrys-national-footprint/ The 5th edition of the Building the Bioeconomy report shows the correlation between economies with pro-innovation policy frameworks and those achieving strong biotechnology outputs. By examining 28 different indicators ranging from publ]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-hosts-embassy-briefing-on-international-economic-development/Tue, 11 Dec 2018 18:10:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio-hosts-embassy-briefing-on-international-economic-development/ The latest blog post from the Department of Health and Human Services (HHS) includes numerous inaccuracies, with the chief example being the distorted view of how drugmakers set their prices in]]>https://www.newslocker.com/en-au/profession/biotechnology/the-administrations-orwellian-defense-of-importing-foreign-price-controls/Mon, 10 Dec 2018 15:47:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/the-administrations-orwellian-defense-of-importing-foreign-price-controls/ New research suggests that the type of yield gains made possible by genetic engineering (GE) will be needed to offset climate change impacts on agriculture.
The researchers said their study, published yesterday in Environmental Research Letters, has “important implications for regions lagging in the adoption of new technologies which could help offset the detrimental effects of climate change.”
Though agricultural productivity in Africa and Asia i]]>https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-crops-can-offset-climate-change-impacts/Mon, 10 Dec 2018 06:56:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/usa-gm-crops-can-offset-climate-change-impacts/ It’s being described as a possible game changer for farmers and even the pastoral industry in northern Australia — the resurgence of cotton.
The CSIRO has predicted that if 15,000 hectares of the crop were grown in the Ord region of the Kimberley, it would be worth $80 million.
If the same was done in Queensland, beef spin-offs would grow that figure to $340 million…
The turning point was the development of a genetically modified cotton variety called Boll]]>https://www.newslocker.com/en-au/profession/biotechnology/aus-gm-cotton-thrives-in-northern-aus/Mon, 10 Dec 2018 06:52:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/aus-gm-cotton-thrives-in-northern-aus/https://www.newslocker.com/en-au/profession/biotechnology/spain-drought-resistant-plants-developed/Mon, 10 Dec 2018 06:48:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/spain-drought-resistant-plants-developed/ The US Department of Agriculture has announced it would deregulate a strain of cotton that university researchers had genetically engineered to carry low levels of poisonous gossypol in its seeds. The idea is that the modified cotton’s seeds could be grown for food.
Cotton is known for its white fibers that can be woven into soft fabrics. But for every pound of fluffy, white lint, the plant produces 1.6 pounds of peanut-size seeds. Those seeds contain high levels]]>https://www.newslocker.com/en-au/profession/biotechnology/usa-usda-approves-edible-cotton/Mon, 10 Dec 2018 06:43:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/usa-usda-approves-edible-cotton/ An ambitious international project to sequence the DNA of every known animal, plant and fungus in the world over the next 10 years has been launched.
Described as “the next moonshot for biology”, the Earth BioGenome Project is expected to cost $4.7bn (£3.6bn) and involve reading the genomes of 1.5m species.
“Having the roadmap, the blueprints … will be a tremendous resource for new discoveries, understanding the rules of life, how evolution wor]]>https://www.newslocker.com/en-au/profession/biotechnology/int-project-underway-to-map-every-plant-animal-fungus-genome/Mon, 10 Dec 2018 06:39:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/int-project-underway-to-map-every-plant-animal-fungus-genome/ Walk into any grocery store and you’ll see lots of different labels plastered across a variety of food packaging. And without additional information accompanying th]]>https://www.newslocker.com/en-au/profession/biotechnology/beyond-labels-10-things-you-should-know-about-gmos/Fri, 07 Dec 2018 16:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/beyond-labels-10-things-you-should-know-about-gmos/ The report flies in the face of presumed progress that has been made since climate change became a high priority worldwide—a priority that became even more solidified in the historic 2015 Paris Agreement.
But, as we covered in a blog highlighting various]]>https://www.newslocker.com/en-au/profession/biotechnology/global-carbon-project-reports-2018-record-year-for-carbon-emissions-airlines-look-to-change-that/Thu, 06 Dec 2018 17:21:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/global-carbon-project-reports-2018-record-year-for-carbon-emissions-airlines-look-to-change-that/ “The latest indications are that for every $1 we spend on medicines, we save $2.50 in health care costs,” Greenwood explained. “Those who are [determined] to reduce the costs spent o]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-talks-innovation-drug-pricing-and-the-midterm-elections-on-forbesbooks-radio/Wed, 05 Dec 2018 15:16:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/greenwood-talks-innovation-drug-pricing-and-the-midterm-elections-on-forbesbooks-radio/ On the Administration’s recent International Pricing Index (IPI), which would move from a market-based payment formula for Medicare Part B drugs to one based on foreign prices, Greenwood explains:
“Importing foreign price controls will take a wrecking ball to our global leadership in drug innovation. It may]]>https://www.newslocker.com/en-au/profession/biotechnology/think-the-drug-pricing-debate-addresses-patient-costs-think-again/Mon, 03 Dec 2018 22:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/think-the-drug-pricing-debate-addresses-patient-costs-think-again/ On the Administration’s recent International Pricing Index (IPI), which would move from a market-based payment formula for Medicare Part B drugs to one based on foreign prices, Greenwood explains:
“Importing foreign price controls will take a wrecking ball to our global leadership in drug innovation. It may]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-think-the-drug-pricing-debate-addresses-patient-costs-think-again/Mon, 03 Dec 2018 22:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/greenwood-think-the-drug-pricing-debate-addresses-patient-costs-think-again/ Recently there have been several corporate producers of vodka that have decided to make their products from non-GMO crops. Smirnoff, in particular, has made videos and a rather large ad campaign highlighting that their product is now made with non-GMO corn and has always been gluten free. To be clear, corn doesn’t have gluten in it, so this claim is sim]]>https://www.newslocker.com/en-au/profession/biotechnology/whats-the-buzz-on-non-gmo-booze/Fri, 30 Nov 2018 14:42:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/whats-the-buzz-on-non-gmo-booze/ Specifically, a Chinese scientist claims to have used CRISPR-Cas9 — the groundbreaking genome editing technology — to tweak the DNA of human embryos, which resulted in the birth of twin girls.
The news was met with criticism from stakeholders across the health care spectrum, which included deep concerns from the]]>https://www.newslocker.com/en-au/profession/biotechnology/claims-of-gene-edited-twins-met-with-criticism-and-concern/Thu, 29 Nov 2018 20:51:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/claims-of-gene-edited-twins-met-with-criticism-and-concern/ During the day-long food and agriculture programming, titled Food, Health and Environmental Future Day, several industry experts, including government officials, company spokespeople, researchers, farmers and even movie producers, harped on the urgency to advance foo]]>https://www.newslocker.com/en-au/profession/biotechnology/boston-globe-need-for-high-tech-food-and-policies-to-match-undeniable/Thu, 29 Nov 2018 16:06:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/boston-globe-need-for-high-tech-food-and-policies-to-match-undeniable/ As November comes to an end and we reflect upon Alzheimer’s Awareness Month, it’s important that we recognize the progress that’s been made over the years. While it’s true there is no “silver-bullet” c]]>https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-awareness-month-hope-on-the-horizon/Wed, 28 Nov 2018 20:37:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-awareness-month-hope-on-the-horizon/ Earlier this Fall, the United Nations raised the alarm on the world’s collective progress in meeting the climate]]>https://www.newslocker.com/en-au/profession/biotechnology/innovations-in-biotechnology-to-save-the-climate/Mon, 26 Nov 2018 16:37:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/innovations-in-biotechnology-to-save-the-climate/ In a new blog post on the GMO Answers Medium page, volunteer expert and registered dietitian Leia Flure explains, in plain language, just how modern agriculture, from GMOs to selective breeding, has had an impact on your Thanksg]]>https://www.newslocker.com/en-au/profession/biotechnology/this-thanksgiving-were-thankful-for-modern-agriculture/Tue, 20 Nov 2018 16:06:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/this-thanksgiving-were-thankful-for-modern-agriculture/ In an article for the Associated Press, reporter Lauren Neergaard dives into the promising potential of gene-editing as it is used in both plants and animals to make better products for human consumption.
“By early next year, the first foods from plants or animals that had their DNA ‘edited’ are expected to begin selling. It’s a diffe]]>https://www.newslocker.com/en-au/profession/biotechnology/2019-will-bring-new-healthier-foods-all-thanks-to-gene-editing/Fri, 16 Nov 2018 19:15:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/2019-will-bring-new-healthier-foods-all-thanks-to-gene-editing/ These drug cost middlemen, also known as PBMs, manage prescription drug benefits on behalf of health plans. It just so happens that Blue Cross Blue Shield plans own one of the largest PBMs in the country – Prime]]>https://www.newslocker.com/en-au/profession/biotechnology/another-year-another-misleading-insurance-company-report/Thu, 15 Nov 2018 22:13:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/another-year-another-misleading-insurance-company-report/ Twain’s words on the region often referred to as “America’s Heartland” have never been truer. States like Iowa are driving inn]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc19-bio-now-accepting-proposals-for-new-programming-at-2019-world-congress-in-des-moines/Thu, 15 Nov 2018 16:57:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/biowc19-bio-now-accepting-proposals-for-new-programming-at-2019-world-congress-in-des-moines/ The survey, commissioned by Research!America in collaboration with the IDSA and supported in part by Pfizer, shows that nearly two-thirds of Americans (65%) say antibiotic resistance is a threat to]]>https://www.newslocker.com/en-au/profession/biotechnology/survey-says-solutions-to-combat-against-antimicrobial-resistance-needed/Wed, 14 Nov 2018 20:14:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/survey-says-solutions-to-combat-against-antimicrobial-resistance-needed/ The BioPreferred® Program helps establish a market for companies]]>https://www.newslocker.com/en-au/profession/biotechnology/lame-duck-is-now-in-session-time-to-fund-farm-bills-energy-title-programs/Wed, 14 Nov 2018 17:01:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/lame-duck-is-now-in-session-time-to-fund-farm-bills-energy-title-programs/https://www.newslocker.com/en-au/profession/biotechnology/bio-celebrates-300-biotech-ipos-since-enactment-of-the-jobs-act/Fri, 09 Nov 2018 18:17:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/bio-celebrates-300-biotech-ipos-since-enactment-of-the-jobs-act/ This support was reflected in a statement titled “The International Statement on Agricultural Applications of Precision Biotechnology,” which was led by Argentina and released at a meeting in Geneva at the World Trade Organization Committee on the Application of Sanitary and Phytosanitary Measures. Both the U.S. Department of State and]]>https://www.newslocker.com/en-au/profession/biotechnology/through-international-support-us-has-opportunity-to-align-own-agencies-on-precision-biotech/Thu, 08 Nov 2018 20:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/through-international-support-us-has-opportunity-to-align-own-agencies-on-precision-biotech/ She writesThe first GE plants had new characteristics that made them resistant to environmental conditions. One of the very first improved crops through genetic engineering saved the papaya industry in Hawaii.
Anyo]]>https://www.newslocker.com/en-au/profession/biotechnology/you-may-not-like-gmos-but-our-planet-sure-does/Wed, 07 Nov 2018 20:38:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/you-may-not-like-gmos-but-our-planet-sure-does/ On Day 1 of BIO’s Patient and Health Advocacy Summit, a group of health care stakeholders joined Merck’s Dr. Julie Gerberding for a discussion about the importance of understanding policies that may stand between patients, and the treatments they need. Panelists included:Carl Schmid, The AIDS Institute
Donna Cryer, Global Liver Ins]]>https://www.newslocker.com/en-au/profession/biotechnology/patient-and-health-advocacy-summit-ensuring-patient-access-and-affordability/Fri, 02 Nov 2018 20:04:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/patient-and-health-advocacy-summit-ensuring-patient-access-and-affordability/https://www.newslocker.com/en-au/profession/biotechnology/illumina-adds-long-read-capabilities-with-planned-12b-acquisition-of-pacbio/Fri, 02 Nov 2018 15:33:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/illumina-adds-long-read-capabilities-with-planned-12b-acquisition-of-pacbio/https://www.newslocker.com/en-au/profession/biotechnology/zika-biomarkers-could-lead-to-prenatal-diagnostic/Fri, 02 Nov 2018 15:20:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/zika-biomarkers-could-lead-to-prenatal-diagnostic/https://www.newslocker.com/en-au/profession/biotechnology/appetite-suppressants-identified-using-zebrafish-larva-and-fluorescent-prey/Fri, 02 Nov 2018 15:05:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/appetite-suppressants-identified-using-zebrafish-larva-and-fluorescent-prey/https://www.newslocker.com/en-au/profession/biotechnology/novel-two-pronged-method-targets-cancer-cells-telomerase-and-chromosomes/Fri, 02 Nov 2018 13:05:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/novel-two-pronged-method-targets-cancer-cells-telomerase-and-chromosomes/ On October 11, 2018, the New Jersey Economic Development Authority and the Israel In]]>https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onepresentation-at-bio-2018-leads-to-international-agreement/Thu, 01 Nov 2018 20:18:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-onepresentation-at-bio-2018-leads-to-international-agreement/https://www.newslocker.com/en-au/profession/biotechnology/sanofi-denali-launch-1b-alliance-to-develop-ripk1-inhibitors-for-neurological-inflammatory-diseases/Thu, 01 Nov 2018 15:36:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/sanofi-denali-launch-1b-alliance-to-develop-ripk1-inhibitors-for-neurological-inflammatory-diseases/https://www.newslocker.com/en-au/profession/biotechnology/conjoined-cells-form-a-potent-immunotherapy-combo/Thu, 01 Nov 2018 15:36:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/conjoined-cells-form-a-potent-immunotherapy-combo/https://www.newslocker.com/en-au/profession/biotechnology/european-consortium-wins-37m-to-develop-study-models-of-neurological-disorders/Thu, 01 Nov 2018 15:33:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/european-consortium-wins-37m-to-develop-study-models-of-neurological-disorders/https://www.newslocker.com/en-au/profession/biotechnology/no-appendix-equals-decreased-parkinsons-risk/Thu, 01 Nov 2018 15:04:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/no-appendix-equals-decreased-parkinsons-risk/https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-disease-drug-that-cools-brains-on-firerdquo-could-enter-human-trials-in-2020/Thu, 01 Nov 2018 14:30:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-disease-drug-that-cools-brains-on-firerdquo-could-enter-human-trials-in-2020/https://www.newslocker.com/en-au/profession/biotechnology/amyloids-shown-to-also-play-beneficial-role-in-developing-healthy-muscle-tissue/Thu, 01 Nov 2018 12:41:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/amyloids-shown-to-also-play-beneficial-role-in-developing-healthy-muscle-tissue/ However, this claim caused quite the stir yesterday when news outlets incorrectly reported on the CDC&rsquo]]>https://www.newslocker.com/en-au/profession/biotechnology/cdc-issues-risk-advisory-on-dressing-chickens-for-halloween-biotech-chickens-may-help/Wed, 31 Oct 2018 18:20:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/cdc-issues-risk-advisory-on-dressing-chickens-for-halloween-biotech-chickens-may-help/https://www.newslocker.com/en-au/profession/biotechnology/ophthotech-expands-eye-disease-pipelines-of-small-molecule-gene-therapy-candidates/Wed, 31 Oct 2018 15:37:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/ophthotech-expands-eye-disease-pipelines-of-small-molecule-gene-therapy-candidates/https://www.newslocker.com/en-au/profession/biotechnology/nip-tuck-crispr-gene-editing-could-give-plastic-surgery-a-lift/Wed, 31 Oct 2018 15:37:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/nip-tuck-crispr-gene-editing-could-give-plastic-surgery-a-lift/https://www.newslocker.com/en-au/profession/biotechnology/early-liver-cancer-detection-through-glycolytic-genes/Wed, 31 Oct 2018 15:35:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/early-liver-cancer-detection-through-glycolytic-genes/https://www.newslocker.com/en-au/profession/biotechnology/fear-in-mind-coping-mechanism-identified-in-new-brain-region/Wed, 31 Oct 2018 15:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/fear-in-mind-coping-mechanism-identified-in-new-brain-region/https://www.newslocker.com/en-au/profession/biotechnology/new-work-opens-door-to-manipulating-aberrant-calcium-signaling-in-immune-system/Wed, 31 Oct 2018 12:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/new-work-opens-door-to-manipulating-aberrant-calcium-signaling-in-immune-system/ The summit concluded with a session on patient-focused drug development (PFDD) with distinguished panelists representing diverse perspectives: Paul Hastings, President and CEO of Nkarta Therapeutics; Laurie Burke, MPH, Founder of LORA Group; Cartier Esham, PhD, EVP of Emerging Companies]]>https://www.newslocker.com/en-au/profession/biotechnology/opportunities-for-patient-and-health-advocates/Tue, 30 Oct 2018 21:48:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/opportunities-for-patient-and-health-advocates/https://www.newslocker.com/en-au/profession/biotechnology/grnenthal-acquires-partial-rights-to-nexium-vimovo-from-astrazeneca-for-up-to-922m/Tue, 30 Oct 2018 15:32:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/grnenthal-acquires-partial-rights-to-nexium-vimovo-from-astrazeneca-for-up-to-922m/https://www.newslocker.com/en-au/profession/biotechnology/microbes-engineered-to-model-endosymbiosis/Tue, 30 Oct 2018 15:14:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/microbes-engineered-to-model-endosymbiosis/https://www.newslocker.com/en-au/profession/biotechnology/vitamin-d-and-cardio-fitness-linked/Tue, 30 Oct 2018 15:12:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/vitamin-d-and-cardio-fitness-linked/https://www.newslocker.com/en-au/profession/biotechnology/softening-up-chemo-resistant-cancer-cells/Tue, 30 Oct 2018 14:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/softening-up-chemo-resistant-cancer-cells/https://www.newslocker.com/en-au/profession/biotechnology/hiv-inhibiting-gene-found-to-resensitize-cancer-to-dna-damaging-agents/Tue, 30 Oct 2018 14:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/hiv-inhibiting-gene-found-to-resensitize-cancer-to-dna-damaging-agents/https://www.newslocker.com/en-au/profession/biotechnology/novel-nano-system-delivers-mrna-to-inflammatory-leukocytes/Tue, 30 Oct 2018 12:46:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/novel-nano-system-delivers-mrna-to-inflammatory-leukocytes/https://www.newslocker.com/en-au/profession/biotechnology/new-insomnia-target-may-help-catch-some-sleep/Mon, 29 Oct 2018 15:40:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/new-insomnia-target-may-help-catch-some-sleep/https://www.newslocker.com/en-au/profession/biotechnology/lilly-dicerna-launch-37b-rnai-collaboration/Mon, 29 Oct 2018 15:22:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/lilly-dicerna-launch-37b-rnai-collaboration/https://www.newslocker.com/en-au/profession/biotechnology/growth-factor-significantly-impacts-fat-and-carb-metabolism/Mon, 29 Oct 2018 15:00:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/growth-factor-significantly-impacts-fat-and-carb-metabolism/https://www.newslocker.com/en-au/profession/biotechnology/when-it-comes-to-gmos-dont-be-afraid-of-what-you-dont-understand/Mon, 29 Oct 2018 14:43:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/when-it-comes-to-gmos-dont-be-afraid-of-what-you-dont-understand/https://www.newslocker.com/en-au/profession/biotechnology/immunocompromised-patients-could-get-help-from-new-vaccine-strategy/Mon, 29 Oct 2018 13:30:00 +0100https://www.newslocker.com/en-au/profession/biotechnology/immunocompromised-patients-could-get-help-from-new-vaccine-strategy/ Held this year—its seventh—at the Park Hyatt hotel in Washington, DC, the Summit concluded today after running a robust program focused squarely on patients and their immeasurable contributions to the drug development process.
The two days of educational panels addressed best practices for engaging with industry,]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-patient-amp-health-advocacy-summit-concludes-today/Fri, 26 Oct 2018 20:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-patient-amp-health-advocacy-summit-concludes-today/https://www.newslocker.com/en-au/profession/biotechnology/industry-groups-fire-back-as-trump-proposes-cutting-part-b-medicare-drug-costs/Fri, 26 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/industry-groups-fire-back-as-trump-proposes-cutting-part-b-medicare-drug-costs/https://www.newslocker.com/en-au/profession/biotechnology/infant-microbiome-develops-in-three-stages/Fri, 26 Oct 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/infant-microbiome-develops-in-three-stages/https://www.newslocker.com/en-au/profession/biotechnology/ear-infection-susceptibility-gene-identified/Fri, 26 Oct 2018 16:11:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ear-infection-susceptibility-gene-identified/https://www.newslocker.com/en-au/profession/biotechnology/probiotics-may-not-always-benefit-gut-health/Fri, 26 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/probiotics-may-not-always-benefit-gut-health/https://www.newslocker.com/en-au/profession/biotechnology/synthego-eyes-product-platform-expansions-with-latest-110m-financing/Thu, 25 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/synthego-eyes-product-platform-expansions-with-latest-110m-financing/https://www.newslocker.com/en-au/profession/biotechnology/sids-link-to-serotonin-neurons-strengthened/Thu, 25 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sids-link-to-serotonin-neurons-strengthened/ The scientists are deeply concerned about a recent European Court of Justice ruling concerning modern genome editing techniques that could lead to a de facto ban of innovative crop breeding.
The position paper argues the European farmers]]>https://www.newslocker.com/en-au/profession/biotechnology/european-scientists-unite-to-safeguard-gene-editing-for-crops/Thu, 25 Oct 2018 16:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/european-scientists-unite-to-safeguard-gene-editing-for-crops/https://www.newslocker.com/en-au/profession/biotechnology/anti-obesity-biochemical-cigarette-exploits-bodys-responses-to-cold-and-smoking/Thu, 25 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/anti-obesity-biochemical-cigarette-exploits-bodys-responses-to-cold-and-smoking/https://www.newslocker.com/en-au/profession/biotechnology/abbvie-takes-control-of-cystic-fibrosis-collaboration-with-galapagos/Thu, 25 Oct 2018 15:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/abbvie-takes-control-of-cystic-fibrosis-collaboration-with-galapagos/https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-inhibited-by-compound-against-undruggable-target/Wed, 24 Oct 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-inhibited-by-compound-against-undruggable-target/https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-immunotherapy-delivered-without-side-effects/Wed, 24 Oct 2018 16:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-immunotherapy-delivered-without-side-effects/https://www.newslocker.com/en-au/profession/biotechnology/zikas-balloon-popped-by-peptide-needle/Wed, 24 Oct 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/zikas-balloon-popped-by-peptide-needle/https://www.newslocker.com/en-au/profession/biotechnology/alexion-dicerna-launch-637m-rnai-collaboration-in-complement-mediated-diseases/Wed, 24 Oct 2018 16:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/alexion-dicerna-launch-637m-rnai-collaboration-in-complement-mediated-diseases/ More accurately described as “fail first,” this dangerous policy will force some patients to fail first on a medicine preferred by their insurance companies before they can receive the therapy prescribed by their doctors. Allo]]>https://www.newslocker.com/en-au/profession/biotechnology/patient-advocates-sounding-the-alarm-over-fail-first/Tue, 23 Oct 2018 21:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/patient-advocates-sounding-the-alarm-over-fail-first/https://www.newslocker.com/en-au/profession/biotechnology/cellular-dumpster-diving-yields-diagnostic-treasure/Tue, 23 Oct 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cellular-dumpster-diving-yields-diagnostic-treasure/https://www.newslocker.com/en-au/profession/biotechnology/takeda-to-co-develop-enterome-crohns-disease-candidate-eb8018/Tue, 23 Oct 2018 16:24:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/takeda-to-co-develop-enterome-crohns-disease-candidate-eb8018/https://www.newslocker.com/en-au/profession/biotechnology/infant-gut-microbiome-predicts-obesity-in-pre-teens/Tue, 23 Oct 2018 16:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/infant-gut-microbiome-predicts-obesity-in-pre-teens/https://www.newslocker.com/en-au/profession/biotechnology/lavender-scent-reduces-anxiety-through-smell-receptors/Tue, 23 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lavender-scent-reduces-anxiety-through-smell-receptors/https://www.newslocker.com/en-au/profession/biotechnology/aromatic-lavender-extract-acts-through-smell-receptors-to-reduce-anxiety/Tue, 23 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aromatic-lavender-extract-acts-through-smell-receptors-to-reduce-anxiety/https://www.newslocker.com/en-au/profession/biotechnology/making-sma-newborn-screening-a-reality-collaborating-with-the-patient-advocacy-community/Mon, 22 Oct 2018 20:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/making-sma-newborn-screening-a-reality-collaborating-with-the-patient-advocacy-community/https://www.newslocker.com/en-au/profession/biotechnology/longeveron-wins-38m-nih-sbir-grant-toward-stem-cell-aging-frailty-research/Mon, 22 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/longeveron-wins-38m-nih-sbir-grant-toward-stem-cell-aging-frailty-research/https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-trial-first-line-chemo-immuno-combo-improves-outcomes/Mon, 22 Oct 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-trial-first-line-chemo-immuno-combo-improves-outcomes/https://www.newslocker.com/en-au/profession/biotechnology/united-therapeutics-to-develop-collplant-technologies-for-3d-bioprinted-lung-transplants/Mon, 22 Oct 2018 15:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/united-therapeutics-to-develop-collplant-technologies-for-3d-bioprinted-lung-transplants/https://www.newslocker.com/en-au/profession/biotechnology/dads-exercise-and-nicotine-exposure-affect-childrens-cognitive-and-metabolic-health/Mon, 22 Oct 2018 14:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dads-exercise-and-nicotine-exposure-affect-childrens-cognitive-and-metabolic-health/https://www.newslocker.com/en-au/profession/biotechnology/tiny-crispr-protein-from-tiny-archaea-may-have-big-diagnostic-impact/Fri, 19 Oct 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tiny-crispr-protein-from-tiny-archaea-may-have-big-diagnostic-impact/https://www.newslocker.com/en-au/profession/biotechnology/drug-uptake-gets-a-boost-in-hard-to-reach-pancreatic-cells/Fri, 19 Oct 2018 16:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/drug-uptake-gets-a-boost-in-hard-to-reach-pancreatic-cells/https://www.newslocker.com/en-au/profession/biotechnology/merrimack-reviews-pipeline-after-phase-ii-failure-of-mm-121-in-lung-cancer/Fri, 19 Oct 2018 16:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/merrimack-reviews-pipeline-after-phase-ii-failure-of-mm-121-in-lung-cancer/https://www.newslocker.com/en-au/profession/biotechnology/gut-bacteria-link-dietary-fiber-with-liver-cancer/Fri, 19 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gut-bacteria-link-dietary-fiber-with-liver-cancer/ In an abrupt reversal of long-standing policy, the Centers for Medicare & Medicaid Services (CMS) announced that Medicare Advantage health plans can impose “step therapy” requirements on patients who need drugs covered under Medicare Part B.
The new directive &m]]>https://www.newslocker.com/en-au/profession/biotechnology/watchdog-report-reaffirms-concerns-with-fail-first/Fri, 19 Oct 2018 15:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/watchdog-report-reaffirms-concerns-with-fail-first/ Attendance was up over previous years and included attendees from 34 countries, giving the event a distinctly international flavor. Many were drawn to the conference’s expertly led panel sessions and the opp]]>https://www.newslocker.com/en-au/profession/biotechnology/2018-bio-investor-forum-wraps-up/Fri, 19 Oct 2018 02:32:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/2018-bio-investor-forum-wraps-up/https://www.newslocker.com/en-au/profession/biotechnology/bio-investor-forum-explores-digiceuticals-as-a-new-class-of-fda-approved-therapeutics/Fri, 19 Oct 2018 01:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-investor-forum-explores-digiceuticals-as-a-new-class-of-fda-approved-therapeutics/ Dispensing with the typical question and answer style fireside chat, Chapman and Pakianathan instead engaged in a dynamic, frank and wide-ranging conversation that drew on their diverse experiences. Both began their careers doin]]>https://www.newslocker.com/en-au/profession/biotechnology/a-patient-centric-approach-to-investing-amp-partnering/Fri, 19 Oct 2018 01:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-patient-centric-approach-to-investing-amp-partnering/ Linda Grais, MD, former Chief Executive Officer, Ocera Therapeutics
Nina Kjellson, Ge]]>https://www.newslocker.com/en-au/profession/biotechnology/lessons-from-view-from-the-board-responding-to-an-acquisition-offer/Fri, 19 Oct 2018 00:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lessons-from-view-from-the-board-responding-to-an-acquisition-offer/https://www.newslocker.com/en-au/profession/biotechnology/fungal-rnas-targeted-by-small-molecule-drugs/Thu, 18 Oct 2018 16:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fungal-rnas-targeted-by-small-molecule-drugs/https://www.newslocker.com/en-au/profession/biotechnology/novartis-to-acquire-endocyte-for-21b-expanding-rlt-pipeline-in-prostate-cancer/Thu, 18 Oct 2018 16:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novartis-to-acquire-endocyte-for-21b-expanding-rlt-pipeline-in-prostate-cancer/https://www.newslocker.com/en-au/profession/biotechnology/methylation-markers-distinguish-aggressive-from-manageable-prostate-cancer/Thu, 18 Oct 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/methylation-markers-distinguish-aggressive-from-manageable-prostate-cancer/https://www.newslocker.com/en-au/profession/biotechnology/drug-resistant-bacteria-zapped-by-probiotic-antibiotic-combination/Thu, 18 Oct 2018 14:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/drug-resistant-bacteria-zapped-by-probiotic-antibiotic-combination/ That was the underlying theme of the opening Plenary Luncheon and Fireside Chat at the 2018 BIO Investor Forum (BIF).
The fireside chat featured an informative and wide-ranging conversation with industry investing veteran Ed Hurwitz, managing director at MPM Capital. The discussion was moderated by Susanne Mulligan, managing director, life sciences banking, at BMO Capital Markets.
BIO Preside]]>https://www.newslocker.com/en-au/profession/biotechnology/on-track-for-a-record-breaking-2018-bif18-opening-plenary/Thu, 18 Oct 2018 00:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/on-track-for-a-record-breaking-2018-bif18-opening-plenary/https://www.newslocker.com/en-au/profession/biotechnology/how-companies-are-using-microbiome-based-therapies-to-improve-patient-outcomes/Thu, 18 Oct 2018 00:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-companies-are-using-microbiome-based-therapies-to-improve-patient-outcomes/https://www.newslocker.com/en-au/profession/biotechnology/the-2019-breakthrough-prize-winners-announced/Wed, 17 Oct 2018 21:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-2019-breakthrough-prize-winners-announced/https://www.newslocker.com/en-au/profession/biotechnology/rna-based-gene-therapy-can-be-turned-on-or-off-via-synbio-switches/Wed, 17 Oct 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rna-based-gene-therapy-can-be-turned-on-or-off-via-synbio-switches/https://www.newslocker.com/en-au/profession/biotechnology/axim-plans-trials-for-flagship-candidate-after-receiving-gmp-license/Wed, 17 Oct 2018 16:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/axim-plans-trials-for-flagship-candidate-after-receiving-gmp-license/ As part of GMO Answers annual Get to Know GMOs Month, we invite you to come with us for an eerie stroll through some of the Internet’s most outrageous GMO myths and images. And then get the real story behind each of these myths.Myth #1: Evil GMO scientists are injecting GMO cro]]>https://www.newslocker.com/en-au/profession/biotechnology/get-to-know-gmos-month-spooky-gmo-myths-debunked/Wed, 17 Oct 2018 16:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/get-to-know-gmos-month-spooky-gmo-myths-debunked/https://www.newslocker.com/en-au/profession/biotechnology/fish-oils-may-slow-breast-cancer-growth-via-immune-inflammatory-mechanisms/Wed, 17 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fish-oils-may-slow-breast-cancer-growth-via-immune-inflammatory-mechanisms/https://www.newslocker.com/en-au/profession/biotechnology/cancer-can-change-neutrophils-behavior-influencing-them-to-support-tumor-growth/Wed, 17 Oct 2018 14:38:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-can-change-neutrophils-behavior-influencing-them-to-support-tumor-growth/ Established in 1945, the UN’s Food and Agricultural Organization is focused on leading international efforts to defeat hunger. And in today’s world, hunger is an increasingly critical issue that the UN is closely watching.
In fact, the UN has been sounding the alarm that we must double food production to feed the world’s growing populatio]]>https://www.newslocker.com/en-au/profession/biotechnology/worldfoodday-biotechnology-to-feed-the-world/Tue, 16 Oct 2018 22:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/worldfoodday-biotechnology-to-feed-the-world/https://www.newslocker.com/en-au/profession/biotechnology/innovation-intersecting-with-investing-welcome-to-the-bio-investor-forum/Tue, 16 Oct 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/innovation-intersecting-with-investing-welcome-to-the-bio-investor-forum/https://www.newslocker.com/en-au/profession/biotechnology/paul-g-allen-65-remembered-as-pioneer-philanthropist-in-science-and-technology/Tue, 16 Oct 2018 16:39:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/paul-g-allen-65-remembered-as-pioneer-philanthropist-in-science-and-technology/https://www.newslocker.com/en-au/profession/biotechnology/birth-method-impacts-on-brain-development-and-behavior/Tue, 16 Oct 2018 15:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/birth-method-impacts-on-brain-development-and-behavior/https://www.newslocker.com/en-au/profession/biotechnology/immunotherapeutic-antibody-helps-prevent-neurodegeneration/Tue, 16 Oct 2018 14:32:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/immunotherapeutic-antibody-helps-prevent-neurodegeneration/https://www.newslocker.com/en-au/profession/biotechnology/crohns-subtype-accurately-predicted-through-mirna-molecule/Tue, 16 Oct 2018 14:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crohns-subtype-accurately-predicted-through-mirna-molecule/https://www.newslocker.com/en-au/profession/biotechnology/organic-farming-with-gene-editing-oxymoron-or-tool-for-sustainable-agriculture/Mon, 15 Oct 2018 20:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/organic-farming-with-gene-editing-oxymoron-or-tool-for-sustainable-agriculture/https://www.newslocker.com/en-au/profession/biotechnology/sarepta-acquires-us-ex-european-rights-to-lysogene-mps-iii-gene-therapy-candidate-lys-saf302/Mon, 15 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sarepta-acquires-us-ex-european-rights-to-lysogene-mps-iii-gene-therapy-candidate-lys-saf302/https://www.newslocker.com/en-au/profession/biotechnology/cancer-initiating-cells-stay-stemmy-via-cdk1sox2-interaction/Mon, 15 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-initiating-cells-stay-stemmy-via-cdk1sox2-interaction/https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-progression-tracked-through-antioxidant-levels/Mon, 15 Oct 2018 15:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-progression-tracked-through-antioxidant-levels/https://www.newslocker.com/en-au/profession/biotechnology/microsoft-eagle-genomics-partner-on-microbiome-research/Mon, 15 Oct 2018 15:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/microsoft-eagle-genomics-partner-on-microbiome-research/https://www.newslocker.com/en-au/profession/biotechnology/dementia-linked-with-spontaneous-mutations-during-embryonic-development/Mon, 15 Oct 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dementia-linked-with-spontaneous-mutations-during-embryonic-development/https://www.newslocker.com/en-au/profession/biotechnology/fat-tissue-found-to-be-a-surprising-source-of-diabetes/Mon, 15 Oct 2018 14:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fat-tissue-found-to-be-a-surprising-source-of-diabetes/ How best to tackle that problem will be the subject of the World Antimicrobial Resistance Congress l]]>https://www.newslocker.com/en-au/profession/biotechnology/world-amr-congress-keynote-panel-to-explore-making-pull-incentives-a-reality/Fri, 12 Oct 2018 18:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/world-amr-congress-keynote-panel-to-explore-making-pull-incentives-a-reality/https://www.newslocker.com/en-au/profession/biotechnology/mouse-pups-have-two-biological-mommies/Fri, 12 Oct 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/mouse-pups-have-two-biological-mommies/https://www.newslocker.com/en-au/profession/biotechnology/immune-design-halts-phase-iii-trial-of-lead-candidate-cmb305-ramps-up-g100-development/Fri, 12 Oct 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/immune-design-halts-phase-iii-trial-of-lead-candidate-cmb305-ramps-up-g100-development/https://www.newslocker.com/en-au/profession/biotechnology/dopaminergic-neurons-generated-by-unexpected-conversion-of-mature-nerve-cells/Fri, 12 Oct 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dopaminergic-neurons-generated-by-unexpected-conversion-of-mature-nerve-cells/https://www.newslocker.com/en-au/profession/biotechnology/novel-parkinsons-therapies-possible-with-new-mouse-model/Fri, 12 Oct 2018 14:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-parkinsons-therapies-possible-with-new-mouse-model/https://www.newslocker.com/en-au/profession/biotechnology/gout-risk-factor-less-about-diet-more-about-genes/Thu, 11 Oct 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gout-risk-factor-less-about-diet-more-about-genes/https://www.newslocker.com/en-au/profession/biotechnology/max-planck-partners-with-themis-bioscience-to-develop-oncolytic-virotherapies/Thu, 11 Oct 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/max-planck-partners-with-themis-bioscience-to-develop-oncolytic-virotherapies/https://www.newslocker.com/en-au/profession/biotechnology/probiotic-good-bacteria-use-fengycins-to-eliminate-bad-bacteria/Thu, 11 Oct 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/probiotic-good-bacteria-use-fengycins-to-eliminate-bad-bacteria/ Let’s rewind to July, when Health and Human Services Secretary Alex Azar directed Food and Drug Administration (FDA) Commissioner Scott Gottlieb to establish a drug importation working group. Azar stated that he was open to a variety of solutions, as lon]]>https://www.newslocker.com/en-au/profession/biotechnology/drug-importation-dangerous-for-patients-consumers-and-american-communities/Thu, 11 Oct 2018 14:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/drug-importation-dangerous-for-patients-consumers-and-american-communities/https://www.newslocker.com/en-au/profession/biotechnology/tracking-molecular-development-of-sepsis-may-lead-to-improved-therapies/Thu, 11 Oct 2018 13:53:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tracking-molecular-development-of-sepsis-may-lead-to-improved-therapies/ Brent Erickson, BIO’s Executive Vice President, Industrial and Environmental
As Brent Erickson, BIO&rs]]>https://www.newslocker.com/en-au/profession/biotechnology/brent-erickson-in-biofuels-digest-its-past-midnight-in-america/Wed, 10 Oct 2018 19:13:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/brent-erickson-in-biofuels-digest-its-past-midnight-in-america/https://www.newslocker.com/en-au/profession/biotechnology/antipsychotic-drug-blocks-triple-negative-breast-cancer-growth/Wed, 10 Oct 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/antipsychotic-drug-blocks-triple-negative-breast-cancer-growth/https://www.newslocker.com/en-au/profession/biotechnology/vc-investment-jumps-51-year-over-year-during-q3/Wed, 10 Oct 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vc-investment-jumps-51-year-over-year-during-q3/https://www.newslocker.com/en-au/profession/biotechnology/myopia-comes-into-gene-expression-focus/Wed, 10 Oct 2018 16:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/myopia-comes-into-gene-expression-focus/ The U.S.-Mexico-Canada Trade Agreement, otherwise known as the USMCA, has achieved an important step in bringing our neighboring countries closer to high U.S. intellectual property standards that have made us the world leader in biotechnology innovation.
To read more about how the updated trade agreement benefits patients, farmers, and consumers around the globe, read BIO’s pr]]>https://www.newslocker.com/en-au/profession/biotechnology/usmca-paves-the-way-for-biotech-innovation/Wed, 10 Oct 2018 15:27:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/usmca-paves-the-way-for-biotech-innovation/https://www.newslocker.com/en-au/profession/biotechnology/micropeptide-discovery-may-lead-to-new-gene-therapy-for-heart-failure/Wed, 10 Oct 2018 13:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/micropeptide-discovery-may-lead-to-new-gene-therapy-for-heart-failure/https://www.newslocker.com/en-au/profession/biotechnology/are-we-ethically-prepared-for-the-brave-new-world-of-genetic-medicine/Tue, 09 Oct 2018 23:41:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/are-we-ethically-prepared-for-the-brave-new-world-of-genetic-medicine/https://www.newslocker.com/en-au/profession/biotechnology/vaccine-tag-might-stop-human-mosquito-malarial-tag/Tue, 09 Oct 2018 16:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vaccine-tag-might-stop-human-mosquito-malarial-tag/https://www.newslocker.com/en-au/profession/biotechnology/crispr-enhancement-cures-genetic-disease-in-mice/Tue, 09 Oct 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crispr-enhancement-cures-genetic-disease-in-mice/https://www.newslocker.com/en-au/profession/biotechnology/affimed-places-cancer-immunotherapy-candidate-afm11-on-clinical-hold-after-patient-death/Tue, 09 Oct 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/affimed-places-cancer-immunotherapy-candidate-afm11-on-clinical-hold-after-patient-death/https://www.newslocker.com/en-au/profession/biotechnology/epigenetic-sequencing-using-enzymatic-detection-method/Tue, 09 Oct 2018 16:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/epigenetic-sequencing-using-enzymatic-detection-method/https://www.newslocker.com/en-au/profession/biotechnology/new-hippocampus-map-shows-structures-and-functions-in-great-detail/Tue, 09 Oct 2018 14:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-hippocampus-map-shows-structures-and-functions-in-great-detail/https://www.newslocker.com/en-au/profession/biotechnology/the-importance-of-accurate-food-labels/Mon, 08 Oct 2018 20:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-importance-of-accurate-food-labels/ These numbers might seem daunting, but a simple solution can help protect you and your loved ones from a messy flu season: getting a flu shot.
Getting a flu shot has been proven to reduce the risk of catchi]]>https://www.newslocker.com/en-au/profession/biotechnology/to-ensure-history-does-not-repeat-itself-get-a-flu-shot/Mon, 08 Oct 2018 18:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/to-ensure-history-does-not-repeat-itself-get-a-flu-shot/ On Saturday, October 6, the South Dakota State Jackrabbits will face off against the Indiana State University Sycamores in the first-ever Precision A]]>https://www.newslocker.com/en-au/profession/biotechnology/precision-agriculture-theres-a-bowl-for-that/Fri, 05 Oct 2018 20:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/precision-agriculture-theres-a-bowl-for-that/https://www.newslocker.com/en-au/profession/biotechnology/checkpoint-inhibitor-generated-by-synthetic-dna-ltemgtin-vivoltemgt/Fri, 05 Oct 2018 16:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/checkpoint-inhibitor-generated-by-synthetic-dna-ltemgtin-vivoltemgt/https://www.newslocker.com/en-au/profession/biotechnology/sanofi-evotec-launch-new-bridge-partnership-to-accelerate-drug-discovery/Fri, 05 Oct 2018 16:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sanofi-evotec-launch-new-bridge-partnership-to-accelerate-drug-discovery/https://www.newslocker.com/en-au/profession/biotechnology/hpv-subtypes-strongly-linked-to-hiv-infection-uncovered/Fri, 05 Oct 2018 16:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hpv-subtypes-strongly-linked-to-hiv-infection-uncovered/https://www.newslocker.com/en-au/profession/biotechnology/ovarian-cancer-risk-reduced-by-low-dose-aspirin-use/Fri, 05 Oct 2018 15:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ovarian-cancer-risk-reduced-by-low-dose-aspirin-use/https://www.newslocker.com/en-au/profession/biotechnology/nanopore-system-can-measure-metabolites-simultaneously-in-biological-fluids/Fri, 05 Oct 2018 14:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nanopore-system-can-measure-metabolites-simultaneously-in-biological-fluids/ Organizers announced a panel session for day one that will cover the Trump Administration’s “American Patients First Blueprint”, a proposed plan for addressing the cost of prescri]]>https://www.newslocker.com/en-au/profession/biotechnology/trumps-drug-pricing-blueprint-to-be-explored-at-upcoming-summit/Thu, 04 Oct 2018 20:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/trumps-drug-pricing-blueprint-to-be-explored-at-upcoming-summit/https://www.newslocker.com/en-au/profession/biotechnology/jampjs-janssen-arrowhead-launch-up-to-37b-rnai-partnership-including-hep-b-candidate/Thu, 04 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/jampjs-janssen-arrowhead-launch-up-to-37b-rnai-partnership-including-hep-b-candidate/https://www.newslocker.com/en-au/profession/biotechnology/nobel-in-chemistry-awarded-for-directed-evolution-of-enzymes-and-antibodies/Thu, 04 Oct 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nobel-in-chemistry-awarded-for-directed-evolution-of-enzymes-and-antibodies/https://www.newslocker.com/en-au/profession/biotechnology/unique-drug-repurposing-collection-made-available-as-public-resource/Thu, 04 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/unique-drug-repurposing-collection-made-available-as-public-resource/https://www.newslocker.com/en-au/profession/biotechnology/psichomics-converts-genome-wide-data-into-bio-information-with-clinical-potential/Thu, 04 Oct 2018 13:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/psichomics-converts-genome-wide-data-into-bio-information-with-clinical-potential/https://www.newslocker.com/en-au/profession/biotechnology/new-member-benefit-online-marketplace-for-custom-scientific-research-services-and-products/Wed, 03 Oct 2018 21:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-member-benefit-online-marketplace-for-custom-scientific-research-services-and-products/https://www.newslocker.com/en-au/profession/biotechnology/marijuana-use-could-be-worse-for-cognitive-development-in-adolescents-than-alcohol/Wed, 03 Oct 2018 16:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/marijuana-use-could-be-worse-for-cognitive-development-in-adolescents-than-alcohol/https://www.newslocker.com/en-au/profession/biotechnology/rna-worlds-big-picture-liquid-crystal-self-assembly/Wed, 03 Oct 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rna-worlds-big-picture-liquid-crystal-self-assembly/ In a video for the Wall Street Journal, reporter Jason Bellini traveled to Brazil to speak with Tad Sonstegard, Chief Scientific Officer at biotech company Recombinetics, to explore how the company’s gene editing technology is on the verge of transforming the beef industry.
In the video, Bellini explains that Angus beef is becoming incre]]>https://www.newslocker.com/en-au/profession/biotechnology/recombinetics-animal-gene-editing-could-transform-the-beef-industry/Wed, 03 Oct 2018 16:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/recombinetics-animal-gene-editing-could-transform-the-beef-industry/https://www.newslocker.com/en-au/profession/biotechnology/roche-go-therapeutics-to-develop-antibody-based-cancer-treatments/Wed, 03 Oct 2018 15:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/roche-go-therapeutics-to-develop-antibody-based-cancer-treatments/https://www.newslocker.com/en-au/profession/biotechnology/mass-spec-algorithm-sorts-known-from-new-natural-product-drug-candidates/Wed, 03 Oct 2018 15:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/mass-spec-algorithm-sorts-known-from-new-natural-product-drug-candidates/https://www.newslocker.com/en-au/profession/biotechnology/algorithm-could-help-scientists-split-a-protein-and-reassemble-it-to-functionality/Wed, 03 Oct 2018 14:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/algorithm-could-help-scientists-split-a-protein-and-reassemble-it-to-functionality/https://www.newslocker.com/en-au/profession/biotechnology/jampjs-janssen-ends-two-aduro-cancer-collaborations-launched-in-2014/Tue, 02 Oct 2018 16:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/jampjs-janssen-ends-two-aduro-cancer-collaborations-launched-in-2014/https://www.newslocker.com/en-au/profession/biotechnology/tissue-specific-rna-carriers-give-cell-level-delivery-confirmation/Tue, 02 Oct 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tissue-specific-rna-carriers-give-cell-level-delivery-confirmation/https://www.newslocker.com/en-au/profession/biotechnology/cholesterol-related-gene-variants-impart-benefits-point-to-new-drugs/Tue, 02 Oct 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cholesterol-related-gene-variants-impart-benefits-point-to-new-drugs/ When their cancers struck, I had just joined Bristol-Myers Squibb which meant traveling back and forth frequently from the East to the West coast to manage their care. It was a very difficult time, both emotionally and physically, to say the least.
I was amazed by t]]>https://www.newslocker.com/en-au/profession/biotechnology/delivering-innovative-medicines-to-patients/Tue, 02 Oct 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/delivering-innovative-medicines-to-patients/https://www.newslocker.com/en-au/profession/biotechnology/major-advance-reported-in-understanding-antibiotic-resistance/Tue, 02 Oct 2018 14:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/major-advance-reported-in-understanding-antibiotic-resistance/https://www.newslocker.com/en-au/profession/biotechnology/toxic-tides-get-a-genetic-explanation/Mon, 01 Oct 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/toxic-tides-get-a-genetic-explanation/https://www.newslocker.com/en-au/profession/biotechnology/immunotherapy-pioneers-take-2018-nobel-prize/Mon, 01 Oct 2018 16:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/immunotherapy-pioneers-take-2018-nobel-prize/https://www.newslocker.com/en-au/profession/biotechnology/merck-amp-co-partners-with-dragonfly-on-nk-based-cancer-immunotherapies/Mon, 01 Oct 2018 16:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/merck-amp-co-partners-with-dragonfly-on-nk-based-cancer-immunotherapies/https://www.newslocker.com/en-au/profession/biotechnology/protein-regulator-of-glioblastoma-migration-identified/Mon, 01 Oct 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/protein-regulator-of-glioblastoma-migration-identified/https://www.newslocker.com/en-au/profession/biotechnology/novel-method-improves-imaging-and-progression-of-atherosclerotic-plaque/Mon, 01 Oct 2018 14:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-method-improves-imaging-and-progression-of-atherosclerotic-plaque/https://www.newslocker.com/en-au/profession/biotechnology/novo-nordisk-cutting-250-more-jobs-this-time-in-us/Fri, 28 Sep 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novo-nordisk-cutting-250-more-jobs-this-time-in-us/https://www.newslocker.com/en-au/profession/biotechnology/roche-acquires-cancer-immunotherapy-developer-tusk-therapeutics/Fri, 28 Sep 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/roche-acquires-cancer-immunotherapy-developer-tusk-therapeutics/https://www.newslocker.com/en-au/profession/biotechnology/brain-defects-linked-to-growth-factor-hormone/Fri, 28 Sep 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/brain-defects-linked-to-growth-factor-hormone/https://www.newslocker.com/en-au/profession/biotechnology/new-dna-vaccine-offers-novel-immunotherapeutic-approach-against-cancer/Fri, 28 Sep 2018 14:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-dna-vaccine-offers-novel-immunotherapeutic-approach-against-cancer/https://www.newslocker.com/en-au/profession/biotechnology/designer-dna-vaccine-for-cancer-immunotherapy/Fri, 28 Sep 2018 14:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/designer-dna-vaccine-for-cancer-immunotherapy/https://www.newslocker.com/en-au/profession/biotechnology/chronic-back-pain-linked-to-three-genetic-variants/Fri, 28 Sep 2018 14:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/chronic-back-pain-linked-to-three-genetic-variants/https://www.newslocker.com/en-au/profession/biotechnology/hiv-cure-may-lie-in-novel-immunotherapy-treatment/Thu, 27 Sep 2018 16:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hiv-cure-may-lie-in-novel-immunotherapy-treatment/https://www.newslocker.com/en-au/profession/biotechnology/hiv-cure-may-lie-in-novel-immunotherapy/Thu, 27 Sep 2018 16:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hiv-cure-may-lie-in-novel-immunotherapy/https://www.newslocker.com/en-au/profession/biotechnology/janssen-ends-collaboration-with-geron-to-develop-cancer-candidate-imetelstat/Thu, 27 Sep 2018 16:32:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/janssen-ends-collaboration-with-geron-to-develop-cancer-candidate-imetelstat/https://www.newslocker.com/en-au/profession/biotechnology/novel-alzheimers-mechanism-may-have-uncovered-new-treatment-strategy/Thu, 27 Sep 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-alzheimers-mechanism-may-have-uncovered-new-treatment-strategy/https://www.newslocker.com/en-au/profession/biotechnology/stem-cells-in-blood-might-be-used-to-grow-new-blood-vessels/Thu, 27 Sep 2018 14:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/stem-cells-in-blood-might-be-used-to-grow-new-blood-vessels/https://www.newslocker.com/en-au/profession/biotechnology/olfactory-ensheathing-cells-may-open-new-route-to-glioblastoma-therapy/Thu, 27 Sep 2018 14:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/olfactory-ensheathing-cells-may-open-new-route-to-glioblastoma-therapy/ Known for his planting of apple orchards from Pennsylvania to Illinois to modern-day Canada, Appleseed would be astonished to learn that today the U.S. grows 240 million bushels of apples on average each yea]]>https://www.newslocker.com/en-au/profession/biotechnology/johnnyappleseedday-how-biotech-is-keeping-apples-fresh-and-cutting-down-on-food-waste/Wed, 26 Sep 2018 21:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/johnnyappleseedday-how-biotech-is-keeping-apples-fresh-and-cutting-down-on-food-waste/https://www.newslocker.com/en-au/profession/biotechnology/investment-market-good-for-deal-making-at-bif18/Wed, 26 Sep 2018 20:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/investment-market-good-for-deal-making-at-bif18/https://www.newslocker.com/en-au/profession/biotechnology/agilent-acquires-cell-analysis-tools-developer-acea-biosciences/Wed, 26 Sep 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/agilent-acquires-cell-analysis-tools-developer-acea-biosciences/https://www.newslocker.com/en-au/profession/biotechnology/old-skin-scars-less-gene-study-shows-why/Wed, 26 Sep 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/old-skin-scars-less-gene-study-shows-why/https://www.newslocker.com/en-au/profession/biotechnology/uncultured-the-unknown-microbiomes-that-monopolize-the-world/Wed, 26 Sep 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/uncultured-the-unknown-microbiomes-that-monopolize-the-world/https://www.newslocker.com/en-au/profession/biotechnology/alexion-to-acquire-syntimmune-for-up-to-12b-expanding-rare-disease-pipeline/Wed, 26 Sep 2018 16:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/alexion-to-acquire-syntimmune-for-up-to-12b-expanding-rare-disease-pipeline/ Source: Farm Weekly (WA) – 16 September 2018
The WA agriculture industry must do more to promote the science behind genetically modified (GM) produce to ensure the technology realises its potential in the State’s grain industry.
That was one of the key messages taken home by Australia’s grain industry leaders who heard multiple presentations on the successes, developments and future prospects for GM technology from world-leading scien]]>https://www.newslocker.com/en-au/profession/biotechnology/aus-science-behind-gm-needs-promotion/Wed, 26 Sep 2018 15:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aus-science-behind-gm-needs-promotion/https://www.newslocker.com/en-au/profession/biotechnology/aus-academy-of-science-sets-ambitious-future-plan/Wed, 26 Sep 2018 15:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aus-academy-of-science-sets-ambitious-future-plan/ Source: Shadow Minister for Primary Industries and Regional Development, Eddie Hughes MP, Media Release EddieHughes_LaborSA_GMMoratorium_MR_140918 copy 2 – 14 September 2018
Labor supports a decision to review South Australia’s genetically modified crop moratorium – which is in place to 2025.
Shadow Minister for Primary Industries and Regional Development Eddie Hughes said the independent review should focus on the]]>https://www.newslocker.com/en-au/profession/biotechnology/aus-sa-labor-supports-gm-ban-review/Wed, 26 Sep 2018 15:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aus-sa-labor-supports-gm-ban-review/ Minister for Primary Industries and Regions SA, Tim Whetsone MP, Media Release– 14 September 2018
Source: http://pir.sa.gov.au/alerts_news_events/news/primary_industries/globally_recognised_agriculture_policy_analyst_to_lead_independent_review_of_gm_moratorium
Experienced economist and agriculture policy analyst emeritus professor Kym Anderson AC has been appointed to undertake an independe]]>https://www.newslocker.com/en-au/profession/biotechnology/aus-sa-govt-announces-gm-ban-review/Wed, 26 Sep 2018 15:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aus-sa-govt-announces-gm-ban-review/https://www.newslocker.com/en-au/profession/biotechnology/membrane-channel-critical-to-blood-pressure-control-visualized-for-first-time/Wed, 26 Sep 2018 14:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/membrane-channel-critical-to-blood-pressure-control-visualized-for-first-time/ So, you want to grow a vegetable. Let’s say you’re looking to grow a jalapeño pepper. You go to your]]>https://www.newslocker.com/en-au/profession/biotechnology/harnessing-the-power-of-ag-microbials/Tue, 25 Sep 2018 21:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/harnessing-the-power-of-ag-microbials/https://www.newslocker.com/en-au/profession/biotechnology/genetic-drones-can-kill-or-cripple-staph-bacteria/Tue, 25 Sep 2018 16:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genetic-drones-can-kill-or-cripple-staph-bacteria/https://www.newslocker.com/en-au/profession/biotechnology/pancreatic-cancer-growth-blocked-by-new-drug/Tue, 25 Sep 2018 16:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pancreatic-cancer-growth-blocked-by-new-drug/https://www.newslocker.com/en-au/profession/biotechnology/novartis-eliminating-2000-jobs-in-uk-switzerland/Tue, 25 Sep 2018 16:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novartis-eliminating-2000-jobs-in-uk-switzerland/https://www.newslocker.com/en-au/profession/biotechnology/digital-health-innovation-to-be-spotlighted-at-the-bio-investor-forum/Tue, 25 Sep 2018 15:27:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/digital-health-innovation-to-be-spotlighted-at-the-bio-investor-forum/https://www.newslocker.com/en-au/profession/biotechnology/gene-therapy-offers-potential-treatment-approach-for-mitochondrial-diseases/Tue, 25 Sep 2018 14:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gene-therapy-offers-potential-treatment-approach-for-mitochondrial-diseases/https://www.newslocker.com/en-au/profession/biotechnology/prion-disease-harms-neurons-via-stress-pathway/Mon, 24 Sep 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/prion-disease-harms-neurons-via-stress-pathway/ World leaders are expected to adopt high-level po]]>https://www.newslocker.com/en-au/profession/biotechnology/un-proposals-to-weaken-ip-will-not-benefit-patients/Mon, 24 Sep 2018 16:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/un-proposals-to-weaken-ip-will-not-benefit-patients/https://www.newslocker.com/en-au/profession/biotechnology/acquired-immunotherapy-resistance-through-transcriptional-repression/Mon, 24 Sep 2018 16:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/acquired-immunotherapy-resistance-through-transcriptional-repression/https://www.newslocker.com/en-au/profession/biotechnology/fda-lifts-holds-on-epizyme-cancer-candidate-sarepta-dmd-gene-therapy/Mon, 24 Sep 2018 16:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-lifts-holds-on-epizyme-cancer-candidate-sarepta-dmd-gene-therapy/https://www.newslocker.com/en-au/profession/biotechnology/new-mrna-biomarker-test-may-show-if-a-driver-is-sleep-deprived/Mon, 24 Sep 2018 13:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-mrna-biomarker-test-may-show-if-a-driver-is-sleep-deprived/https://www.newslocker.com/en-au/profession/biotechnology/drowsy-driver-blood-test-steered-by-rna-biomarker/Mon, 24 Sep 2018 13:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/drowsy-driver-blood-test-steered-by-rna-biomarker/ Of course, people have different ideas of what food waste is when you mention it to them. For some, it means, throwing away food on your plate after a meal. For parents of picky eaters, it’s]]>https://www.newslocker.com/en-au/profession/biotechnology/gmos-responding-to-the-issue-of-food-waste-and-loss/Fri, 21 Sep 2018 17:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gmos-responding-to-the-issue-of-food-waste-and-loss/https://www.newslocker.com/en-au/profession/biotechnology/human-egg-precursor-generated-in-a-dish/Fri, 21 Sep 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/human-egg-precursor-generated-in-a-dish/https://www.newslocker.com/en-au/profession/biotechnology/laser-capture-rna-seq-cuts-open-neuropsychiatric-genomic-dark-matter/Fri, 21 Sep 2018 16:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/laser-capture-rna-seq-cuts-open-neuropsychiatric-genomic-dark-matter/https://www.newslocker.com/en-au/profession/biotechnology/gtxs-enobosarm-fails-phase-ii-trial-in-stress-urinary-incontinence-stock-plunges-90/Fri, 21 Sep 2018 15:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gtxs-enobosarm-fails-phase-ii-trial-in-stress-urinary-incontinence-stock-plunges-90/https://www.newslocker.com/en-au/profession/biotechnology/natural-antibiotic-shows-promise-against-drug-resistant/Fri, 21 Sep 2018 13:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/natural-antibiotic-shows-promise-against-drug-resistant/https://www.newslocker.com/en-au/profession/biotechnology/kanglemycin-a-shows-promise-in-the-treatment-of-drug-resistant-tb/Fri, 21 Sep 2018 13:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/kanglemycin-a-shows-promise-in-the-treatment-of-drug-resistant-tb/https://www.newslocker.com/en-au/profession/biotechnology/rna-based-crispr-has-detailed-molecular-structure-revealed/Fri, 21 Sep 2018 13:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rna-based-crispr-has-detailed-molecular-structure-revealed/https://www.newslocker.com/en-au/profession/biotechnology/detailed-structure-of-crispr-enzyme-for-rna-editing-technology-described/Fri, 21 Sep 2018 13:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/detailed-structure-of-crispr-enzyme-for-rna-editing-technology-described/https://www.newslocker.com/en-au/profession/biotechnology/pancreatic-cancer-therapies-may-be-improved-through-novel-live-tumor-imaging-method/Thu, 20 Sep 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pancreatic-cancer-therapies-may-be-improved-through-novel-live-tumor-imaging-method/https://www.newslocker.com/en-au/profession/biotechnology/amicus-expands-into-gene-therapy-with-celenex-acquisition/Thu, 20 Sep 2018 16:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/amicus-expands-into-gene-therapy-with-celenex-acquisition/https://www.newslocker.com/en-au/profession/biotechnology/why-do-some-genes-get-all-the-likes/Thu, 20 Sep 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/why-do-some-genes-get-all-the-likes/https://www.newslocker.com/en-au/profession/biotechnology/flu-virus-explodes-in-some-cells-fizzles-in-others/Thu, 20 Sep 2018 16:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/flu-virus-explodes-in-some-cells-fizzles-in-others/ As we plan the 2019 BIO International Convention in Philadelphia, we work with our Program Committee to s]]>https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one/Thu, 20 Sep 2018 15:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/it-starts-with-one/https://www.newslocker.com/en-au/profession/biotechnology/novel-cell-culture-platform-may-lead-to-development-of-improved-cancer-therapies/Thu, 20 Sep 2018 14:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-cell-culture-platform-may-lead-to-development-of-improved-cancer-therapies/https://www.newslocker.com/en-au/profession/biotechnology/scientists-discover-noisiest-step-in-the-protein-production-process/Thu, 20 Sep 2018 14:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/scientists-discover-noisiest-step-in-the-protein-production-process/ Healthcare Ready is a national nonprofit that leverages unique relationships with government, nonprofit and med]]>https://www.newslocker.com/en-au/profession/biotechnology/the-role-and-value-of-public-private-partnerships-in-preparedness/Wed, 19 Sep 2018 19:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-role-and-value-of-public-private-partnerships-in-preparedness/https://www.newslocker.com/en-au/profession/biotechnology/clovis-ceo-ex-cfo-agree-to-pay-20m-to-settle-sec-charges/Wed, 19 Sep 2018 16:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/clovis-ceo-ex-cfo-agree-to-pay-20m-to-settle-sec-charges/https://www.newslocker.com/en-au/profession/biotechnology/green-tea-antioxidant-helps-sneak-rna-drug-into-cells/Wed, 19 Sep 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/green-tea-antioxidant-helps-sneak-rna-drug-into-cells/https://www.newslocker.com/en-au/profession/biotechnology/some-cancer-drugs-might-be-repurposed-to-treat-vascular-inflammation/Wed, 19 Sep 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/some-cancer-drugs-might-be-repurposed-to-treat-vascular-inflammation/https://www.newslocker.com/en-au/profession/biotechnology/nuclear-pore-control-may-stop-cancer-cells-from-proliferating/Wed, 19 Sep 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nuclear-pore-control-may-stop-cancer-cells-from-proliferating/ And the answer is, “Well, it depends on what you ask, how you ask it, and what’s in the news that day.”
Ultimately, there’s a lot of misconceptions about GMOs out there that negatively impacts people’s perceptions of GMOs. We’ve found that when we actually have good, productive, one-on-one conversations with people about this issue, finding common groun]]>https://www.newslocker.com/en-au/profession/biotechnology/american-perceptions-of-gmos-myths-vs-facts/Wed, 19 Sep 2018 15:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/american-perceptions-of-gmos-myths-vs-facts/https://www.newslocker.com/en-au/profession/biotechnology/googles-ai-trained-to-see-mutations/Tue, 18 Sep 2018 16:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/googles-ai-trained-to-see-mutations/https://www.newslocker.com/en-au/profession/biotechnology/novo-nordisk-eliminating-400-jobs-in-rampd-restructuring/Tue, 18 Sep 2018 16:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novo-nordisk-eliminating-400-jobs-in-rampd-restructuring/https://www.newslocker.com/en-au/profession/biotechnology/administering-malaria-drugs-to-mosquitoes/Tue, 18 Sep 2018 16:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/administering-malaria-drugs-to-mosquitoes/https://www.newslocker.com/en-au/profession/biotechnology/machine-learning-method-sheds-light-on-cell-organization/Tue, 18 Sep 2018 14:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/machine-learning-method-sheds-light-on-cell-organization/https://www.newslocker.com/en-au/profession/biotechnology/medical-research-from-mars-can-fail-patients-from-venus/Tue, 18 Sep 2018 14:49:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/medical-research-from-mars-can-fail-patients-from-venus/https://www.newslocker.com/en-au/profession/biotechnology/lymphatic-vessels-in-brain-provide-new-route-to-treat-ms/Tue, 18 Sep 2018 14:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lymphatic-vessels-in-brain-provide-new-route-to-treat-ms/ First, it directs the establishment of a joint study by the United States Patent and Trademark Office (PTO) and Small Business Administration on ways to identify best practices for increasing patenting rates]]>https://www.newslocker.com/en-au/profession/biotechnology/bipartisan-success-act-is-good-for-american-innovation/Mon, 17 Sep 2018 22:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bipartisan-success-act-is-good-for-american-innovation/https://www.newslocker.com/en-au/profession/biotechnology/shark-dna-in-the-water-cue-music-from-jaws/Mon, 17 Sep 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/shark-dna-in-the-water-cue-music-from-jaws/https://www.newslocker.com/en-au/profession/biotechnology/cleaning-product-use-alters-infant-microbiome-to-cause-obesity/Mon, 17 Sep 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cleaning-product-use-alters-infant-microbiome-to-cause-obesity/https://www.newslocker.com/en-au/profession/biotechnology/united-therapeutics-acquires-north-american-rights-to-samumed-ipf-candidate-sm04646/Mon, 17 Sep 2018 15:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/united-therapeutics-acquires-north-american-rights-to-samumed-ipf-candidate-sm04646/https://www.newslocker.com/en-au/profession/biotechnology/microbiome-response-can-serve-as-early-warning-to-nerve-gas-exposure/Mon, 17 Sep 2018 14:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/microbiome-response-can-serve-as-early-warning-to-nerve-gas-exposure/https://www.newslocker.com/en-au/profession/biotechnology/is-dna-divine/Sat, 15 Sep 2018 22:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/is-dna-divine/ As part of this week’s festivities, BIO hosted an event along with below50 and the Low Carbon Fuels Coalition to discuss how states]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-global-climate-action-summit-to-drive-towards-decarbonization/Fri, 14 Sep 2018 19:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-global-climate-action-summit-to-drive-towards-decarbonization/ It is against this backdrop that the Biotechnology Innovation Organization (BIO) will host the BIO Investor Forum in San Francisco—a biotech hub—October 17th and 18th.
Dr. Beth Seidenberg, a freq]]>https://www.newslocker.com/en-au/profession/biotechnology/pathbreaking-biotech-investordr-beth-seidenbergto-speak-at-bif18/Fri, 14 Sep 2018 16:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pathbreaking-biotech-investordr-beth-seidenbergto-speak-at-bif18/https://www.newslocker.com/en-au/profession/biotechnology/bull-market-bodes-well-for-bif18/Fri, 14 Sep 2018 16:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bull-market-bodes-well-for-bif18/https://www.newslocker.com/en-au/profession/biotechnology/altered-levels-of-neonatal-inflammatory-markers-associated-with-childhood-leukemia/Fri, 14 Sep 2018 16:42:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/altered-levels-of-neonatal-inflammatory-markers-associated-with-childhood-leukemia/https://www.newslocker.com/en-au/profession/biotechnology/lilly-diabetes-center-of-excellence-established/Fri, 14 Sep 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lilly-diabetes-center-of-excellence-established/https://www.newslocker.com/en-au/profession/biotechnology/supernus-to-acquire-biscayne-neurotherapeutics-adding-epilepsy-candidate/Fri, 14 Sep 2018 15:56:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/supernus-to-acquire-biscayne-neurotherapeutics-adding-epilepsy-candidate/https://www.newslocker.com/en-au/profession/biotechnology/skin-development-finding-could-lead-to-novel-therapies-for-burns-and-birth-defects/Fri, 14 Sep 2018 14:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/skin-development-finding-could-lead-to-novel-therapies-for-burns-and-birth-defects/https://www.newslocker.com/en-au/profession/biotechnology/newly-named-ieastrocytes-viewed-as-a-key-gatekeeper-and-mediator-of-disease/Fri, 14 Sep 2018 14:07:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/newly-named-ieastrocytes-viewed-as-a-key-gatekeeper-and-mediator-of-disease/https://www.newslocker.com/en-au/profession/biotechnology/dna/Fri, 14 Sep 2018 03:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dna/ At issue is a little-known tactic called “spread pricing”, a strategy designed to pad the pockets of PBMs at the expense of the client, who in this particular case were Iowa taxpayers funding the state’s Medicaid program. As pharmacist Mark Frahm learned firsthand, what on]]>https://www.newslocker.com/en-au/profession/biotechnology/bloomberg-exposes-how-drug-cost-middlemen-rake-in-millions/Thu, 13 Sep 2018 19:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bloomberg-exposes-how-drug-cost-middlemen-rake-in-millions/https://www.newslocker.com/en-au/profession/biotechnology/fda-extends-pdufa-date-for-acordas-inbrija-3-days-after-company-loses-ampyra-appeal/Thu, 13 Sep 2018 16:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-extends-pdufa-date-for-acordas-inbrija-3-days-after-company-loses-ampyra-appeal/https://www.newslocker.com/en-au/profession/biotechnology/chronic-pain-gets-placebo-treatment/Thu, 13 Sep 2018 16:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/chronic-pain-gets-placebo-treatment/ Citrus greening is a disease that infects citrus plants causing them to produce fruits that are green, misshapen and bitter, unsuitable for sale as fruit or juice.
In Florida, citrus greening has caused a cumulative loss of $2.9 billion in grower revenues from 2007 to 2014, an average of $374 millio]]>https://www.newslocker.com/en-au/profession/biotechnology/citrus-greening-spreading-to-california-gene-editing-could-save-us-industry/Thu, 13 Sep 2018 15:58:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/citrus-greening-spreading-to-california-gene-editing-could-save-us-industry/https://www.newslocker.com/en-au/profession/biotechnology/if-a-bear-spits-in-the-woods-do-new-antibiotics-arise/Thu, 13 Sep 2018 15:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/if-a-bear-spits-in-the-woods-do-new-antibiotics-arise/https://www.newslocker.com/en-au/profession/biotechnology/boehringer-ingelheim-acquires-viral-based-cancer-immunotherapy-developer-viratherapeutics/Thu, 13 Sep 2018 15:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/boehringer-ingelheim-acquires-viral-based-cancer-immunotherapy-developer-viratherapeutics/https://www.newslocker.com/en-au/profession/biotechnology/common-diarrhea-causing-bacterium-found-to-produce-electricity/Thu, 13 Sep 2018 14:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/common-diarrhea-causing-bacterium-found-to-produce-electricity/https://www.newslocker.com/en-au/profession/biotechnology/research-links-specific-ltemgth-pyloriltemgt-strain-with-stomach-cancer-risk/Thu, 13 Sep 2018 14:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/research-links-specific-ltemgth-pyloriltemgt-strain-with-stomach-cancer-risk/https://www.newslocker.com/en-au/profession/biotechnology/cannabis-use-during-pregnancy-affects-social-behavior-of-male-offspring/Wed, 12 Sep 2018 16:39:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cannabis-use-during-pregnancy-affects-social-behavior-of-male-offspring/https://www.newslocker.com/en-au/profession/biotechnology/gilead-to-develop-hepatitis-b-therapies-using-precisions-arcus-genome-editing-platform/Wed, 12 Sep 2018 16:38:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gilead-to-develop-hepatitis-b-therapies-using-precisions-arcus-genome-editing-platform/https://www.newslocker.com/en-au/profession/biotechnology/adhd-doubles-risk-of-early-onset-parkinsons/Wed, 12 Sep 2018 16:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/adhd-doubles-risk-of-early-onset-parkinsons/https://www.newslocker.com/en-au/profession/biotechnology/vital-therapies-halts-elad-development-explores-options-after-phase-iii-failure/Wed, 12 Sep 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vital-therapies-halts-elad-development-explores-options-after-phase-iii-failure/https://www.newslocker.com/en-au/profession/biotechnology/caffeine-consumption-might-help-lower-chronic-kidney-disease-mortality/Wed, 12 Sep 2018 14:07:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/caffeine-consumption-might-help-lower-chronic-kidney-disease-mortality/https://www.newslocker.com/en-au/profession/biotechnology/rotavirus-study-could-lead-to-development-of-new-treatments-for-the-disease/Wed, 12 Sep 2018 13:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rotavirus-study-could-lead-to-development-of-new-treatments-for-the-disease/https://www.newslocker.com/en-au/profession/biotechnology/rotavirus-study-could-lead-to-development-of-new-treatments-for-disease/Wed, 12 Sep 2018 13:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rotavirus-study-could-lead-to-development-of-new-treatments-for-disease/ Jim Greenwood, BIO’s President and CEO, has been on the air describing for radio listeners across the country the urgent need to spur acces]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-highlights-role-of-innovation-in-solving-opioid-crisis/Tue, 11 Sep 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/greenwood-highlights-role-of-innovation-in-solving-opioid-crisis/https://www.newslocker.com/en-au/profession/biotechnology/binge-drinking-has-different-effects-on-male-and-female-brains/Tue, 11 Sep 2018 15:41:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/binge-drinking-has-different-effects-on-male-and-female-brains/https://www.newslocker.com/en-au/profession/biotechnology/2018-lasker-award-winners-gene-expression-researchers-propofol-discoverer-pioneer-for-rna-biology-and-women-in-stem/Tue, 11 Sep 2018 15:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/2018-lasker-award-winners-gene-expression-researchers-propofol-discoverer-pioneer-for-rna-biology-and-women-in-stem/https://www.newslocker.com/en-au/profession/biotechnology/circadian-rhythm-gene-may-serve-as-target-for-glioblastoma-therapies/Tue, 11 Sep 2018 14:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/circadian-rhythm-gene-may-serve-as-target-for-glioblastoma-therapies/https://www.newslocker.com/en-au/profession/biotechnology/new-approach-combines-three-methods-to-detect-structural-variants-in-cancer-cells/Tue, 11 Sep 2018 13:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-approach-combines-three-methods-to-detect-structural-variants-in-cancer-cells/https://www.newslocker.com/en-au/profession/biotechnology/the-patient-perspective-valuable-for-drug-development/Mon, 10 Sep 2018 20:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/the-patient-perspective-valuable-for-drug-development/https://www.newslocker.com/en-au/profession/biotechnology/cafc-upholds-broad-institute-crispr-patents/Mon, 10 Sep 2018 18:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cafc-upholds-broad-institute-crispr-patents/https://www.newslocker.com/en-au/profession/biotechnology/biopharmas-deny-wrongdoing-as-sec-files-charges-in-27m-stock-schemes/Mon, 10 Sep 2018 16:27:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biopharmas-deny-wrongdoing-as-sec-files-charges-in-27m-stock-schemes/https://www.newslocker.com/en-au/profession/biotechnology/vaccine-induced-t-cells-go-sugar-free/Mon, 10 Sep 2018 16:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vaccine-induced-t-cells-go-sugar-free/https://www.newslocker.com/en-au/profession/biotechnology/family-genetics-key-to-severity-of-autism-and-other-neurodevelopmental-disorders/Mon, 10 Sep 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/family-genetics-key-to-severity-of-autism-and-other-neurodevelopmental-disorders/ Surprise BillingIn case you missed it, a Texas high school teacher named Drew Calver suffered from a heart attack back in 2017. Calver’s neighbor rushed him to the nearest hospital where he underwent routine procedures to clear his blocked artery. After spending four days at the facility, Drew was]]>https://www.newslocker.com/en-au/profession/biotechnology/hits-to-patients-keep-on-coming/Mon, 10 Sep 2018 14:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hits-to-patients-keep-on-coming/https://www.newslocker.com/en-au/profession/biotechnology/interaction-of-oncolytic-viruses-observed-with-both-tumor-and-healthy-cells/Mon, 10 Sep 2018 13:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/interaction-of-oncolytic-viruses-observed-with-both-tumor-and-healthy-cells/ Locus Biosciences, a private, emerging biotechnology company, won in the Early Stage Entrepreneurs category. Locus Biosciences is]]>https://www.newslocker.com/en-au/profession/biotechnology/announcing-buzz-of-bio-winners-for-the-2018-bio-investor-forum/Fri, 07 Sep 2018 18:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/announcing-buzz-of-bio-winners-for-the-2018-bio-investor-forum/ Peter Beetham, a plant scientist and CEO of the agricultural biotech firm Cibus, writes in Scientific American about how this “new revolution in plant breeding” is ushering in a new era of agriculture innovation:
As a scientist who has spent his career in agricultural biotech, I’ve watched with some sympathy as the public st]]>https://www.newslocker.com/en-au/profession/biotechnology/gmos-are-not-agricultures-future-biotech-is/Fri, 07 Sep 2018 17:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gmos-are-not-agricultures-future-biotech-is/https://www.newslocker.com/en-au/profession/biotechnology/memories-strengthened-through-epigenetic-mechanism/Fri, 07 Sep 2018 16:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/memories-strengthened-through-epigenetic-mechanism/https://www.newslocker.com/en-au/profession/biotechnology/thermo-fisher-acquiring-bds-advanced-bioprocessing-business/Fri, 07 Sep 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/thermo-fisher-acquiring-bds-advanced-bioprocessing-business/https://www.newslocker.com/en-au/profession/biotechnology/bravery-brain-cells-could-point-to-new-treatments-for-severe-anxiety/Fri, 07 Sep 2018 15:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bravery-brain-cells-could-point-to-new-treatments-for-severe-anxiety/https://www.newslocker.com/en-au/profession/biotechnology/excessive-daytime-sleepiness-could-be-linked-to-alzheimers/Fri, 07 Sep 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/excessive-daytime-sleepiness-could-be-linked-to-alzheimers/https://www.newslocker.com/en-au/profession/biotechnology/gsk-eliminates-650-us-jobs-in-restructuring/Thu, 06 Sep 2018 16:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gsk-eliminates-650-us-jobs-in-restructuring/ And the healthcare AI market is booming.  Recognizing the strength of this market, the BIO Investor Forum will explore its opportunities and challenges during the annual conference in San Francis]]>https://www.newslocker.com/en-au/profession/biotechnology/healthcare-ai-is-booming/Thu, 06 Sep 2018 16:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/healthcare-ai-is-booming/https://www.newslocker.com/en-au/profession/biotechnology/pouring-stem-cell-factors-into-wounds-could-heal-skin-ulcers/Thu, 06 Sep 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pouring-stem-cell-factors-into-wounds-could-heal-skin-ulcers/https://www.newslocker.com/en-au/profession/biotechnology/how-unsaturated-fats-protect-against-cardiovascular-disease-revealed/Thu, 06 Sep 2018 16:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-unsaturated-fats-protect-against-cardiovascular-disease-revealed/https://www.newslocker.com/en-au/profession/biotechnology/bee-venom-takes-the-sting-out-of-eczema/Thu, 06 Sep 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bee-venom-takes-the-sting-out-of-eczema/https://www.newslocker.com/en-au/profession/biotechnology/beigene-springworks-to-study-combination-therapy-for-advanced-solid-tumors/Thu, 06 Sep 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/beigene-springworks-to-study-combination-therapy-for-advanced-solid-tumors/https://www.newslocker.com/en-au/profession/biotechnology/viruses-go-lytic-or-latent-based-on-viral-dna-mechanics/Wed, 05 Sep 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/viruses-go-lytic-or-latent-based-on-viral-dna-mechanics/https://www.newslocker.com/en-au/profession/biotechnology/hiv-therapy-looks-to-zap-synthetic-dna-through-skin/Wed, 05 Sep 2018 16:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hiv-therapy-looks-to-zap-synthetic-dna-through-skin/https://www.newslocker.com/en-au/profession/biotechnology/agios-celgene-end-collaboration-to-develop-cancer-treatment-ag-881/Wed, 05 Sep 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/agios-celgene-end-collaboration-to-develop-cancer-treatment-ag-881/https://www.newslocker.com/en-au/profession/biotechnology/prescription-painkiller-boosts-risk-of-heart-attack-stroke/Wed, 05 Sep 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/prescription-painkiller-boosts-risk-of-heart-attack-stroke/https://www.newslocker.com/en-au/profession/biotechnology/low-dose-and-short-term-diclofenac-use-linked-with-heart-attack-and-stroke/Wed, 05 Sep 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/low-dose-and-short-term-diclofenac-use-linked-with-heart-attack-and-stroke/https://www.newslocker.com/en-au/profession/biotechnology/copy-number-alteration-found-to-be-associated-with-cancer-mortality/Wed, 05 Sep 2018 14:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/copy-number-alteration-found-to-be-associated-with-cancer-mortality/https://www.newslocker.com/en-au/profession/biotechnology/sartorius-stedim-biotech-repligen-partner-on-perfusion-enabled-bioreactors/Tue, 04 Sep 2018 20:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sartorius-stedim-biotech-repligen-partner-on-perfusion-enabled-bioreactors/https://www.newslocker.com/en-au/profession/biotechnology/muddied-by-mutations-or-drugs-cell-signaling-can-herald-cancer/Tue, 04 Sep 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/muddied-by-mutations-or-drugs-cell-signaling-can-herald-cancer/https://www.newslocker.com/en-au/profession/biotechnology/united-therapeutics-to-co-develop-mannkinds-dry-powder-treprostinil-for-pah/Tue, 04 Sep 2018 15:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/united-therapeutics-to-co-develop-mannkinds-dry-powder-treprostinil-for-pah/https://www.newslocker.com/en-au/profession/biotechnology/thousands-of-antibiotic-combinations-found-to-be-more-effective-than-predicted/Tue, 04 Sep 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/thousands-of-antibiotic-combinations-found-to-be-more-effective-than-predicted/https://www.newslocker.com/en-au/profession/biotechnology/ivf-and-hypertension-new-association-uncovered-during-adolescence/Tue, 04 Sep 2018 15:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ivf-and-hypertension-new-association-uncovered-during-adolescence/ In fact, of the more than 300 biotechnology startups in Brazil, nearly half are working on breakthroughs to help farmers and the consumers who depend on them.
This week, Brazil’s g]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-latin-america-to-showcase-brazils-agricultural-breakthroughs/Tue, 04 Sep 2018 15:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-latin-america-to-showcase-brazils-agricultural-breakthroughs/https://www.newslocker.com/en-au/profession/biotechnology/nanosponges-offer-new-approach-to-treatment-of-rheumatoid-arthritis/Tue, 04 Sep 2018 14:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nanosponges-offer-new-approach-to-treatment-of-rheumatoid-arthritis/ GMO Answers volunteer expert and farmer Katie Pratt joined GMO Answers at their booth during the Institute of Food Technologists (IFT) Convention in Chica]]>https://www.newslocker.com/en-au/profession/biotechnology/what-happens-when-a-farmer-attends-a-food-science-convention/Fri, 31 Aug 2018 19:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/what-happens-when-a-farmer-attends-a-food-science-convention/https://www.newslocker.com/en-au/profession/biotechnology/sports-supplement-inhibits-growth-of-drug-resistant-breast-tumors/Fri, 31 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sports-supplement-inhibits-growth-of-drug-resistant-breast-tumors/https://www.newslocker.com/en-au/profession/biotechnology/national-immunization-awareness-month-is-timely-reminder-of-modern-marvel-of-vaccines/Thu, 30 Aug 2018 21:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/national-immunization-awareness-month-is-timely-reminder-of-modern-marvel-of-vaccines/https://www.newslocker.com/en-au/profession/biotechnology/cannabis-extract-reduces-psychotic-symptoms/Thu, 30 Aug 2018 16:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cannabis-extract-reduces-psychotic-symptoms/https://www.newslocker.com/en-au/profession/biotechnology/stems-cells-used-as-delivery-truck-for-brain-cancer-drugs/Thu, 30 Aug 2018 16:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/stems-cells-used-as-delivery-truck-for-brain-cancer-drugs/https://www.newslocker.com/en-au/profession/biotechnology/pfizer-halts-studies-of-dmd-candidate-domagrozumab-after-phase-ii-failure/Thu, 30 Aug 2018 15:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pfizer-halts-studies-of-dmd-candidate-domagrozumab-after-phase-ii-failure/https://www.newslocker.com/en-au/profession/biotechnology/spinal-cord-injury-triple-treatment-promotes-axons-to-bridge-the-gap/Thu, 30 Aug 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/spinal-cord-injury-triple-treatment-promotes-axons-to-bridge-the-gap/https://www.newslocker.com/en-au/profession/biotechnology/ms-drug-slows-brain-shrinkage-by-nearly-half/Thu, 30 Aug 2018 14:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ms-drug-slows-brain-shrinkage-by-nearly-half/https://www.newslocker.com/en-au/profession/biotechnology/drug-slows-brain-shrinkage-in-progressive-ms-patients-by-nearly-half/Thu, 30 Aug 2018 14:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/drug-slows-brain-shrinkage-in-progressive-ms-patients-by-nearly-half/https://www.newslocker.com/en-au/profession/biotechnology/dream-genes-needed-for-rem-sleep/Wed, 29 Aug 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dream-genes-needed-for-rem-sleep/https://www.newslocker.com/en-au/profession/biotechnology/massachusetts-biopharma-shows-workforce-investment-growth/Wed, 29 Aug 2018 16:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/massachusetts-biopharma-shows-workforce-investment-growth/https://www.newslocker.com/en-au/profession/biotechnology/oral-microbiome-therapy-may-improve-cirrhosis-symptoms/Wed, 29 Aug 2018 15:56:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/oral-microbiome-therapy-may-improve-cirrhosis-symptoms/https://www.newslocker.com/en-au/profession/biotechnology/elusive-neutrophil-progenitor-found-to-promote-tumor-formation/Wed, 29 Aug 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/elusive-neutrophil-progenitor-found-to-promote-tumor-formation/https://www.newslocker.com/en-au/profession/biotechnology/modifying-neurobehavioral-factors-seen-as-critical-to-controlling-obesity/Wed, 29 Aug 2018 13:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/modifying-neurobehavioral-factors-seen-as-critical-to-controlling-obesity/https://www.newslocker.com/en-au/profession/biotechnology/controlling-obesity-may-depend-on-modifying-neurobehavioral-factors/Wed, 29 Aug 2018 13:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/controlling-obesity-may-depend-on-modifying-neurobehavioral-factors/ To bolster these efforts, the National Vaccine Program Office teamed up with the Office of Disease Prevention and Health Promotion to create a series of short videos highlighting the importance of vaccines. Each segment focuses on a specific condition like whooping cough, shingles, or pneumoc]]>https://www.newslocker.com/en-au/profession/biotechnology/vaccine-video-series-aims-to-educate-on-the-benefits-of-immunization/Tue, 28 Aug 2018 20:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vaccine-video-series-aims-to-educate-on-the-benefits-of-immunization/https://www.newslocker.com/en-au/profession/biotechnology/new-brain-cell-has-unique-shape-behavior-gene-signature/Tue, 28 Aug 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-brain-cell-has-unique-shape-behavior-gene-signature/https://www.newslocker.com/en-au/profession/biotechnology/melanoma-combo-immunotherapy-increases-toll-for-improved-efficacy/Tue, 28 Aug 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/melanoma-combo-immunotherapy-increases-toll-for-improved-efficacy/https://www.newslocker.com/en-au/profession/biotechnology/genentech-affimed-launch-up-to-5b-cancer-immunotherapy-collaboration/Tue, 28 Aug 2018 16:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genentech-affimed-launch-up-to-5b-cancer-immunotherapy-collaboration/https://www.newslocker.com/en-au/profession/biotechnology/primary-breast-tumors-put-the-brakes-on-metastases/Tue, 28 Aug 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/primary-breast-tumors-put-the-brakes-on-metastases/https://www.newslocker.com/en-au/profession/biotechnology/new-algorithm-opens-door-to-better-understanding-of-circadian-rhythms/Tue, 28 Aug 2018 13:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-algorithm-opens-door-to-better-understanding-of-circadian-rhythms/https://www.newslocker.com/en-au/profession/biotechnology/report-patients-more-likely-to-skip-therapy-as-out-of-pocket-costs-rise/Mon, 27 Aug 2018 21:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/report-patients-more-likely-to-skip-therapy-as-out-of-pocket-costs-rise/https://www.newslocker.com/en-au/profession/biotechnology/cancers-last-gasp-could-be-if-hypoxia-pathway-is-blocked/Mon, 27 Aug 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancers-last-gasp-could-be-if-hypoxia-pathway-is-blocked/https://www.newslocker.com/en-au/profession/biotechnology/marijuana-found-in-breast-milk-almost-a-week-after-use/Mon, 27 Aug 2018 16:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/marijuana-found-in-breast-milk-almost-a-week-after-use/https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-imbruvicarituxan-combination-for-rare-blood-cancer/Mon, 27 Aug 2018 16:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-imbruvicarituxan-combination-for-rare-blood-cancer/https://www.newslocker.com/en-au/profession/biotechnology/british-heart-foundation-launches-30m-big-beat-challenge-award/Mon, 27 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/british-heart-foundation-launches-30m-big-beat-challenge-award/https://www.newslocker.com/en-au/profession/biotechnology/novel-approach-stops-immune-cell-death-associated-with-multiple-diseases/Mon, 27 Aug 2018 14:24:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-approach-stops-immune-cell-death-associated-with-multiple-diseases/https://www.newslocker.com/en-au/profession/biotechnology/senate-passes-budget-increases-for-nih-research-initiatives/Fri, 24 Aug 2018 21:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/senate-passes-budget-increases-for-nih-research-initiatives/ Specifically, BIO comments are with regards to the low number of approvals the EPA has issued for advanced and]]>https://www.newslocker.com/en-au/profession/biotechnology/epa-lag-in-cellulosic-ethanol-approvals-hurting-rural-america/Fri, 24 Aug 2018 20:42:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/epa-lag-in-cellulosic-ethanol-approvals-hurting-rural-america/https://www.newslocker.com/en-au/profession/biotechnology/melanoma-drug-resistance-mechanism-and-biomarker-identified/Fri, 24 Aug 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/melanoma-drug-resistance-mechanism-and-biomarker-identified/https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-shires-projected-blockbuster-hae-treatment-takhzyro/Fri, 24 Aug 2018 16:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-shires-projected-blockbuster-hae-treatment-takhzyro/https://www.newslocker.com/en-au/profession/biotechnology/epigenetics-of-sleep-loss-linked-with-weight-gain-and-muscle-loss-in-humans/Fri, 24 Aug 2018 15:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/epigenetics-of-sleep-loss-linked-with-weight-gain-and-muscle-loss-in-humans/https://www.newslocker.com/en-au/profession/biotechnology/new-cancer-immunotherapy-activates-necroptosis-mechanisms/Fri, 24 Aug 2018 15:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-cancer-immunotherapy-activates-necroptosis-mechanisms/https://www.newslocker.com/en-au/profession/biotechnology/aging-als-and-dementia-have-common-molecular-link/Fri, 24 Aug 2018 15:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aging-als-and-dementia-have-common-molecular-link/https://www.newslocker.com/en-au/profession/biotechnology/natural-sugar-could-curb-diabetes/Thu, 23 Aug 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/natural-sugar-could-curb-diabetes/https://www.newslocker.com/en-au/profession/biotechnology/beneficial-microbiome-modulation-from-baby-poo-derived-probiotic-cocktail/Thu, 23 Aug 2018 16:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/beneficial-microbiome-modulation-from-baby-poo-derived-probiotic-cocktail/https://www.newslocker.com/en-au/profession/biotechnology/newly-discovered-immune-system-micro-organ-could-aid-better-vaccine-development/Thu, 23 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/newly-discovered-immune-system-micro-organ-could-aid-better-vaccine-development/https://www.newslocker.com/en-au/profession/biotechnology/bluebird-bio-gritstone-oncology-partner-on-tcr-cancer-cell-therapies/Thu, 23 Aug 2018 15:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bluebird-bio-gritstone-oncology-partner-on-tcr-cancer-cell-therapies/https://www.newslocker.com/en-au/profession/biotechnology/hif1a-identified-as-potential-target-for-treating-myelodysplastic-syndromes/Thu, 23 Aug 2018 14:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hif1a-identified-as-potential-target-for-treating-myelodysplastic-syndromes/ While recent trade rifts between the US and China have threatened industries including US coal producers, farmers and crude oil]]>https://www.newslocker.com/en-au/profession/biotechnology/makehistory-highlighting-history-i-china/Thu, 23 Aug 2018 14:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/makehistory-highlighting-history-i-china/ Sonja Begemann with Ag Professional reports that Chilton is “putting away her lab goggles for the la]]>https://www.newslocker.com/en-au/profession/biotechnology/plant-biotech-pioneer-retires/Wed, 22 Aug 2018 20:32:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/plant-biotech-pioneer-retires/ According to a report written by researchers with the University of Southern California’s]]>https://www.newslocker.com/en-au/profession/biotechnology/pbs-newshour-why-a-patient-paid-a-285-copay-for-a-40-drug/Wed, 22 Aug 2018 19:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pbs-newshour-why-a-patient-paid-a-285-copay-for-a-40-drug/https://www.newslocker.com/en-au/profession/biotechnology/tau-tangles-cleared-by-senolytic-drugs-in-alzheimers-mice/Wed, 22 Aug 2018 16:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tau-tangles-cleared-by-senolytic-drugs-in-alzheimers-mice/https://www.newslocker.com/en-au/profession/biotechnology/breastfeeding-mothers-may-have-added-protection-against-stroke/Wed, 22 Aug 2018 16:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/breastfeeding-mothers-may-have-added-protection-against-stroke/https://www.newslocker.com/en-au/profession/biotechnology/universal-flu-vaccine-candidate-effective-in-mice/Wed, 22 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/universal-flu-vaccine-candidate-effective-in-mice/https://www.newslocker.com/en-au/profession/biotechnology/abbvie-exercises-option-to-develop-argenx-cancer-immunotherapy-argx-115/Wed, 22 Aug 2018 15:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/abbvie-exercises-option-to-develop-argenx-cancer-immunotherapy-argx-115/https://www.newslocker.com/en-au/profession/biotechnology/new-subtype-of-multiple-sclerosis-described/Wed, 22 Aug 2018 14:41:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-subtype-of-multiple-sclerosis-described/https://www.newslocker.com/en-au/profession/biotechnology/senate-has-the-power-to-get-miracle-medications-to-opioid-addicts/Tue, 21 Aug 2018 19:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/senate-has-the-power-to-get-miracle-medications-to-opioid-addicts/https://www.newslocker.com/en-au/profession/biotechnology/senate-has-the-power-to-expand-access-to-medication-for-opioid-addiction/Tue, 21 Aug 2018 19:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/senate-has-the-power-to-expand-access-to-medication-for-opioid-addiction/https://www.newslocker.com/en-au/profession/biotechnology/genetic-diseases-more-severe-with-adverse-coding-regulatory-variant-combos/Tue, 21 Aug 2018 16:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genetic-diseases-more-severe-with-adverse-coding-regulatory-variant-combos/https://www.newslocker.com/en-au/profession/biotechnology/inflammation-regulated-by-bodys-internal-clock/Tue, 21 Aug 2018 16:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/inflammation-regulated-by-bodys-internal-clock/https://www.newslocker.com/en-au/profession/biotechnology/antibiotic-class-emerges-through-digestive-enzyme/Tue, 21 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/antibiotic-class-emerges-through-digestive-enzyme/https://www.newslocker.com/en-au/profession/biotechnology/ge-healthcare-swedish-government-open-an-innovation-center-in-uppsala/Tue, 21 Aug 2018 15:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ge-healthcare-swedish-government-open-an-innovation-center-in-uppsala/https://www.newslocker.com/en-au/profession/biotechnology/identification-of-sprouty-1-and-sprouty-2-provide-basis-for-new-immunotherapies/Tue, 21 Aug 2018 14:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/identification-of-sprouty-1-and-sprouty-2-provide-basis-for-new-immunotherapies/https://www.newslocker.com/en-au/profession/biotechnology/vaping-exposes-users-to-reactive-carbonyls-causes-dna-damage/Mon, 20 Aug 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vaping-exposes-users-to-reactive-carbonyls-causes-dna-damage/ Unfortunately, changes to our patent laws over the last 15 years, through legislation, agency actions, and court decisions, have severely]]>https://www.newslocker.com/en-au/profession/biotechnology/new-documentary-highlights-consequences-of-bad-patent-laws/Mon, 20 Aug 2018 16:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-documentary-highlights-consequences-of-bad-patent-laws/https://www.newslocker.com/en-au/profession/biotechnology/could-antidepressants-prevent-age-related-cognitive-and-sensory-decline/Mon, 20 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/could-antidepressants-prevent-age-related-cognitive-and-sensory-decline/https://www.newslocker.com/en-au/profession/biotechnology/a-handful-of-strawberries-per-day-could-keep-gut-inflammation-away/Mon, 20 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-handful-of-strawberries-per-day-could-keep-gut-inflammation-away/https://www.newslocker.com/en-au/profession/biotechnology/harbour-biomed-to-develop-kelun-biotechs-cancer-immunotherapy-candidate-a167/Mon, 20 Aug 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/harbour-biomed-to-develop-kelun-biotechs-cancer-immunotherapy-candidate-a167/https://www.newslocker.com/en-au/profession/biotechnology/using-photosensitizers-instead-of-antibiotics-to-kill-mrsa/Mon, 20 Aug 2018 14:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/using-photosensitizers-instead-of-antibiotics-to-kill-mrsa/ In an article for Wired, Megan Molteni reports that wheat, a key commodity crop, is the latest plant to have its genome fully mapped.
In a Science report published Thursday, an international team of more than 200 researchers presents the first high-quality, co]]>https://www.newslocker.com/en-au/profession/biotechnology/bread-with-reduced-gluten-wheat-researchers-successfully-map-wheat-genome/Fri, 17 Aug 2018 20:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bread-with-reduced-gluten-wheat-researchers-successfully-map-wheat-genome/ “The Trump Administration’s recommended changes to this legislation will improve our ability to save lives and protect Americans from 21st century healt]]>https://www.newslocker.com/en-au/profession/biotechnology/changes-to-the-pandemic-and-all-hazards-preparedness-act-are-essential-to-saving-lives-in-disasters/Fri, 17 Aug 2018 16:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/changes-to-the-pandemic-and-all-hazards-preparedness-act-are-essential-to-saving-lives-in-disasters/https://www.newslocker.com/en-au/profession/biotechnology/no-mitochondrial-pain-no-longevity-gain/Fri, 17 Aug 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/no-mitochondrial-pain-no-longevity-gain/https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-diagnosis-could-be-in-the-eyes-of-the-holder/Fri, 17 Aug 2018 16:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-diagnosis-could-be-in-the-eyes-of-the-holder/https://www.newslocker.com/en-au/profession/biotechnology/circulating-tumor-cells-get-sucked-up-by-malaria-protein/Fri, 17 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/circulating-tumor-cells-get-sucked-up-by-malaria-protein/https://www.newslocker.com/en-au/profession/biotechnology/new-mouse-model-will-allow-detailed-study-of-pulmonary-fibrosis/Fri, 17 Aug 2018 13:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-mouse-model-will-allow-detailed-study-of-pulmonary-fibrosis/https://www.newslocker.com/en-au/profession/biotechnology/blind-mice-see-after-gene-factors-stimulate-genesis-of-rod-photoreceptors/Thu, 16 Aug 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/blind-mice-see-after-gene-factors-stimulate-genesis-of-rod-photoreceptors/https://www.newslocker.com/en-au/profession/biotechnology/hiv-biologic-drug-reduces-viral-load-while-boosting-immunity/Thu, 16 Aug 2018 16:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hiv-biologic-drug-reduces-viral-load-while-boosting-immunity/https://www.newslocker.com/en-au/profession/biotechnology/anticancer-drugs-treat-acute-liver-failure/Thu, 16 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/anticancer-drugs-treat-acute-liver-failure/https://www.newslocker.com/en-au/profession/biotechnology/runx-proteins-found-to-be-integral-to-efficient-dna-repair/Thu, 16 Aug 2018 13:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/runx-proteins-found-to-be-integral-to-efficient-dna-repair/ As Eric Niler writes in a piece for National Geographic, “one way to measure the rise of Crispr and other forms of gene-editing is by scientific publication. From two dozen journal articles in all of 2008, Crispr-related scientific-paper submissions now number 10 per day, and will shortly reach 10,000 t]]>https://www.newslocker.com/en-au/profession/biotechnology/7-crops-that-could-benefit-from-crispr/Wed, 15 Aug 2018 17:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/7-crops-that-could-benefit-from-crispr/https://www.newslocker.com/en-au/profession/biotechnology/zombie-gene-helps-elephants-outpace-cancer/Wed, 15 Aug 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/zombie-gene-helps-elephants-outpace-cancer/https://www.newslocker.com/en-au/profession/biotechnology/sexual-behavior-determined-by-immune-cells-in-the-brain/Wed, 15 Aug 2018 16:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sexual-behavior-determined-by-immune-cells-in-the-brain/https://www.newslocker.com/en-au/profession/biotechnology/circadian-rhythms-and-mood-disorders-genetically-linked/Wed, 15 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/circadian-rhythms-and-mood-disorders-genetically-linked/https://www.newslocker.com/en-au/profession/biotechnology/lab-on-a-chip-uses-bacteria-to-help-transport-biological-cargo/Wed, 15 Aug 2018 14:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lab-on-a-chip-uses-bacteria-to-help-transport-biological-cargo/https://www.newslocker.com/en-au/profession/biotechnology/endocannabinoid-mechanism-found-to-mellow-out-intestinal-inflammation/Tue, 14 Aug 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/endocannabinoid-mechanism-found-to-mellow-out-intestinal-inflammation/https://www.newslocker.com/en-au/profession/biotechnology/oligonucleotide-nanostructure-targets-cancer-cells-for-rna-therapy/Tue, 14 Aug 2018 16:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/oligonucleotide-nanostructure-targets-cancer-cells-for-rna-therapy/https://www.newslocker.com/en-au/profession/biotechnology/study-finds-genetic-basis-of-common-diseases-may-span-tens-of-thousands-of-snps/Tue, 14 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/study-finds-genetic-basis-of-common-diseases-may-span-tens-of-thousands-of-snps/https://www.newslocker.com/en-au/profession/biotechnology/whole-exome-sequencing-identifies-new-alzheimers-related-genes/Tue, 14 Aug 2018 13:58:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/whole-exome-sequencing-identifies-new-alzheimers-related-genes/https://www.newslocker.com/en-au/profession/biotechnology/whitehaven-stocks-surge-but-cochlear-and-challenger-fall-on-disappointing-results/Tue, 14 Aug 2018 07:32:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/whitehaven-stocks-surge-but-cochlear-and-challenger-fall-on-disappointing-results/https://www.newslocker.com/en-au/profession/biotechnology/kidney-cancer-biomarker-predicts-disease-risk-and-survival/Mon, 13 Aug 2018 15:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/kidney-cancer-biomarker-predicts-disease-risk-and-survival/https://www.newslocker.com/en-au/profession/biotechnology/study-finds-childhood-diabetes-lowers-lifespan-by-18-years/Mon, 13 Aug 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/study-finds-childhood-diabetes-lowers-lifespan-by-18-years/https://www.newslocker.com/en-au/profession/biotechnology/infant-diarrhea-deaths-drop-sharply-in-malawi-due-to-rotavirus-vaccine/Mon, 13 Aug 2018 14:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/infant-diarrhea-deaths-drop-sharply-in-malawi-due-to-rotavirus-vaccine/https://www.newslocker.com/en-au/profession/biotechnology/genome-sequencing-identifies-cause-of-early-infantile-epileptic-encephalopathy/Mon, 13 Aug 2018 13:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genome-sequencing-identifies-cause-of-early-infantile-epileptic-encephalopathy/https://www.newslocker.com/en-au/profession/biotechnology/genetic-cause-of-early-infantile-epileptic-encephalopathy-identified/Mon, 13 Aug 2018 13:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genetic-cause-of-early-infantile-epileptic-encephalopathy-identified/https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-alnylams-onpattro-for-polyneuropathy-of-hattr-amyloidosis/Fri, 10 Aug 2018 21:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-alnylams-onpattro-for-polyneuropathy-of-hattr-amyloidosis/ In a piece for Massive Science, Marco Giovannetti with the Gregor Mendel Institute explores why GM crops are better for the environment than you think. Too often, GMOs are recklessly grouped in with agriculture practices that hurt the environment, ho]]>https://www.newslocker.com/en-au/profession/biotechnology/massive-science-biotechnology-agriculture-good-for-the-planet/Fri, 10 Aug 2018 19:32:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/massive-science-biotechnology-agriculture-good-for-the-planet/https://www.newslocker.com/en-au/profession/biotechnology/could-glaucoma-be-an-autoimmune-disease/Fri, 10 Aug 2018 16:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/could-glaucoma-be-an-autoimmune-disease/https://www.newslocker.com/en-au/profession/biotechnology/crispr-method-dramatically-improves-gene-editing-delivery-to-mosquitoes/Fri, 10 Aug 2018 16:27:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crispr-method-dramatically-improves-gene-editing-delivery-to-mosquitoes/https://www.newslocker.com/en-au/profession/biotechnology/astellas-expands-its-eye-disorder-pipeline-with-quethera-purchase/Fri, 10 Aug 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/astellas-expands-its-eye-disorder-pipeline-with-quethera-purchase/https://www.newslocker.com/en-au/profession/biotechnology/epigenetic-changes-implicated-in-congestive-heart-failure/Fri, 10 Aug 2018 14:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/epigenetic-changes-implicated-in-congestive-heart-failure/https://www.newslocker.com/en-au/profession/biotechnology/antibodies-may-prove-to-be-promising-therapeutics-against-ebola/Fri, 10 Aug 2018 14:11:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/antibodies-may-prove-to-be-promising-therapeutics-against-ebola/https://www.newslocker.com/en-au/profession/biotechnology/win-a-free-company-presentation-at-bif18-with-the-buzz-of-bio-contest/Thu, 09 Aug 2018 19:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/win-a-free-company-presentation-at-bif18-with-the-buzz-of-bio-contest/https://www.newslocker.com/en-au/profession/biotechnology/autism-social-interaction-difficulties-caused-by-poor-synapse-maturation/Thu, 09 Aug 2018 16:24:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/autism-social-interaction-difficulties-caused-by-poor-synapse-maturation/https://www.newslocker.com/en-au/profession/biotechnology/sarepta-licenses-up-to-three-cns-targeting-gene-therapies-from-lacerta/Thu, 09 Aug 2018 15:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sarepta-licenses-up-to-three-cns-targeting-gene-therapies-from-lacerta/https://www.newslocker.com/en-au/profession/biotechnology/ketogenic-diet-may-increase-risk-of-type-2-diabetes/Thu, 09 Aug 2018 14:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ketogenic-diet-may-increase-risk-of-type-2-diabetes/https://www.newslocker.com/en-au/profession/biotechnology/transport-protein-study-may-lead-to-new-therapies-for-psychiatric-disorders/Thu, 09 Aug 2018 14:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/transport-protein-study-may-lead-to-new-therapies-for-psychiatric-disorders/https://www.newslocker.com/en-au/profession/biotechnology/dnarna-sequencing-technique-offers-hope-to-drug-resistant-multiple-myeloma-patients/Thu, 09 Aug 2018 14:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dnarna-sequencing-technique-offers-hope-to-drug-resistant-multiple-myeloma-patients/https://www.newslocker.com/en-au/profession/biotechnology/dnarna-sequencing-offers-hope-to-drug-resistant-multiple-myeloma-patients/Thu, 09 Aug 2018 14:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dnarna-sequencing-offers-hope-to-drug-resistant-multiple-myeloma-patients/https://www.newslocker.com/en-au/profession/biotechnology/dna-and-rna-sequencing-technique-offers-hope-to-drug-resistant-multiple-myeloma-patients/Thu, 09 Aug 2018 14:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dna-and-rna-sequencing-technique-offers-hope-to-drug-resistant-multiple-myeloma-patients/ But there’s a]]>https://www.newslocker.com/en-au/profession/biotechnology/no-seriouslytrust-the-experts/Wed, 08 Aug 2018 16:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/no-seriouslytrust-the-experts/https://www.newslocker.com/en-au/profession/biotechnology/praxis-wins-15m-nih-sbir-grant-toward-abuse-deterrent-prodrug-stimulant/Wed, 08 Aug 2018 14:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/praxis-wins-15m-nih-sbir-grant-toward-abuse-deterrent-prodrug-stimulant/https://www.newslocker.com/en-au/profession/biotechnology/lab-grown-neural-stem-cells-help-repair-spinal-injuries/Wed, 08 Aug 2018 14:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lab-grown-neural-stem-cells-help-repair-spinal-injuries/https://www.newslocker.com/en-au/profession/biotechnology/reputed-oncogene-may-act-as-a-tumor-suppressor/Wed, 08 Aug 2018 14:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/reputed-oncogene-may-act-as-a-tumor-suppressor/https://www.newslocker.com/en-au/profession/biotechnology/clinical-trial-will-assess-profile-of-gut-microbiome-in-heart-failure-patients/Wed, 08 Aug 2018 14:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/clinical-trial-will-assess-profile-of-gut-microbiome-in-heart-failure-patients/https://www.newslocker.com/en-au/profession/biotechnology/single-cell-genetic-atlas-of-breast-development-reveals-new-cancer-targets/Wed, 08 Aug 2018 14:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/single-cell-genetic-atlas-of-breast-development-reveals-new-cancer-targets/ It seems like every where you turn, somehow, someway, gene editing is being talked about. Just recently, 60 minutes ran a piece about the tremendous promise gene editing tools like CRISPR hold in human health. For the first time ever, CRISPR is being licensed to agricultural companies like J.R. Simplot Company to sustainably produce]]>https://www.newslocker.com/en-au/profession/biotechnology/vote-for-gene-editing-panel-at-2019-sxsw/Tue, 07 Aug 2018 17:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vote-for-gene-editing-panel-at-2019-sxsw/https://www.newslocker.com/en-au/profession/biotechnology/for-a-healthy-gut-put-a-cherry-on-top/Tue, 07 Aug 2018 16:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/for-a-healthy-gut-put-a-cherry-on-top/https://www.newslocker.com/en-au/profession/biotechnology/aging-cells-rejuvenated-when-hydrogen-sulfide-gives-splicing-factors-a-lift/Tue, 07 Aug 2018 16:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aging-cells-rejuvenated-when-hydrogen-sulfide-gives-splicing-factors-a-lift/https://www.newslocker.com/en-au/profession/biotechnology/spark-therapeutics-stock-tumbles-after-mixed-results-from-phase-iii-trial-of-hemophilia-a-candidate/Tue, 07 Aug 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/spark-therapeutics-stock-tumbles-after-mixed-results-from-phase-iii-trial-of-hemophilia-a-candidate/https://www.newslocker.com/en-au/profession/biotechnology/allergan-to-develop-editas-crispr-therapy-edit-101-for-lca10/Tue, 07 Aug 2018 16:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/allergan-to-develop-editas-crispr-therapy-edit-101-for-lca10/https://www.newslocker.com/en-au/profession/biotechnology/novel-approach-could-lead-to-creation-of-new-thiophosphate-based-nucleotide-drugs/Tue, 07 Aug 2018 14:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-approach-could-lead-to-creation-of-new-thiophosphate-based-nucleotide-drugs/https://www.newslocker.com/en-au/profession/biotechnology/heart-attacks-ruled-out-three-times-faster-with-new-blood-test/Mon, 06 Aug 2018 16:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/heart-attacks-ruled-out-three-times-faster-with-new-blood-test/https://www.newslocker.com/en-au/profession/biotechnology/regeneron-to-invest-100m-in-bluebird-bio-as-companies-partner-in-cancer-therapies/Mon, 06 Aug 2018 16:11:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/regeneron-to-invest-100m-in-bluebird-bio-as-companies-partner-in-cancer-therapies/https://www.newslocker.com/en-au/profession/biotechnology/reversible-technique-developed-for-stem-cell-expansion/Mon, 06 Aug 2018 16:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/reversible-technique-developed-for-stem-cell-expansion/https://www.newslocker.com/en-au/profession/biotechnology/study-on-henipaviruses-reveals-potential-new-targets-to-treat-them-and-other-viruses/Mon, 06 Aug 2018 14:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/study-on-henipaviruses-reveals-potential-new-targets-to-treat-them-and-other-viruses/https://www.newslocker.com/en-au/profession/biotechnology/lethal-viruses-hijack-dna-damage-response-may-be-exploited-for-cancer/Mon, 06 Aug 2018 14:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lethal-viruses-hijack-dna-damage-response-may-be-exploited-for-cancer/https://www.newslocker.com/en-au/profession/biotechnology/novel-method-allows-researchers-to-precisely-engineer-and-monitor-protein-function/Mon, 06 Aug 2018 14:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-method-allows-researchers-to-precisely-engineer-and-monitor-protein-function/https://www.newslocker.com/en-au/profession/biotechnology/crispr-cas12a-more-precise-than-crispr-cas9/Fri, 03 Aug 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crispr-cas12a-more-precise-than-crispr-cas9/https://www.newslocker.com/en-au/profession/biotechnology/smell-interpretation-study-gets-a-wing-up-from-locusts/Fri, 03 Aug 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/smell-interpretation-study-gets-a-wing-up-from-locusts/https://www.newslocker.com/en-au/profession/biotechnology/brown-fat-flexes-its-muscle/Fri, 03 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/brown-fat-flexes-its-muscle/https://www.newslocker.com/en-au/profession/biotechnology/salix-cedars-sinai-partner-on-gut-microbiomerelated-gi-treatments/Fri, 03 Aug 2018 15:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/salix-cedars-sinai-partner-on-gut-microbiomerelated-gi-treatments/https://www.newslocker.com/en-au/profession/biotechnology/innovative-immunofluorescence-technique-greatly-refines-cellular-analysis/Fri, 03 Aug 2018 14:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/innovative-immunofluorescence-technique-greatly-refines-cellular-analysis/https://www.newslocker.com/en-au/profession/biotechnology/thalidomides-birth-defect-causing-mechanism-finally-uncovered/Thu, 02 Aug 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/thalidomides-birth-defect-causing-mechanism-finally-uncovered/https://www.newslocker.com/en-au/profession/biotechnology/obesity-affects-flu-transmission-rates/Thu, 02 Aug 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/obesity-affects-flu-transmission-rates/https://www.newslocker.com/en-au/profession/biotechnology/exercise-pathway-that-regulates-muscle-remodeling-may-have-implications-for-metabolic-diseases/Thu, 02 Aug 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/exercise-pathway-that-regulates-muscle-remodeling-may-have-implications-for-metabolic-diseases/https://www.newslocker.com/en-au/profession/biotechnology/epizyme-halts-phase-ii-trial-of-tazemetostat-in-dlbcl-continues-talks-to-lift-clinical-hold/Thu, 02 Aug 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/epizyme-halts-phase-ii-trial-of-tazemetostat-in-dlbcl-continues-talks-to-lift-clinical-hold/https://www.newslocker.com/en-au/profession/biotechnology/epizyme-halts-phase-ii-trial-of-tazemetostat-in-dlbcl-cohorts-continues-talks-to-lift-clinical-hold/Thu, 02 Aug 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/epizyme-halts-phase-ii-trial-of-tazemetostat-in-dlbcl-cohorts-continues-talks-to-lift-clinical-hold/https://www.newslocker.com/en-au/profession/biotechnology/rare-lung-cell-type-appears-to-play-important-role-in-cystic-fibrosis/Thu, 02 Aug 2018 13:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rare-lung-cell-type-appears-to-play-important-role-in-cystic-fibrosis/https://www.newslocker.com/en-au/profession/biotechnology/bio-latin-america-agricultural-biotechnology-in-brazil/Wed, 01 Aug 2018 16:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-latin-america-agricultural-biotechnology-in-brazil/https://www.newslocker.com/en-au/profession/biotechnology/fathers-genomic-imprinting-promotes-mothers-loving-care/Wed, 01 Aug 2018 16:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fathers-genomic-imprinting-promotes-mothers-loving-care/https://www.newslocker.com/en-au/profession/biotechnology/single-cell-rna-sequencing-protocol-gets-powerful-upgrade/Wed, 01 Aug 2018 16:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/single-cell-rna-sequencing-protocol-gets-powerful-upgrade/https://www.newslocker.com/en-au/profession/biotechnology/torque-unveils-manufacturing-platform-for-its-deep-primed-t-cell-cancer-therapies/Wed, 01 Aug 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/torque-unveils-manufacturing-platform-for-its-deep-primed-t-cell-cancer-therapies/https://www.newslocker.com/en-au/profession/biotechnology/cancer-cells-feel-acids-sting/Wed, 01 Aug 2018 14:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-cells-feel-acids-sting/https://www.newslocker.com/en-au/profession/biotechnology/cancer-cells-become-vulnerable-at-acidic-ph/Wed, 01 Aug 2018 14:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-cells-become-vulnerable-at-acidic-ph/ In short, the ECJ ruled that organisms obtained by directed mutagenesis – a set of genome editing techniques, such as CRISPR, which make it possible to alter the genome of a living spe]]>https://www.newslocker.com/en-au/profession/biotechnology/will-ecj-ruling-be-the-deathblow-for-plant-biotech-in-europe/Tue, 31 Jul 2018 17:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/will-ecj-ruling-be-the-deathblow-for-plant-biotech-in-europe/https://www.newslocker.com/en-au/profession/biotechnology/dna-crosslink-repair-central-to-crispr-insert-success/Tue, 31 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dna-crosslink-repair-central-to-crispr-insert-success/https://www.newslocker.com/en-au/profession/biotechnology/leo-pharma-to-acquire-bayer-prescription-dermatology-portfolio/Tue, 31 Jul 2018 16:27:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/leo-pharma-to-acquire-bayer-prescription-dermatology-portfolio/https://www.newslocker.com/en-au/profession/biotechnology/cancer-immunotherapy-looks-to-exploit-hair-loss-gene/Tue, 31 Jul 2018 16:11:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-immunotherapy-looks-to-exploit-hair-loss-gene/https://www.newslocker.com/en-au/profession/biotechnology/cannabis-combo-therapy-triples-pancreatic-cancer-survival-rate/Tue, 31 Jul 2018 15:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cannabis-combo-therapy-triples-pancreatic-cancer-survival-rate/ “The most fundamental way in which the industry creates value is by discovering and manufacturing innovative medicines that help people live longer, healthier, more productive lives,” Read notes. “But the industry’s value creation is even more tangible when you look at its impact on GDP and job creat]]>https://www.newslocker.com/en-au/profession/biotechnology/pfizer-ceo-how-the-biopharmaceutical-industry-creates-value-and-jobs-for-the-us-economy/Tue, 31 Jul 2018 15:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pfizer-ceo-how-the-biopharmaceutical-industry-creates-value-and-jobs-for-the-us-economy/https://www.newslocker.com/en-au/profession/biotechnology/otsukaastex-aml-candidate-guadecitabine-fails-phase-iii-trial/Tue, 31 Jul 2018 15:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/otsukaastex-aml-candidate-guadecitabine-fails-phase-iii-trial/https://www.newslocker.com/en-au/profession/biotechnology/genetic-hotspot-studies-could-lead-to-better-understanding-of-cancer/Tue, 31 Jul 2018 13:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genetic-hotspot-studies-could-lead-to-better-understanding-of-cancer/ Rep. Barbara Comstock of Virginia’s 10th congressional district
BIO strongly support this and similarly focused legislative initiatives, and has long worked to expand participation in STEM education and biotechnology professions. Our member co]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-commends-rep-comstock-for-introduction-of-success-act/Mon, 30 Jul 2018 16:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-commends-rep-comstock-for-introduction-of-success-act/https://www.newslocker.com/en-au/profession/biotechnology/hair-loss-caused-by-fatty-diet-reversed/Mon, 30 Jul 2018 16:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hair-loss-caused-by-fatty-diet-reversed/https://www.newslocker.com/en-au/profession/biotechnology/bacteria-blamed-for-rapid-tooth-decay-open-wide-genomically/Mon, 30 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bacteria-blamed-for-rapid-tooth-decay-open-wide-genomically/https://www.newslocker.com/en-au/profession/biotechnology/insys-weighs-next-steps-after-fda-rejects-nda-for-acute-pain-treatment-buvaya/Mon, 30 Jul 2018 15:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/insys-weighs-next-steps-after-fda-rejects-nda-for-acute-pain-treatment-buvaya/https://www.newslocker.com/en-au/profession/biotechnology/macrophage-produced-protein-plays-essential-role-in-arterial-health/Mon, 30 Jul 2018 14:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/macrophage-produced-protein-plays-essential-role-in-arterial-health/https://www.newslocker.com/en-au/profession/biotechnology/phosphatases-in-line-for-target-based-discovery/Fri, 27 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/phosphatases-in-line-for-target-based-discovery/https://www.newslocker.com/en-au/profession/biotechnology/cannabis-doesnt-help-exercising-copd-patients/Fri, 27 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cannabis-doesnt-help-exercising-copd-patients/https://www.newslocker.com/en-au/profession/biotechnology/achaogen-eliminating-80-jobs-28-of-staff-in-restructuring/Fri, 27 Jul 2018 16:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/achaogen-eliminating-80-jobs-28-of-staff-in-restructuring/https://www.newslocker.com/en-au/profession/biotechnology/huntingtons-could-be-slowed-by-blocking-aggregation-mechanism/Fri, 27 Jul 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/huntingtons-could-be-slowed-by-blocking-aggregation-mechanism/https://www.newslocker.com/en-au/profession/biotechnology/sperms-rna-to-go-expedites-embryonic-implantation/Thu, 26 Jul 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sperms-rna-to-go-expedites-embryonic-implantation/https://www.newslocker.com/en-au/profession/biotechnology/potential-alzheimers-and-age-related-cognitive-decline-target-identified/Thu, 26 Jul 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/potential-alzheimers-and-age-related-cognitive-decline-target-identified/https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-symptoms-associated-with-contact-sports/Thu, 26 Jul 2018 16:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-symptoms-associated-with-contact-sports/https://www.newslocker.com/en-au/profession/biotechnology/fda-places-clinical-hold-on-sarepta-dmd-micro-dystrophin-gene-therapy-trial/Thu, 26 Jul 2018 15:54:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-places-clinical-hold-on-sarepta-dmd-micro-dystrophin-gene-therapy-trial/ Many brands tout their products as non-GMO even when their products contain ingredients that couldn]]>https://www.newslocker.com/en-au/profession/biotechnology/confronting-misinformation-and-fearmongeringone-brand-at-a-time/Thu, 26 Jul 2018 15:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/confronting-misinformation-and-fearmongeringone-brand-at-a-time/ Much of the event’s success can be traced to the]]>https://www.newslocker.com/en-au/profession/biotechnology/early-stage-portfolios-can-win-over-active-investors-at-bio-investor-forum/Wed, 25 Jul 2018 22:38:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/early-stage-portfolios-can-win-over-active-investors-at-bio-investor-forum/https://www.newslocker.com/en-au/profession/biotechnology/innovative-policies-drive-the-biobased-economy/Wed, 25 Jul 2018 22:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/innovative-policies-drive-the-biobased-economy/https://www.newslocker.com/en-au/profession/biotechnology/as-out-of-pocket-costs-rise-insurers-spend-big-on-administrative-costs/Wed, 25 Jul 2018 21:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/as-out-of-pocket-costs-rise-insurers-spend-big-on-administrative-costs/https://www.newslocker.com/en-au/profession/biotechnology/gsk-invests-300m-in-23andme-as-companies-collaborate-on-drug-development/Wed, 25 Jul 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gsk-invests-300m-in-23andme-as-companies-collaborate-on-drug-development/https://www.newslocker.com/en-au/profession/biotechnology/dna-enhancer-video-rules-out-hit-and-run-activity/Wed, 25 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dna-enhancer-video-rules-out-hit-and-run-activity/https://www.newslocker.com/en-au/profession/biotechnology/viral-microbiome-changes-could-be-an-underlying-cause-of-ibd/Wed, 25 Jul 2018 16:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/viral-microbiome-changes-could-be-an-underlying-cause-of-ibd/https://www.newslocker.com/en-au/profession/biotechnology/single-course-of-antibiotics-early-in-life-may-increase-type-1-diabetes-risk/Wed, 25 Jul 2018 16:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/single-course-of-antibiotics-early-in-life-may-increase-type-1-diabetes-risk/https://www.newslocker.com/en-au/profession/biotechnology/hiv-transmission-blocked-by-often-overlooked-class-of-antibody/Tue, 24 Jul 2018 16:41:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hiv-transmission-blocked-by-often-overlooked-class-of-antibody/https://www.newslocker.com/en-au/profession/biotechnology/peaceable-gut-microbiota-express-symbiosis-promoting-factors-in-response-to-iga/Tue, 24 Jul 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/peaceable-gut-microbiota-express-symbiosis-promoting-factors-in-response-to-iga/https://www.newslocker.com/en-au/profession/biotechnology/hiv-drug-reduces-neurodegenerative-disease-pathology-in-fruit-flies/Tue, 24 Jul 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hiv-drug-reduces-neurodegenerative-disease-pathology-in-fruit-flies/https://www.newslocker.com/en-au/profession/biotechnology/chiesi-gains-us-rights-to-protalix-phase-iii-fabry-disease-candidate-prx-102/Tue, 24 Jul 2018 15:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/chiesi-gains-us-rights-to-protalix-phase-iii-fabry-disease-candidate-prx-102/ Our nation’s life sciences industry is thriving but other countries are adopting policies designed to attract biotechnology firms to their shores, and as a result, the U.S. is losing some of its competitive advantage. In fact, as shown in a recent report commissioned by the Information Technolo]]>https://www.newslocker.com/en-au/profession/biotechnology/greenwood-america-leads-in-biopharmaceutical-innovation-lets-keep-it-that-way/Tue, 24 Jul 2018 15:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/greenwood-america-leads-in-biopharmaceutical-innovation-lets-keep-it-that-way/https://www.newslocker.com/en-au/profession/biotechnology/merck-amp-co-partners-with-sutro-on-cytokine-derivatives-for-cancer-autoimmune-disorders/Tue, 24 Jul 2018 14:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/merck-amp-co-partners-with-sutro-on-cytokine-derivatives-for-cancer-autoimmune-disorders/ The National Academies of Sciences, Engineering, and Medicine last week released a report on how to address the most pressing problems of American agriculture. The list of those problems is long and scary: climate change, food waste, water scarcity, food-borne illness, pests, and disease.The report identifies five scientific tools to improve sustainability a]]>https://www.newslocker.com/en-au/profession/biotechnology/a-new-nas-report-says-gene-editing-is-a-breakthrough-opportunity/Mon, 23 Jul 2018 20:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-new-nas-report-says-gene-editing-is-a-breakthrough-opportunity/https://www.newslocker.com/en-au/profession/biotechnology/wrinkles-and-hair-loss-reversed-through-mitochondrial-restoration/Mon, 23 Jul 2018 16:41:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/wrinkles-and-hair-loss-reversed-through-mitochondrial-restoration/https://www.newslocker.com/en-au/profession/biotechnology/venter-institute-denies-wrongdoing-as-human-longevity-sues/Mon, 23 Jul 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/venter-institute-denies-wrongdoing-as-human-longevity-sues/https://www.newslocker.com/en-au/profession/biotechnology/genome-tailored-diets-may-be-premature/Mon, 23 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genome-tailored-diets-may-be-premature/https://www.newslocker.com/en-au/profession/biotechnology/parasite-speed-saves-malaria-from-immune-capture/Mon, 23 Jul 2018 16:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/parasite-speed-saves-malaria-from-immune-capture/https://www.newslocker.com/en-au/profession/biotechnology/sangamo-looks-to-expand-into-car-treg-cell-therapies-with-txcell-acquisition/Mon, 23 Jul 2018 15:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sangamo-looks-to-expand-into-car-treg-cell-therapies-with-txcell-acquisition/https://www.newslocker.com/en-au/profession/biotechnology/age-associated-skin-wrinkles-and-hair-loss-reversed-in-mice/Mon, 23 Jul 2018 14:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/age-associated-skin-wrinkles-and-hair-loss-reversed-in-mice/https://www.newslocker.com/en-au/profession/biotechnology/rare-disease-hub-draws-support-from-drug-developers/Fri, 20 Jul 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rare-disease-hub-draws-support-from-drug-developers/https://www.newslocker.com/en-au/profession/biotechnology/mixed-mrna-tails-less-easily-docked/Fri, 20 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/mixed-mrna-tails-less-easily-docked/https://www.newslocker.com/en-au/profession/biotechnology/crispr-defense-thwarted-through-viral-cooperation/Fri, 20 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crispr-defense-thwarted-through-viral-cooperation/https://www.newslocker.com/en-au/profession/biotechnology/paralyzed-mice-walk-following-drug-therapy/Fri, 20 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/paralyzed-mice-walk-following-drug-therapy/https://www.newslocker.com/en-au/profession/biotechnology/got-milk-roche-to-apply-puretech-exosomes-platform-in-1b-collaboration/Fri, 20 Jul 2018 15:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/got-milk-roche-to-apply-puretech-exosomes-platform-in-1b-collaboration/https://www.newslocker.com/en-au/profession/biotechnology/gmo-answers-live-at-ift-2018/Fri, 20 Jul 2018 15:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gmo-answers-live-at-ift-2018/https://www.newslocker.com/en-au/profession/biotechnology/enzyme-identified-that-helps-make-cancer-resistant-to-cisplatin/Fri, 20 Jul 2018 14:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/enzyme-identified-that-helps-make-cancer-resistant-to-cisplatin/ The BIO World Congress continues to be the largest industrial biotechnology conference in the world, and this year’s event included 44 pe]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc18-day-3-wrap-up/Thu, 19 Jul 2018 21:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biowc18-day-3-wrap-up/https://www.newslocker.com/en-au/profession/biotechnology/trol-act-reintroduced-in-house/Thu, 19 Jul 2018 20:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/trol-act-reintroduced-in-house/ BIO’s “Innovate for the Future” Tour included a trip down to Salinas, the city also known as America’s Salad B]]>https://www.newslocker.com/en-au/profession/biotechnology/innovate-for-the-future-tour-2018-forbes-agtech-summit/Thu, 19 Jul 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/innovate-for-the-future-tour-2018-forbes-agtech-summit/https://www.newslocker.com/en-au/profession/biotechnology/messy-dna-repair-championed-by-shieldin/Thu, 19 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/messy-dna-repair-championed-by-shieldin/https://www.newslocker.com/en-au/profession/biotechnology/when-good-cholesterol-goes-bad/Thu, 19 Jul 2018 16:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/when-good-cholesterol-goes-bad/https://www.newslocker.com/en-au/profession/biotechnology/novartis-licenses-morphosysgalapagos-atopic-dermatitis-candidate-mor106-for-11b/Thu, 19 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novartis-licenses-morphosysgalapagos-atopic-dermatitis-candidate-mor106-for-11b/https://www.newslocker.com/en-au/profession/biotechnology/autism-and-moms-microbiome-could-be-linked/Thu, 19 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/autism-and-moms-microbiome-could-be-linked/https://www.newslocker.com/en-au/profession/biotechnology/critical-role-of-prmt5-protein-uncovered-in-the-production-of-myelin/Thu, 19 Jul 2018 14:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/critical-role-of-prmt5-protein-uncovered-in-the-production-of-myelin/ As the media has covered widely in recent weeks, tactics used by health]]>https://www.newslocker.com/en-au/profession/biotechnology/insurers-should-prevent-pharmacy-counter-sticker-shock-not-encourage-it/Thu, 19 Jul 2018 14:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/insurers-should-prevent-pharmacy-counter-sticker-shock-not-encourage-it/ At a conference where biofuels, enzymes, proteins and industrial processes take center stage, some attendees may have been questioning the role industrial biotechnology has in fashion.
However, as moderator Jim Lane, editor of The]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc18-day-2-wrap-up/Wed, 18 Jul 2018 23:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biowc18-day-2-wrap-up/https://www.newslocker.com/en-au/profession/biotechnology/leukemia-cells-take-the-fast-track-to-the-nervous-system/Wed, 18 Jul 2018 19:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/leukemia-cells-take-the-fast-track-to-the-nervous-system/https://www.newslocker.com/en-au/profession/biotechnology/why-flu-recovery-is-slower-for-women/Wed, 18 Jul 2018 16:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/why-flu-recovery-is-slower-for-women/https://www.newslocker.com/en-au/profession/biotechnology/beef-jerky-and-other-processed-meats-linked-with-mania/Wed, 18 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/beef-jerky-and-other-processed-meats-linked-with-mania/https://www.newslocker.com/en-au/profession/biotechnology/extra-vinculin-keeps-heart-cells-shapely-keeps-aging-hearts-in-shape/Wed, 18 Jul 2018 16:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/extra-vinculin-keeps-heart-cells-shapely-keeps-aging-hearts-in-shape/https://www.newslocker.com/en-au/profession/biotechnology/new-stem-cellbased-bone-engineering-technique-advances-regenerative-medicine/Wed, 18 Jul 2018 14:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-stem-cellbased-bone-engineering-technique-advances-regenerative-medicine/ Thankfully, the biopharmaceutical industry is hard at work developing novel and safer, next-generation therapies to treat both pain and addiction, but one challenge in particular continues to stand in the way: getting pharm]]>https://www.newslocker.com/en-au/profession/biotechnology/insurers-and-pbms-limit-access-to-safer-opioid-alternatives/Wed, 18 Jul 2018 14:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/insurers-and-pbms-limit-access-to-safer-opioid-alternatives/ BIO’s President and CEO Jim Greenwood provided welcoming remarks ahead of the lunch plenary session, highlighting the growth of the biobased economy and BIO’s commitment to fostering innovation in industrial biotechnology.
“I’ve been BIO CEO for more than 13 years, and it has been amazing to see World Congress grow i]]>https://www.newslocker.com/en-au/profession/biotechnology/biowc18-day-1-wrap-up/Tue, 17 Jul 2018 22:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biowc18-day-1-wrap-up/ But in the current political environment, the economic arguments to support our work may be even more persuas]]>https://www.newslocker.com/en-au/profession/biotechnology/my-pledge-at-world-congress-bio-will-lead-on-gene-editing/Tue, 17 Jul 2018 18:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/my-pledge-at-world-congress-bio-will-lead-on-gene-editing/https://www.newslocker.com/en-au/profession/biotechnology/crispr-cas3-platform-developer-locus-biosciences-acquires-epibiome-phage-technology/Tue, 17 Jul 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crispr-cas3-platform-developer-locus-biosciences-acquires-epibiome-phage-technology/https://www.newslocker.com/en-au/profession/biotechnology/cancers-grip-may-be-loosened-by-tampering-with-dna-clamp/Tue, 17 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancers-grip-may-be-loosened-by-tampering-with-dna-clamp/https://www.newslocker.com/en-au/profession/biotechnology/weight-loss-drug-looks-to-spice-things-up/Tue, 17 Jul 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/weight-loss-drug-looks-to-spice-things-up/https://www.newslocker.com/en-au/profession/biotechnology/fetal-gene-therapy-prevents-fatal-form-of-gaucher-disease/Tue, 17 Jul 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fetal-gene-therapy-prevents-fatal-form-of-gaucher-disease/https://www.newslocker.com/en-au/profession/biotechnology/phrma-replace-drug-rebates-to-pbms-insurers-with-fees-ties-to-value/Tue, 17 Jul 2018 15:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/phrma-replace-drug-rebates-to-pbms-insurers-with-fees-ties-to-value/https://www.newslocker.com/en-au/profession/biotechnology/phrma-replace-drug-rebates-to-pbms-insurers-with-fees-tied-to-value/Tue, 17 Jul 2018 15:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/phrma-replace-drug-rebates-to-pbms-insurers-with-fees-tied-to-value/https://www.newslocker.com/en-au/profession/biotechnology/high-resolution-nanoscope-opens-door-to-better-understanding-of-amyloid-plaques/Tue, 17 Jul 2018 13:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/high-resolution-nanoscope-opens-door-to-better-understanding-of-amyloid-plaques/https://www.newslocker.com/en-au/profession/biotechnology/amyloid-plaques-better-understood-through-use-of-high-resolution-nanoscope/Tue, 17 Jul 2018 13:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/amyloid-plaques-better-understood-through-use-of-high-resolution-nanoscope/https://www.newslocker.com/en-au/profession/biotechnology/llama-derived-nanobody-may-tread-narrow-anticancer-path/Mon, 16 Jul 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/llama-derived-nanobody-may-tread-narrow-anticancer-path/https://www.newslocker.com/en-au/profession/biotechnology/biomarkers-potential-for-diagnosing-traumatic-brain-injury-solidified/Mon, 16 Jul 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biomarkers-potential-for-diagnosing-traumatic-brain-injury-solidified/https://www.newslocker.com/en-au/profession/biotechnology/spero-wins-up-to-54m-toward-development-of-lead-antibiotic-spr994-for-uti/Mon, 16 Jul 2018 15:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/spero-wins-up-to-54m-toward-development-of-lead-antibiotic-spr994-for-uti/https://www.newslocker.com/en-au/profession/biotechnology/fragile-x-symptoms-may-be-helped-with-new-pharmacological-approach/Mon, 16 Jul 2018 14:38:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fragile-x-symptoms-may-be-helped-with-new-pharmacological-approach/https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-first-smallpox-indicated-treatment-sigas-tpoxx/Fri, 13 Jul 2018 22:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-first-smallpox-indicated-treatment-sigas-tpoxx/https://www.newslocker.com/en-au/profession/biotechnology/human-dna-sentry-keeps-long-strands-atop-watch-list/Fri, 13 Jul 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/human-dna-sentry-keeps-long-strands-atop-watch-list/https://www.newslocker.com/en-au/profession/biotechnology/vc-investment-more-than-doubles-in-q2-driven-by-megadeals/Fri, 13 Jul 2018 16:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vc-investment-more-than-doubles-in-q2-driven-by-megadeals/https://www.newslocker.com/en-au/profession/biotechnology/novel-rna-based-vaccine-provides-protection-against-malaria/Fri, 13 Jul 2018 16:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-rna-based-vaccine-provides-protection-against-malaria/ The growth in patients’ out-of-pocket costs generally has outpaced the growth in what insurers are spending on]]>https://www.newslocker.com/en-au/profession/biotechnology/debunking-a-common-myth-on-out-of-pocket-costs/Fri, 13 Jul 2018 15:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/debunking-a-common-myth-on-out-of-pocket-costs/https://www.newslocker.com/en-au/profession/biotechnology/deletion-of-addiction-gene-keeps-mice-off-cocaine/Fri, 13 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/deletion-of-addiction-gene-keeps-mice-off-cocaine/https://www.newslocker.com/en-au/profession/biotechnology/new-method-developed-to-help-determine-effectiveness-of-cancer-drugs/Fri, 13 Jul 2018 13:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-method-developed-to-help-determine-effectiveness-of-cancer-drugs/https://www.newslocker.com/en-au/profession/biotechnology/cancer-drug-effectiveness-evaluated-using-new-methodology/Fri, 13 Jul 2018 13:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-drug-effectiveness-evaluated-using-new-methodology/ This proposal, entitled “Changes to the Claims Construction Standard for Interpreting Claims in Trial Proceedings Before the PTAB,” will help ensure that patent claims have the same meaning, whether they are reviewed by the PTO, a federal court, o]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-comments-on-proposed-pto-rules-change/Thu, 12 Jul 2018 19:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-comments-on-proposed-pto-rules-change/https://www.newslocker.com/en-au/profession/biotechnology/nonviral-crispr-technology-developed-for-faster-cheaper-t-cell-engineering/Thu, 12 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nonviral-crispr-technology-developed-for-faster-cheaper-t-cell-engineering/https://www.newslocker.com/en-au/profession/biotechnology/gsk-sells-psoriasisdermatitis-candidate-tapinarof-to-dermavant/Thu, 12 Jul 2018 16:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gsk-sells-psoriasisdermatitis-candidate-tapinarof-to-dermavant/https://www.newslocker.com/en-au/profession/biotechnology/effects-of-genetic-mutations-in-pik3ca-on-glioblastoma-drug-treatment/Thu, 12 Jul 2018 16:27:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/effects-of-genetic-mutations-in-pik3ca-on-glioblastoma-drug-treatment/https://www.newslocker.com/en-au/profession/biotechnology/genmab-immatics-launch-up-to-28b-cancer-immunotherapy-partnership/Thu, 12 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genmab-immatics-launch-up-to-28b-cancer-immunotherapy-partnership/ Much of the success of Thailand’s diver]]>https://www.newslocker.com/en-au/profession/biotechnology/makehistory-highlighting-history-thailand/Thu, 12 Jul 2018 14:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/makehistory-highlighting-history-thailand/https://www.newslocker.com/en-au/profession/biotechnology/immunotherapy-boosts-survival-rates-of-melanoma-brain-metastases-patients/Thu, 12 Jul 2018 14:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/immunotherapy-boosts-survival-rates-of-melanoma-brain-metastases-patients/https://www.newslocker.com/en-au/profession/biotechnology/worried-about-gmos-at-the-grocery-store-heres-what-you-need-to-know/Wed, 11 Jul 2018 20:32:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/worried-about-gmos-at-the-grocery-store-heres-what-you-need-to-know/https://www.newslocker.com/en-au/profession/biotechnology/otsuka-to-acquire-visterra-for-430m-adding-to-its-pipeline-and-platforms/Wed, 11 Jul 2018 16:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/otsuka-to-acquire-visterra-for-430m-adding-to-its-pipeline-and-platforms/https://www.newslocker.com/en-au/profession/biotechnology/cancer-linked-rearrangements-pepper-genomes-regulatory-regions/Wed, 11 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-linked-rearrangements-pepper-genomes-regulatory-regions/https://www.newslocker.com/en-au/profession/biotechnology/four-questions-for-the-energy-and-commerce-hearing-on-340b/Wed, 11 Jul 2018 15:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/four-questions-for-the-energy-and-commerce-hearing-on-340b/https://www.newslocker.com/en-au/profession/biotechnology/cause-of-crispr-failure-identified-and-reversed/Wed, 11 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cause-of-crispr-failure-identified-and-reversed/https://www.newslocker.com/en-au/profession/biotechnology/new-technique-quickly-tests-effects-of-anticancer-drugs-at-cellular-level/Wed, 11 Jul 2018 14:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-technique-quickly-tests-effects-of-anticancer-drugs-at-cellular-level/https://www.newslocker.com/en-au/profession/biotechnology/anti-cancer-drug-effects-measured-at-single-cell-level-by-multidimensional-technique/Wed, 11 Jul 2018 14:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/anti-cancer-drug-effects-measured-at-single-cell-level-by-multidimensional-technique/ Not to be missed, however, are several sponsored workshops designed to assist attendees of the 2018 BIO World Congress in taking advantage of invalua]]>https://www.newslocker.com/en-au/profession/biotechnology/invaluable-workshops-available-at-2018-bio-world-congress/Tue, 10 Jul 2018 17:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/invaluable-workshops-available-at-2018-bio-world-congress/https://www.newslocker.com/en-au/profession/biotechnology/huntingtons-treatment-may-come-from-fix-of-broken-dna-repair-mechanism/Tue, 10 Jul 2018 16:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/huntingtons-treatment-may-come-from-fix-of-broken-dna-repair-mechanism/https://www.newslocker.com/en-au/profession/biotechnology/lifespan-extended-health-improved-by-senolytic-drugs/Tue, 10 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/lifespan-extended-health-improved-by-senolytic-drugs/https://www.newslocker.com/en-au/profession/biotechnology/fetal-gene-editing-with-synthetic-nucleotides-cures-beta-thalassemia-in-mice/Tue, 10 Jul 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fetal-gene-editing-with-synthetic-nucleotides-cures-beta-thalassemia-in-mice/https://www.newslocker.com/en-au/profession/biotechnology/aquinox-axes-half-its-workforce-after-phase-iii-failure-of-lead-drug-rospitor/Tue, 10 Jul 2018 15:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aquinox-axes-half-its-workforce-after-phase-iii-failure-of-lead-drug-rospitor/https://www.newslocker.com/en-au/profession/biotechnology/curcumin-shown-to-inhibit-dyrk2-and-reduce-cancer-burden/Tue, 10 Jul 2018 14:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/curcumin-shown-to-inhibit-dyrk2-and-reduce-cancer-burden/ This progress would be impossible without the help and leadership of the Food and Drug Administration]]>https://www.newslocker.com/en-au/profession/biotechnology/fda-protects-patients-while-promoting-innovation/Mon, 09 Jul 2018 21:53:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-protects-patients-while-promoting-innovation/https://www.newslocker.com/en-au/profession/biotechnology/jumping-genes-hop-across-species-to-stir-human-evolution/Mon, 09 Jul 2018 16:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/jumping-genes-hop-across-species-to-stir-human-evolution/https://www.newslocker.com/en-au/profession/biotechnology/antibiotic-antigen-conjugates-bring-immunotherapy-to-deadly-bacteria/Mon, 09 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/antibiotic-antigen-conjugates-bring-immunotherapy-to-deadly-bacteria/https://www.newslocker.com/en-au/profession/biotechnology/axovant-licenses-benitec-gene-therapy-candidates-for-opmd-neurological-disorders/Mon, 09 Jul 2018 15:59:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/axovant-licenses-benitec-gene-therapy-candidates-for-opmd-neurological-disorders/https://www.newslocker.com/en-au/profession/biotechnology/smart-bandage-for-hands-free-monitoring-and-treatment-of-chronic-wounds/Mon, 09 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/smart-bandage-for-hands-free-monitoring-and-treatment-of-chronic-wounds/https://www.newslocker.com/en-au/profession/biotechnology/thermal-protein-profiling-may-offer-new-insights-on-antibiotic-resistance/Mon, 09 Jul 2018 13:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/thermal-protein-profiling-may-offer-new-insights-on-antibiotic-resistance/https://www.newslocker.com/en-au/profession/biotechnology/some-hope-biogen-eisai-release-positive-phase-ii-results-for-alzheimers-candidate/Fri, 06 Jul 2018 21:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/some-hope-biogen-eisai-release-positive-phase-ii-results-for-alzheimers-candidate/https://www.newslocker.com/en-au/profession/biotechnology/goji-berry-superfruit-compounds-may-treat-parasitic-diseases/Fri, 06 Jul 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/goji-berry-superfruit-compounds-may-treat-parasitic-diseases/https://www.newslocker.com/en-au/profession/biotechnology/mitochondrial-dna-talks-back-to-nuclear-dna/Fri, 06 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/mitochondrial-dna-talks-back-to-nuclear-dna/https://www.newslocker.com/en-au/profession/biotechnology/regulus-axing-60-of-workforce-pauses-patient-recruitment-for-lead-program/Fri, 06 Jul 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/regulus-axing-60-of-workforce-pauses-patient-recruitment-for-lead-program/https://www.newslocker.com/en-au/profession/biotechnology/teratoma-derived-stem-cells-rebuild-muscle-in-model-of-muscular-dystrophy/Fri, 06 Jul 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/teratoma-derived-stem-cells-rebuild-muscle-in-model-of-muscular-dystrophy/https://www.newslocker.com/en-au/profession/biotechnology/new-crispr-approach-converts-skin-cells-into-pluripotent-stem-cells/Fri, 06 Jul 2018 14:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-crispr-approach-converts-skin-cells-into-pluripotent-stem-cells/https://www.newslocker.com/en-au/profession/biotechnology/molecular-link-between-dementia-blood-vessel-changes-reveals-treatment-possibilities/Thu, 05 Jul 2018 16:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/molecular-link-between-dementia-blood-vessel-changes-reveals-treatment-possibilities/https://www.newslocker.com/en-au/profession/biotechnology/crispr-induced-mutations-give-wing-to-a-butterfly-effect/Thu, 05 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crispr-induced-mutations-give-wing-to-a-butterfly-effect/ For example, he ignores the fact that the trend on prescription drug costs is actually heading in the right direction. Not surprisingly, he also neglects to mention that insurance companies have continued to shift more prescri]]>https://www.newslocker.com/en-au/profession/biotechnology/i-maks-distorted-view-of-the-us-patent-system/Thu, 05 Jul 2018 16:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/i-maks-distorted-view-of-the-us-patent-system/https://www.newslocker.com/en-au/profession/biotechnology/zynerba-scraps-development-of-thc-prodrug-zyn001-after-failed-trial/Thu, 05 Jul 2018 15:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/zynerba-scraps-development-of-thc-prodrug-zyn001-after-failed-trial/https://www.newslocker.com/en-au/profession/biotechnology/food-additives-and-drugs-change-antibiotic-effectiveness/Thu, 05 Jul 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/food-additives-and-drugs-change-antibiotic-effectiveness/https://www.newslocker.com/en-au/profession/biotechnology/artificial-bimolecular-networks-open-door-to-sophisticated-diagnostic-testing/Thu, 05 Jul 2018 14:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/artificial-bimolecular-networks-open-door-to-sophisticated-diagnostic-testing/https://www.newslocker.com/en-au/profession/biotechnology/why-e10-petrol-may-not-be-driving-your-car-or-your-dollar-further/Tue, 03 Jul 2018 21:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/why-e10-petrol-may-not-be-driving-your-car-or-your-dollar-further/ Recent innovation in biotechnology has allowed companies to develop alternative proteins using animal stem cells. Right now, there are only a few companies working with, producing and]]>https://www.newslocker.com/en-au/profession/biotechnology/4-reasons-why-alternative-proteins-could-be-part-of-your-july-4th-in-the-future/Tue, 03 Jul 2018 18:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/4-reasons-why-alternative-proteins-could-be-part-of-your-july-4th-in-the-future/https://www.newslocker.com/en-au/profession/biotechnology/novartis-aveo-spar-as-exclusive-antibody-deal-ends/Tue, 03 Jul 2018 16:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novartis-aveo-spar-as-exclusive-antibody-deal-ends/https://www.newslocker.com/en-au/profession/biotechnology/aspirin-intensifies-disposal-of-alzheimers-plaque/Tue, 03 Jul 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aspirin-intensifies-disposal-of-alzheimers-plaque/https://www.newslocker.com/en-au/profession/biotechnology/eww-that-smell-key-basis-for-bo-production-identified/Tue, 03 Jul 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/eww-that-smell-key-basis-for-bo-production-identified/https://www.newslocker.com/en-au/profession/biotechnology/stem-cells-renew-heart-function-in-primates-with-cardiac-failure/Tue, 03 Jul 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/stem-cells-renew-heart-function-in-primates-with-cardiac-failure/https://www.newslocker.com/en-au/profession/biotechnology/catalent-to-acquire-juniper-adding-early-drug-development-capabilities/Tue, 03 Jul 2018 15:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/catalent-to-acquire-juniper-adding-early-drug-development-capabilities/https://www.newslocker.com/en-au/profession/biotechnology/biological-switch-may-offer-better-control-of-gene-editing/Tue, 03 Jul 2018 13:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biological-switch-may-offer-better-control-of-gene-editing/https://www.newslocker.com/en-au/profession/biotechnology/metastatic-cancer-tracking-gets-computational-upgrade/Mon, 02 Jul 2018 16:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/metastatic-cancer-tracking-gets-computational-upgrade/https://www.newslocker.com/en-au/profession/biotechnology/20-blood-test-could-contribute-to-global-hbv-elimination/Mon, 02 Jul 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/20-blood-test-could-contribute-to-global-hbv-elimination/https://www.newslocker.com/en-au/profession/biotechnology/compugen-advancing-cancer-immunotherapies-to-clinical-trials/Mon, 02 Jul 2018 15:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/compugen-advancing-cancer-immunotherapies-to-clinical-trials/https://www.newslocker.com/en-au/profession/biotechnology/team-sheds-light-on-genetic-complexity-of-neurodevelopmental-disorders/Mon, 02 Jul 2018 14:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/team-sheds-light-on-genetic-complexity-of-neurodevelopmental-disorders/https://www.newslocker.com/en-au/profession/biotechnology/autism-genetic-complexity-comes-to-light/Mon, 02 Jul 2018 14:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/autism-genetic-complexity-comes-to-light/ To offset these costs, many pharmaceutical companies offer programs that assist patients with their out of pocket costs, in]]>https://www.newslocker.com/en-au/profession/biotechnology/co-pay-accumulator-programs-are-a-bad-deal-for-patients/Mon, 02 Jul 2018 14:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/co-pay-accumulator-programs-are-a-bad-deal-for-patients/ Long-term solutions to combating this crisis will depend upon biomedical innovation and the development of novel and safer, next generation therapi]]>https://www.newslocker.com/en-au/profession/biotechnology/house-passes-support-for-patients-and-communities-act-to-combat-americas-opioid-crisis/Fri, 29 Jun 2018 18:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/house-passes-support-for-patients-and-communities-act-to-combat-americas-opioid-crisis/https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-drugs-targeting-tau-may-actually-exacerbate-disease/Fri, 29 Jun 2018 16:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-drugs-targeting-tau-may-actually-exacerbate-disease/https://www.newslocker.com/en-au/profession/biotechnology/biogen-raising-minority-stake-in-samsung-bioepis-in-672m-deal/Fri, 29 Jun 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biogen-raising-minority-stake-in-samsung-bioepis-in-672m-deal/https://www.newslocker.com/en-au/profession/biotechnology/pancreatic-tumors-run-hot-cold-depending-on-tumor-cell-intrinsic-factors/Fri, 29 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pancreatic-tumors-run-hot-cold-depending-on-tumor-cell-intrinsic-factors/https://www.newslocker.com/en-au/profession/biotechnology/approved-anti-cancer-drugs-reveal-new-target-non-coding-rnas/Fri, 29 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/approved-anti-cancer-drugs-reveal-new-target-non-coding-rnas/https://www.newslocker.com/en-au/profession/biotechnology/car-t-cells-just-got-some-killer-competition/Fri, 29 Jun 2018 15:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/car-t-cells-just-got-some-killer-competition/https://www.newslocker.com/en-au/profession/biotechnology/bayer-broad-institute-launch-precision-cardiology-laboratory/Fri, 29 Jun 2018 15:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bayer-broad-institute-launch-precision-cardiology-laboratory/https://www.newslocker.com/en-au/profession/biotechnology/study-concludes-microtubule-stabilizing-drugs-may-not-be-effective-against-alzheimers/Fri, 29 Jun 2018 14:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/study-concludes-microtubule-stabilizing-drugs-may-not-be-effective-against-alzheimers/https://www.newslocker.com/en-au/profession/biotechnology/barking-up-the-right-dog-genomes-sniffing-out-domestication-genes/Thu, 28 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/barking-up-the-right-dog-genomes-sniffing-out-domestication-genes/https://www.newslocker.com/en-au/profession/biotechnology/key-protein-mediating-inflammatory-response-discovered/Thu, 28 Jun 2018 16:06:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/key-protein-mediating-inflammatory-response-discovered/https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-treatment-response-activated-by-skin-disease-immunotherapy/Thu, 28 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-treatment-response-activated-by-skin-disease-immunotherapy/https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-treatment-boosted-by-immunotherapy/Thu, 28 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-treatment-boosted-by-immunotherapy/https://www.newslocker.com/en-au/profession/biotechnology/arsanis-halts-phase-ii-trial-of-pneumonia-candidate-asn100/Thu, 28 Jun 2018 15:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/arsanis-halts-phase-ii-trial-of-pneumonia-candidate-asn100/https://www.newslocker.com/en-au/profession/biotechnology/new-altsubgt2altsubgt-receptor-study-offers-insights-on-memory-loss-associated-with-aging/Thu, 28 Jun 2018 14:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-altsubgt2altsubgt-receptor-study-offers-insights-on-memory-loss-associated-with-aging/https://www.newslocker.com/en-au/profession/biotechnology/new-a2a-receptor-study-offers-insights-on-memory-loss-associated-with-aging/Thu, 28 Jun 2018 14:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-a2a-receptor-study-offers-insights-on-memory-loss-associated-with-aging/ More patients are finding that what they have to pay for prescription drugs is simply unaffordable. That’s why BIO has repeatedly called on policymakers to advance reforms that will help provide all patients affordable access to]]>https://www.newslocker.com/en-au/profession/biotechnology/new-report-offers-distorted-view-of-biopharma-industry/Wed, 27 Jun 2018 17:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-report-offers-distorted-view-of-biopharma-industry/https://www.newslocker.com/en-au/profession/biotechnology/editing-autism-gene-with-nano-crispr-curbs-repetitive-behaviors/Wed, 27 Jun 2018 16:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/editing-autism-gene-with-nano-crispr-curbs-repetitive-behaviors/https://www.newslocker.com/en-au/profession/biotechnology/easy-evolution-accelerates-enzyme-engineering/Wed, 27 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/easy-evolution-accelerates-enzyme-engineering/https://www.newslocker.com/en-au/profession/biotechnology/cancer-cells-resist-dying-through-telomerase-regulation/Wed, 27 Jun 2018 16:16:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-cells-resist-dying-through-telomerase-regulation/https://www.newslocker.com/en-au/profession/biotechnology/summit-plans-cost-cuts-stock-falls-80-after-dmd-candidate-ezutromid-fails-phase-ii-trial/Wed, 27 Jun 2018 16:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/summit-plans-cost-cuts-stock-falls-80-after-dmd-candidate-ezutromid-fails-phase-ii-trial/https://www.newslocker.com/en-au/profession/biotechnology/crispr-gold-treats-mice-with-autism/Wed, 27 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/crispr-gold-treats-mice-with-autism/https://www.newslocker.com/en-au/profession/biotechnology/novel-alcoholism-treatment-modulates-gpcr-activation-may-lessen-withdrawal-symptoms/Wed, 27 Jun 2018 13:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novel-alcoholism-treatment-modulates-gpcr-activation-may-lessen-withdrawal-symptoms/https://www.newslocker.com/en-au/profession/biotechnology/new-approach-shows-promise-in-treatment-of-alcoholism/Wed, 27 Jun 2018 13:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-approach-shows-promise-in-treatment-of-alcoholism/ The ISAAA report shows the global biotech crop area increased in 2017 by 3 percent or 4.7 million hectares or 11.6 million acres; Global economic gains contr]]>https://www.newslocker.com/en-au/profession/biotechnology/as-more-countries-adopt-crop-biotechnology-farm-families-and-the-environment-benefit/Tue, 26 Jun 2018 21:22:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/as-more-countries-adopt-crop-biotechnology-farm-families-and-the-environment-benefit/https://www.newslocker.com/en-au/profession/biotechnology/ge-healthcare-spun-off-as-a-standalone-company/Tue, 26 Jun 2018 16:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ge-healthcare-spun-off-as-a-standalone-company/https://www.newslocker.com/en-au/profession/biotechnology/pill-may-replace-injection-to-deliver-insulin-other-peptide-drugs/Tue, 26 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/pill-may-replace-injection-to-deliver-insulin-other-peptide-drugs/https://www.newslocker.com/en-au/profession/biotechnology/brain-cancer-gets-the-polio-treatment/Tue, 26 Jun 2018 16:07:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/brain-cancer-gets-the-polio-treatment/ That’s why educating consumers about our food is so important. In a new blog post from GMO Answers, GMO Answers Expert professor and farmer Tim Durham addresses some of the top myths and misconceptions abo]]>https://www.newslocker.com/en-au/profession/biotechnology/modern-farming-how-one-scientist-explains-the-evolving-industry/Tue, 26 Jun 2018 15:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/modern-farming-how-one-scientist-explains-the-evolving-industry/https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-diseasendashdown-syndrome-link-is-not-all-about-app/Tue, 26 Jun 2018 15:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-diseasendashdown-syndrome-link-is-not-all-about-app/https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-diseaseampndashdown-syndrome-link-is-not-all-about-app/Tue, 26 Jun 2018 15:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/alzheimers-diseaseampndashdown-syndrome-link-is-not-all-about-app/https://www.newslocker.com/en-au/profession/biotechnology/abbvie-alphabet-backed-calico-extend-aging-collaboration-by-1b-three-years/Tue, 26 Jun 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/abbvie-alphabet-backed-calico-extend-aging-collaboration-by-1b-three-years/https://www.newslocker.com/en-au/profession/biotechnology/team-deciphers-structure-of-tropoelastin-which-imparts-flexibility-to-tissues/Tue, 26 Jun 2018 13:58:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/team-deciphers-structure-of-tropoelastin-which-imparts-flexibility-to-tissues/https://www.newslocker.com/en-au/profession/biotechnology/stretchy-tissue-molecule-decoded/Tue, 26 Jun 2018 13:58:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/stretchy-tissue-molecule-decoded/https://www.newslocker.com/en-au/profession/biotechnology/former-anti-gmo-activist-to-accept-gmos-is-to-accept-science/Mon, 25 Jun 2018 21:26:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/former-anti-gmo-activist-to-accept-gmos-is-to-accept-science/https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-gws-epidolex-as-first-plant-derived-cannabinoid-prescription-drug/Mon, 25 Jun 2018 21:07:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-gws-epidolex-as-first-plant-derived-cannabinoid-prescription-drug/https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-gws-epidiolex-as-first-plant-derived-cannabinoid-prescription-drug/Mon, 25 Jun 2018 21:07:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-approves-gws-epidiolex-as-first-plant-derived-cannabinoid-prescription-drug/https://www.newslocker.com/en-au/profession/biotechnology/path-for-embattled-breast-cancer-drugs-cleared-by-one-protein-inhibitor/Mon, 25 Jun 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/path-for-embattled-breast-cancer-drugs-cleared-by-one-protein-inhibitor/https://www.newslocker.com/en-au/profession/biotechnology/oxygen-starved-cancer-cells-languish-without-aspartate/Mon, 25 Jun 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/oxygen-starved-cancer-cells-languish-without-aspartate/https://www.newslocker.com/en-au/profession/biotechnology/autism-risk-increased-in-offspring-from-mothers-with-diabetes/Mon, 25 Jun 2018 16:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/autism-risk-increased-in-offspring-from-mothers-with-diabetes/https://www.newslocker.com/en-au/profession/biotechnology/merrimack-halts-development-of-pancreatic-cancer-candidate-after-phase-ii-failure/Mon, 25 Jun 2018 15:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/merrimack-halts-development-of-pancreatic-cancer-candidate-after-phase-ii-failure/https://www.newslocker.com/en-au/profession/biotechnology/gut-microbiome-understanding-insight-facilitated-by-new-platform/Mon, 25 Jun 2018 14:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gut-microbiome-understanding-insight-facilitated-by-new-platform/https://www.newslocker.com/en-au/profession/biotechnology/bio-congratulates-2018-george-washington-carver-and-rosalind-franklin-award-recipients/Fri, 22 Jun 2018 17:39:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-congratulates-2018-george-washington-carver-and-rosalind-franklin-award-recipients/https://www.newslocker.com/en-au/profession/biotechnology/genetic-overlap-in-psychiatric-disorders-lots-in-neurological-disorders-not-much/Fri, 22 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genetic-overlap-in-psychiatric-disorders-lots-in-neurological-disorders-not-much/https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-risk-reduced-in-younger-women-with-higher-body-fat/Fri, 22 Jun 2018 16:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-risk-reduced-in-younger-women-with-higher-body-fat/https://www.newslocker.com/en-au/profession/biotechnology/cancer-metastasis-hobbled-by-new-compound/Fri, 22 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/cancer-metastasis-hobbled-by-new-compound/https://www.newslocker.com/en-au/profession/biotechnology/ancient-syphilis-genomes-reconstructed/Fri, 22 Jun 2018 15:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ancient-syphilis-genomes-reconstructed/ “Innovation has been the life blood of this country since its founding,” said Secretary of Commerce Wilbur Ross earlier this week in a press release announcing the 10 millionth patent issued by the United States Patent and Trademark Office (USPTO).
Strong, reliable and enforceable patent laws are the drivers of the biotechnology innovation ecosystem. Without these strong paten]]>https://www.newslocker.com/en-au/profession/biotechnology/a-milestone-for-americas-patent-system/Thu, 21 Jun 2018 22:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/a-milestone-for-americas-patent-system/ Continuing to Deny Coverage
A new study from the University of Pennsylvania (UPenn) School of Medicine finds that insurance denials for hepatitis C drugs among patients with both private and public insurers remains high across the United States. As Dr. Vincent Lo Re III, associate professor of Infectious Disease an]]>https://www.newslocker.com/en-au/profession/biotechnology/insurers-shift-costs-and-facts/Thu, 21 Jun 2018 22:05:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/insurers-shift-costs-and-facts/ That is the question posed by reporters Ly Truong and Claire Press in a recent BBC article “Making food crops that feed themselves.” In an attempt to answer this question, Truong and Press visited Vietnam where rice farming is emblematic of t]]>https://www.newslocker.com/en-au/profession/biotechnology/making-food-crops-that-feed-themselves/Thu, 21 Jun 2018 18:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/making-food-crops-that-feed-themselves/https://www.newslocker.com/en-au/profession/biotechnology/could-alzheimers-be-triggered-by-herpes-virus/Thu, 21 Jun 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/could-alzheimers-be-triggered-by-herpes-virus/https://www.newslocker.com/en-au/profession/biotechnology/fat-cell-suppressor-emerges-from-the-stromal-shadows/Thu, 21 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fat-cell-suppressor-emerges-from-the-stromal-shadows/https://www.newslocker.com/en-au/profession/biotechnology/six-ipos-raising-more-than-a-half-billion-this-week/Thu, 21 Jun 2018 16:34:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/six-ipos-raising-more-than-a-half-billion-this-week/https://www.newslocker.com/en-au/profession/biotechnology/old-tb-vaccine-improves-diabetes-blood-sugar-levels/Thu, 21 Jun 2018 16:08:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/old-tb-vaccine-improves-diabetes-blood-sugar-levels/https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-epigenetics-study-reveals-potential-drug-targets/Wed, 20 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-epigenetics-study-reveals-potential-drug-targets/https://www.newslocker.com/en-au/profession/biotechnology/inherited-pancreatic-cancer-gene-mutations-discovered-in-patients-with-no-family-history/Wed, 20 Jun 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/inherited-pancreatic-cancer-gene-mutations-discovered-in-patients-with-no-family-history/https://www.newslocker.com/en-au/profession/biotechnology/ucal-and-partners-win-us-patent-related-to-crispr-cas9/Wed, 20 Jun 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ucal-and-partners-win-us-patent-related-to-crispr-cas9/https://www.newslocker.com/en-au/profession/biotechnology/rna-seq-identifies-asymptomatic-individuals-who-will-develop-active-tb/Wed, 20 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/rna-seq-identifies-asymptomatic-individuals-who-will-develop-active-tb/https://www.newslocker.com/en-au/profession/biotechnology/two-vaccines-are-better-than-one-for-malaria/Tue, 19 Jun 2018 16:13:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/two-vaccines-are-better-than-one-for-malaria/https://www.newslocker.com/en-au/profession/biotechnology/synthetic-dna-as-easy-as-1-2-3-with-one-and-done-enzymes/Tue, 19 Jun 2018 16:10:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/synthetic-dna-as-easy-as-1-2-3-with-one-and-done-enzymes/https://www.newslocker.com/en-au/profession/biotechnology/novo-nordisk-inks-collab-with-kallyope-for-gutbrain-axis-drug-discovery/Tue, 19 Jun 2018 15:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/novo-nordisk-inks-collab-with-kallyope-for-gutbrain-axis-drug-discovery/https://www.newslocker.com/en-au/profession/biotechnology/aggressive-brain-cancer-can-be-driven-by-tumor-suppressor/Tue, 19 Jun 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aggressive-brain-cancer-can-be-driven-by-tumor-suppressor/ Research into GMO bananas could help save the crop in Africa, where is it a staple in the diet and under attack from d]]>https://www.newslocker.com/en-au/profession/biotechnology/gmos-help-us-combat-global-food-security-and-sustainability-challenges/Tue, 19 Jun 2018 14:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gmos-help-us-combat-global-food-security-and-sustainability-challenges/https://www.newslocker.com/en-au/profession/biotechnology/fda-lifts-clinical-hold-on-solid-biosciences-trial-for-dmd-gene-therapy/Mon, 18 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fda-lifts-clinical-hold-on-solid-biosciences-trial-for-dmd-gene-therapy/https://www.newslocker.com/en-au/profession/biotechnology/optogenetic-hack-advances-synthetic-morphogenesis/Mon, 18 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/optogenetic-hack-advances-synthetic-morphogenesis/https://www.newslocker.com/en-au/profession/biotechnology/when-bacteria-create-the-warhead-for-their-own-destruction/Mon, 18 Jun 2018 16:13:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/when-bacteria-create-the-warhead-for-their-own-destruction/https://www.newslocker.com/en-au/profession/biotechnology/sanofi-agrees-to-transfer-infectious-disease-unit-100-employees-to-evotec/Mon, 18 Jun 2018 16:07:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sanofi-agrees-to-transfer-infectious-disease-unit-100-employees-to-evotec/https://www.newslocker.com/en-au/profession/biotechnology/microbiome-contributes-to-obesity-related-depression-and-anxiety-in-mice/Mon, 18 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/microbiome-contributes-to-obesity-related-depression-and-anxiety-in-mice/ But it’s not just the pursuit of the next breakthrough medicine or technology that our industry is focused on – we’re looking for the next brilliant scientist or savvy entrepreneur to help bring these cures across t]]>https://www.newslocker.com/en-au/profession/biotechnology/future-leaders-in-biotechnology/Mon, 18 Jun 2018 14:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/future-leaders-in-biotechnology/https://www.newslocker.com/en-au/profession/biotechnology/microbiome-lax-may-relieve-constipation/Fri, 15 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/microbiome-lax-may-relieve-constipation/https://www.newslocker.com/en-au/profession/biotechnology/aggressive-lymphoma-linked-with-jak-inhibitor-use/Fri, 15 Jun 2018 16:29:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/aggressive-lymphoma-linked-with-jak-inhibitor-use/https://www.newslocker.com/en-au/profession/biotechnology/teva-halts-phase-iii-trial-of-fremanezumab-in-chronic-cluster-headaches/Fri, 15 Jun 2018 15:57:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/teva-halts-phase-iii-trial-of-fremanezumab-in-chronic-cluster-headaches/ However, just like there are some outliers in the “world is r]]>https://www.newslocker.com/en-au/profession/biotechnology/always-follow-the-science-neurologica-blog-advises/Fri, 15 Jun 2018 15:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/always-follow-the-science-neurologica-blog-advises/https://www.newslocker.com/en-au/profession/biotechnology/gene-expression-map-created-of-cells-in-aging-brain/Fri, 15 Jun 2018 14:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/gene-expression-map-created-of-cells-in-aging-brain/https://www.newslocker.com/en-au/profession/biotechnology/sex-determination-for-males-hinges-on-gene-enhancer/Fri, 15 Jun 2018 13:24:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sex-determination-for-males-hinges-on-gene-enhancer/https://www.newslocker.com/en-au/profession/biotechnology/key-enhancer-of-gene-critical-for-male-sex-development-identified/Fri, 15 Jun 2018 13:24:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/key-enhancer-of-gene-critical-for-male-sex-development-identified/ BIO shares Senator Hatch’s view that the unintended consequences created by the America Invents Act add unproductive litigation pressure on innovators and disrupt the balanced procedures that have historically made the Hatch-Waxman Act a success.
Read the full remarks, as prepared for de]]>https://www.newslocker.com/en-au/profession/biotechnology/senator-hatch-calls-out-ipr-flaws/Thu, 14 Jun 2018 22:48:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/senator-hatch-calls-out-ipr-flaws/https://www.newslocker.com/en-au/profession/biotechnology/new-prostate-cancer-subtype-identified-responsive-to-immunotherapy/Thu, 14 Jun 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-prostate-cancer-subtype-identified-responsive-to-immunotherapy/https://www.newslocker.com/en-au/profession/biotechnology/probiotic-live-vaccine-both-curb-cholera/Thu, 14 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/probiotic-live-vaccine-both-curb-cholera/https://www.newslocker.com/en-au/profession/biotechnology/shionogi-sage-to-partner-on-developing-depression-drug-in-three-asian-markets/Thu, 14 Jun 2018 15:25:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/shionogi-sage-to-partner-on-developing-depression-drug-in-three-asian-markets/https://www.newslocker.com/en-au/profession/biotechnology/exosomes-shown-to-be-involved-in-spread-of-amyloid-beta-in-alzheimers/Thu, 14 Jun 2018 14:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/exosomes-shown-to-be-involved-in-spread-of-amyloid-beta-in-alzheimers/https://www.newslocker.com/en-au/profession/biotechnology/melanoma-immunotherapy-most-effective-in-older-patients/Wed, 13 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/melanoma-immunotherapy-most-effective-in-older-patients/https://www.newslocker.com/en-au/profession/biotechnology/early-dementia-detected-in-hypertensive-patients-using-mri/Wed, 13 Jun 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/early-dementia-detected-in-hypertensive-patients-using-mri/https://www.newslocker.com/en-au/profession/biotechnology/flex-pharma-axes-60-of-workforce-explores-sale-after-halting-phase-ii-trials-in-als-cmt/Wed, 13 Jun 2018 15:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/flex-pharma-axes-60-of-workforce-explores-sale-after-halting-phase-ii-trials-in-als-cmt/https://www.newslocker.com/en-au/profession/biotechnology/greenwood-comment-on-pabnab/Wed, 13 Jun 2018 15:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/greenwood-comment-on-pabnab/https://www.newslocker.com/en-au/profession/biotechnology/testicular-cancer-mapped-genomically-and-epigenomically/Wed, 13 Jun 2018 14:52:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/testicular-cancer-mapped-genomically-and-epigenomically/https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-protein-transition-provides-insight-into-disease-progression/Wed, 13 Jun 2018 14:01:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/parkinsons-protein-transition-provides-insight-into-disease-progression/https://www.newslocker.com/en-au/profession/biotechnology/could-psychedelic-drugs-treat-depression-and-anxiety/Tue, 12 Jun 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/could-psychedelic-drugs-treat-depression-and-anxiety/https://www.newslocker.com/en-au/profession/biotechnology/addicted-to-aggression-brain-protein-may-hold-the-answer/Tue, 12 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/addicted-to-aggression-brain-protein-may-hold-the-answer/https://www.newslocker.com/en-au/profession/biotechnology/sartorius-inks-automation-cooperation-agreement-with-siemens/Tue, 12 Jun 2018 16:09:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sartorius-inks-automation-cooperation-agreement-with-siemens/https://www.newslocker.com/en-au/profession/biotechnology/immunotherapy-biomarker-predicts-lung-cancer-response-and-survival/Tue, 12 Jun 2018 16:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/immunotherapy-biomarker-predicts-lung-cancer-response-and-survival/https://www.newslocker.com/en-au/profession/biotechnology/outlook-for-biopharma-mampa-remains-bullish-into-2019/Tue, 12 Jun 2018 14:33:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/outlook-for-biopharma-mampa-remains-bullish-into-2019/https://www.newslocker.com/en-au/profession/biotechnology/nasal-brush-identifies-genetic-biomarker-of-asthma/Tue, 12 Jun 2018 14:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nasal-brush-identifies-genetic-biomarker-of-asthma/https://www.newslocker.com/en-au/profession/biotechnology/surgery-in-a-pill-developed-to-mimic-benefits-of-bariatric-surgery-on-type-2-diabetes/Mon, 11 Jun 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/surgery-in-a-pill-developed-to-mimic-benefits-of-bariatric-surgery-on-type-2-diabetes/https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-risk-prediction-improved-by-dna-test-sensitive-to-new-gene-variants/Mon, 11 Jun 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/prostate-cancer-risk-prediction-improved-by-dna-test-sensitive-to-new-gene-variants/https://www.newslocker.com/en-au/profession/biotechnology/vical-halts-development-of-hsv-2-vaccine-after-phase-ii-failure/Mon, 11 Jun 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/vical-halts-development-of-hsv-2-vaccine-after-phase-ii-failure/https://www.newslocker.com/en-au/profession/biotechnology/sanofi-pasteur-translate-bio-launch-mrna-vaccine-partnership/Mon, 11 Jun 2018 15:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/sanofi-pasteur-translate-bio-launch-mrna-vaccine-partnership/https://www.newslocker.com/en-au/profession/biotechnology/false-negative-test-results-put-severe-influenza-patients-at-serious-risk/Mon, 11 Jun 2018 14:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/false-negative-test-results-put-severe-influenza-patients-at-serious-risk/https://www.newslocker.com/en-au/profession/biotechnology/instantaneous-single-cell-transcriptome-visualization/Mon, 11 Jun 2018 13:56:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/instantaneous-single-cell-transcriptome-visualization/https://www.newslocker.com/en-au/profession/biotechnology/synthego-launches-engineered-cells-product-portfolio/Fri, 08 Jun 2018 21:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/synthego-launches-engineered-cells-product-portfolio/https://www.newslocker.com/en-au/profession/biotechnology/ape-genomes-assembled-without-human-fillers/Fri, 08 Jun 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/ape-genomes-assembled-without-human-fillers/https://www.newslocker.com/en-au/profession/biotechnology/xiangxue-pharmaceutical-purchases-flexfactory-from-ge-healthcare/Fri, 08 Jun 2018 16:23:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/xiangxue-pharmaceutical-purchases-flexfactory-from-ge-healthcare/https://www.newslocker.com/en-au/profession/biotechnology/off-the-shelf-genome-engineering/Fri, 08 Jun 2018 16:13:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/off-the-shelf-genome-engineering/https://www.newslocker.com/en-au/profession/biotechnology/blood-tests-developed-that-identify-women-at-risk-of-preterm-birth/Fri, 08 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/blood-tests-developed-that-identify-women-at-risk-of-preterm-birth/https://www.newslocker.com/en-au/profession/biotechnology/fujifilm-diosynth-opens-cambridge-ma-collaboration-center/Fri, 08 Jun 2018 15:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/fujifilm-diosynth-opens-cambridge-ma-collaboration-center/https://www.newslocker.com/en-au/profession/biotechnology/tumor-biology-study-suggests-promising-new-route-to-cancer-drug-development/Fri, 08 Jun 2018 15:18:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/tumor-biology-study-suggests-promising-new-route-to-cancer-drug-development/ What a history-making week in Boston! A whopping 18,289 U.S. and international attendees – the most in the last 10 years – joined us in the epicenter of the biotechnology industry for four days of inspiring programming, 46, 916 partnering meetings (setting a new Guinness World Record for &ldqu]]>https://www.newslocker.com/en-au/profession/biotechnology/bio2018-makes-history-in-boston/Thu, 07 Jun 2018 22:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio2018-makes-history-in-boston/https://www.newslocker.com/en-au/profession/biotechnology/heralding-in-a-new-era-of-precision-medicine/Thu, 07 Jun 2018 21:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/heralding-in-a-new-era-of-precision-medicine/https://www.newslocker.com/en-au/profession/biotechnology/defining-and-communicating-value/Thu, 07 Jun 2018 20:31:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/defining-and-communicating-value/ These remarkable tools have revolutionized how we interact with the world around us and are beginning to profoundly impact the fields of life sciences and healthcare.
A panel discussion held yesterday at the 2018 BIO International Convention, entitled What Role Will You Play in the Digital Revolution? s]]>https://www.newslocker.com/en-au/profession/biotechnology/navigating-healthcares-role-in-the-digital-revolution/Thu, 07 Jun 2018 20:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/navigating-healthcares-role-in-the-digital-revolution/https://www.newslocker.com/en-au/profession/biotechnology/better-understanding-the-patient-voice-at-bio-2018/Thu, 07 Jun 2018 20:17:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/better-understanding-the-patient-voice-at-bio-2018/ Glen Govannetti, global]]>https://www.newslocker.com/en-au/profession/biotechnology/biotech-leaders-talk-deal-making-and-state-of-the-industry/Thu, 07 Jun 2018 19:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biotech-leaders-talk-deal-making-and-state-of-the-industry/https://www.newslocker.com/en-au/profession/biotechnology/scouring-the-genome-for-autism-insights/Thu, 07 Jun 2018 19:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/scouring-the-genome-for-autism-insights/https://www.newslocker.com/en-au/profession/biotechnology/real-opportunity-to-boost-diversity-in-biotech/Thu, 07 Jun 2018 17:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/real-opportunity-to-boost-diversity-in-biotech/https://www.newslocker.com/en-au/profession/biotechnology/understanding-the-patient-voice-unique-perspectives-on-healthcare/Thu, 07 Jun 2018 17:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/understanding-the-patient-voice-unique-perspectives-on-healthcare/https://www.newslocker.com/en-au/profession/biotechnology/probiotic-shot-may-alleviate-brain-stress/Thu, 07 Jun 2018 16:41:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/probiotic-shot-may-alleviate-brain-stress/https://www.newslocker.com/en-au/profession/biotechnology/colon-stem-cells-rely-on-this-repair-signal-but-it-can-go-awry/Thu, 07 Jun 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/colon-stem-cells-rely-on-this-repair-signal-but-it-can-go-awry/ Just as genome editing is a groundbreaking technology with the potential to treat and cure human disease, the applications of genome editing for food, agriculture and animal welfare are at the forefront of tomorrow’s modern agricultural system.
The BIO 2018 Convention session, “Advances in Genome Editing: The Next Frontier in Agriculture” looked at the many ways this te]]>https://www.newslocker.com/en-au/profession/biotechnology/how-is-genome-editing-revolutionizing-agriculture/Thu, 07 Jun 2018 16:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/how-is-genome-editing-revolutionizing-agriculture/https://www.newslocker.com/en-au/profession/biotechnology/breathing-paralysis-improved-through-transplantation-of-lab-grown-neurons/Thu, 07 Jun 2018 16:12:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/breathing-paralysis-improved-through-transplantation-of-lab-grown-neurons/ It was with applause and admiration that BIO presented the BIO Lifetime Champion Award to South Dakota Governor Dennis Daugaard. Last night, on June 5, 2018, Governor Daugaard was recognized for his 22 years of dedication to South Dakota and to helping biotech innovation thrive.
BIO President and CEO, Jim Greenwood, spoke on how Governor Daugaard, throughout his 22 years in office, signed forth legislation that helped grow and diversify the bio]]>https://www.newslocker.com/en-au/profession/biotechnology/bio-presents-governor-dennis-daugaard-with-the-bio-lifetime-champion-award/Thu, 07 Jun 2018 15:51:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-presents-governor-dennis-daugaard-with-the-bio-lifetime-champion-award/https://www.newslocker.com/en-au/profession/biotechnology/biogen-buys-option-to-tms-phase-ii-stroke-candidate/Thu, 07 Jun 2018 15:43:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biogen-buys-option-to-tms-phase-ii-stroke-candidate/https://www.newslocker.com/en-au/profession/biotechnology/studies-demonstrate-potential-use-of-bacteria-to-prevent-stress-related-disorders/Thu, 07 Jun 2018 15:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/studies-demonstrate-potential-use-of-bacteria-to-prevent-stress-related-disorders/https://www.newslocker.com/en-au/profession/biotechnology/new-thermo-fisher-center-offers-access-to-precision-medicine-technologies-expertise/Thu, 07 Jun 2018 14:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-thermo-fisher-center-offers-access-to-precision-medicine-technologies-expertise/https://www.newslocker.com/en-au/profession/biotechnology/antibody-offers-new-approach-to-treating-inflammatory-diseases/Thu, 07 Jun 2018 13:53:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/antibody-offers-new-approach-to-treating-inflammatory-diseases/https://www.newslocker.com/en-au/profession/biotechnology/epigenetic-hierarchies-may-be-topped-by-tissue-specific-pioneer-factors/Wed, 06 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/epigenetic-hierarchies-may-be-topped-by-tissue-specific-pioneer-factors/https://www.newslocker.com/en-au/profession/biotechnology/artificial-human-prions-created-in-the-lab/Wed, 06 Jun 2018 16:19:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/artificial-human-prions-created-in-the-lab/https://www.newslocker.com/en-au/profession/biotechnology/genentech-microbiotica-to-develop-microbiome-based-ibd-treatments/Wed, 06 Jun 2018 15:55:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genentech-microbiotica-to-develop-microbiome-based-ibd-treatments/https://www.newslocker.com/en-au/profession/biotechnology/targeting-cilia-could-offer-universal-approach-to-combat-anticancer-drug-resistance/Wed, 06 Jun 2018 15:47:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/targeting-cilia-could-offer-universal-approach-to-combat-anticancer-drug-resistance/https://www.newslocker.com/en-au/profession/biotechnology/human-glutamine-transporter-study-may-generate-leads-for-drug-development/Wed, 06 Jun 2018 13:50:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/human-glutamine-transporter-study-may-generate-leads-for-drug-development/https://www.newslocker.com/en-au/profession/biotechnology/dog-germs-diversify-may-threaten-humans-with-flu-pandemics/Tue, 05 Jun 2018 16:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/dog-germs-diversify-may-threaten-humans-with-flu-pandemics/https://www.newslocker.com/en-au/profession/biotechnology/speeding-drug-development-with-clinical-trials-in-a-dish/Tue, 05 Jun 2018 16:14:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/speeding-drug-development-with-clinical-trials-in-a-dish/https://www.newslocker.com/en-au/profession/biotechnology/artificial-bone-marrow-supports-blood-stem-cells-for-disease-modelling-and-drug-discovery/Tue, 05 Jun 2018 16:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/artificial-bone-marrow-supports-blood-stem-cells-for-disease-modelling-and-drug-discovery/https://www.newslocker.com/en-au/profession/biotechnology/genetic-engineering-and-directed-evolution-improve-stability-of-therapeutic-proteins/Tue, 05 Jun 2018 14:37:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/genetic-engineering-and-directed-evolution-improve-stability-of-therapeutic-proteins/https://www.newslocker.com/en-au/profession/biotechnology/bio-2018-depression-pain-drug-developers-starve-for-dollars-as-cancer-companies-feast/Tue, 05 Jun 2018 14:36:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/bio-2018-depression-pain-drug-developers-starve-for-dollars-as-cancer-companies-feast/ This afternoon USPTO Director Andrei Iancu delivered remarks at the BIO International Convention’s Intellectual Property Track opening plenary. During the well-attended session, Director Iancu addressed a key policy priority for BIO – reform within the Patent Trial and Appeal Board (PTAB).
Last month, t]]>https://www.newslocker.com/en-au/profession/biotechnology/director-of-uspto-addressed-intellectual-property-track-opening-plenary/Mon, 04 Jun 2018 23:02:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/director-of-uspto-addressed-intellectual-property-track-opening-plenary/https://www.newslocker.com/en-au/profession/biotechnology/new-study-shows-strong-interest-in-china-partnerships/Mon, 04 Jun 2018 20:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-study-shows-strong-interest-in-china-partnerships/https://www.newslocker.com/en-au/profession/biotechnology/biogeneius-award-tomorrows-life-science-leaders/Mon, 04 Jun 2018 17:21:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/biogeneius-award-tomorrows-life-science-leaders/https://www.newslocker.com/en-au/profession/biotechnology/green-tea-compound-dissolves-plaques-in-blood-vessels-may-boost-heart-health/Mon, 04 Jun 2018 16:35:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/green-tea-compound-dissolves-plaques-in-blood-vessels-may-boost-heart-health/https://www.newslocker.com/en-au/profession/biotechnology/early-detection-of-lung-cancer-shows-promise-in-liquid-biopsy-study/Mon, 04 Jun 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/early-detection-of-lung-cancer-shows-promise-in-liquid-biopsy-study/https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-genetic-test-may-help-women-forgo-chemotherapy/Mon, 04 Jun 2018 15:11:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/breast-cancer-genetic-test-may-help-women-forgo-chemotherapy/https://www.newslocker.com/en-au/profession/biotechnology/new-egg-tumor-model-developed-to-study-cancer/Mon, 04 Jun 2018 14:20:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/new-egg-tumor-model-developed-to-study-cancer/ Expected to bring at least 16,500 people together for partnering, education, collaboration and networking, this Convention will let you get done in four days what would have taken a]]>https://www.newslocker.com/en-au/profession/biotechnology/countdown-to-bio-2018-blastoff/Mon, 04 Jun 2018 13:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/countdown-to-bio-2018-blastoff/ At Food, Health and Environmental Future Day, BIO will also be hosting a]]>https://www.newslocker.com/en-au/profession/biotechnology/addressing-food-innovation-across-the-value-chain-at-convention/Fri, 01 Jun 2018 21:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/addressing-food-innovation-across-the-value-chain-at-convention/https://www.newslocker.com/en-au/profession/biotechnology/six-tips-to-evaluating-that-exciting-science-article-you-just-read/Fri, 01 Jun 2018 20:28:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/six-tips-to-evaluating-that-exciting-science-article-you-just-read/ One of NORD’s greates]]>https://www.newslocker.com/en-au/profession/biotechnology/nord-and-the-orphan-drug-act-celebrate-35-years-driving-rare-disease-advocacy-research-and-innovation/Fri, 01 Jun 2018 20:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/nord-and-the-orphan-drug-act-celebrate-35-years-driving-rare-disease-advocacy-research-and-innovation/https://www.newslocker.com/en-au/profession/biotechnology/microbiome-herbal-medicine-and-probiotics-combine-to-extend-lifespan/Fri, 01 Jun 2018 16:46:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/microbiome-herbal-medicine-and-probiotics-combine-to-extend-lifespan/https://www.newslocker.com/en-au/profession/biotechnology/humans-big-brains-may-be-partly-due-to-three-newly-found-genes/Fri, 01 Jun 2018 16:45:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/humans-big-brains-may-be-partly-due-to-three-newly-found-genes/https://www.newslocker.com/en-au/profession/biotechnology/roche-halts-development-of-sma-candidate-olexosime/Fri, 01 Jun 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/roche-halts-development-of-sma-candidate-olexosime/https://www.newslocker.com/en-au/profession/biotechnology/roche-halts-development-of-sma-candidate-olesoxime/Fri, 01 Jun 2018 16:40:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/roche-halts-development-of-sma-candidate-olesoxime/ Carl Feldbaum was a law student of Arlen Specter at University of Pennsylvania Law School in the 1960s. When Specter became Philadelphia’s district attorney, he hired Feldbaum as an assistant DA. When Pennsylvanians elected Specter to be their U.S. Senator in 1980, he hired and promoted his former law student to the position of chief of staff.
Feldbaum had been the top staffer of one of Washington’s key deal]]>https://www.newslocker.com/en-au/profession/biotechnology/countdown-to-bio2018-one-days-to-go/Fri, 01 Jun 2018 16:39:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/countdown-to-bio2018-one-days-to-go/ Carl Feldbaum was a law student of Arlen Specter at University of Pennsylvania Law School in the 1960s. When Specter became Philadelphia’s district attorney, he hired Feldbaum as an assistant DA. When Pennsylvanians elected Specter to be their U.S. Senator in 1980, he hired and promoted his former law student to the position of chief of staff.
Feldbaum had been the top staffer of one of Washington’s key deal]]>https://www.newslocker.com/en-au/profession/biotechnology/countdown-to-bio2018-one-day-to-go/Fri, 01 Jun 2018 16:39:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/countdown-to-bio2018-one-day-to-go/https://www.newslocker.com/en-au/profession/biotechnology/regeneration-of-dental-enamel-possible-using-new-approach/Fri, 01 Jun 2018 16:15:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/regeneration-of-dental-enamel-possible-using-new-approach/https://www.newslocker.com/en-au/profession/biotechnology/amgen-md-anderson-launch-two-cancer-collaborations/Fri, 01 Jun 2018 15:44:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/amgen-md-anderson-launch-two-cancer-collaborations/ Secretary Azar speaking at]]>https://www.newslocker.com/en-au/profession/biotechnology/hhs-secretary-azar-calls-for-strengthened-global-health-through-innovation/Fri, 01 Jun 2018 14:30:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/hhs-secretary-azar-calls-for-strengthened-global-health-through-innovation/https://www.newslocker.com/en-au/profession/biotechnology/artificial-sensory-nerves-may-one-day-provide-prosthetic-limbs-with-sense-of-touch/Fri, 01 Jun 2018 14:03:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/artificial-sensory-nerves-may-one-day-provide-prosthetic-limbs-with-sense-of-touch/ This week, Informa Agribusiness Consulting Group (Informa) released the report The Impact of Delays in Chinese Approvals of Biotech Crops, quantifying the economi]]>https://www.newslocker.com/en-au/profession/biotechnology/informa-agribusiness-systematic-change-needed-for-us-china-and-the-world-to-benefit-from-biotech-innovation/Thu, 31 May 2018 23:04:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/informa-agribusiness-systematic-change-needed-for-us-china-and-the-world-to-benefit-from-biotech-innovation/https://www.newslocker.com/en-au/profession/biotechnology/baking-soda-may-clean-cancers-circadian-clock/Thu, 31 May 2018 17:00:00 +0200https://www.newslocker.com/en-au/profession/biotechnology/baking-soda-may-clean-cancers-circadian-clock/